Novel E3 ubiquitin ligase ligand, protein degradation agent and application thereof

CN118946561APending Publication Date: 2024-11-12GLUETACS THERAPEUTICS (SHANGHAI) CO LTD
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202480000889.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-03-10
Filing Date
2024-03-11
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing CRBN E3 ubiquitin ligase ligands suffer from poor solubility and weak binding force, making it difficult to effectively design bifunctional protein degraders for different targets, and molecular gel degraders have deficiencies in pharmacokinetics and selectivity. .

Method used

Develop novel CRBN E3 ubiquitin ligase ligands with stronger CRBN binding capacity and druggability, and design them as bifunctional protein degraders that can specifically bind to target proteins, label and degrade target proteins through ubiquitination, Improve pharmacological activity.

Benefits of technology

It achieves efficient degradation of different targets, improves pharmacokinetic properties and pharmacological activity, enhances selectivity for pathogenic proteins, and provides better potential for treating and preventing diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118946561A_ABST
    Figure CN118946561A_ABST
Patent Text Reader

Abstract

The present disclosure relates to compounds of Formula (I) and Formula (II) or salts, enantiomers, stereoisomers, solvates, isotope enriched analogs, prodrugs or polymorphs thereof, and uses thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds of formula (I) or salts, enantiomers, stereoisomers, solvates, isotope enriched analogs, prodrugs or polymorphs thereof as active ingredients and uses thereof. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Novel E3 ubiquitin ligase ligands, protein degrading agents and their applications Technical Field

[0001] This disclosure relates to protein-degrading compounds of formula (I), cerebellar protein (CRBN) E3 ubiquitin ligase ligand compounds of formula (II), and their applications. The protein-degrading compounds of formula (I) can effectively treat or prevent diseases or conditions related to the degraded protein. The CRBN E3 ubiquitin ligase ligand compounds of formula (II) can bind to CRBN E3 ligase and are used to prepare the protein-degrading compounds of formula (I). Background Technology

[0002] Bifunctional protein degradation targeted drugs consist of three parts: a ligand head that binds to a specific target protein at one end, a small molecule ligand of E3 ubiquitin ligase at the other end, and these two parts are connected by linking units of different lengths and types in the middle. Bifunctional protein degradation small molecule compounds can utilize the binding interaction of the two ligands to simultaneously bind to a specific target protein and E3 ubiquitin ligase, thereby recruiting the E3 ubiquitin ligase to the vicinity of the specific target protein and enabling the E3 ubiquitin ligase to ubiquitinate the target protein. The target protein, after multiple ubiquitination, is recognized and degraded by the proteasome in the body. The biggest difference between protein degradation targeted drugs and traditional inhibitory small molecule drugs is that they mobilize the entire cell as a drug effector unit. This drug action mode only requires the small molecule drug to bind briefly to the target protein, tagged with "needs to be cleared," thus low drug concentrations are sufficient, greatly reducing the risk of off-target effects and potentially eliminating tumor progression caused by abnormal expression of driver genes and drug resistance caused by acquired mutations in driver genes.

[0003] E3 ubiquitin ligases involved in the design of targeted drugs for protein degradation include more than 600 different proteins, but only a few have been successfully applied in the research of degradative agents. Cereblon (CRBN) E3 ubiquitin ligase is one of the most widely used E3 ubiquitin ligases. Currently known CRBN-type E3 ubiquitin ligase ligands (CRBN ligands) include thalidomide and its analogues lenalidomide and pomalidomide, all of which have a phthalimide backbone. Currently clinically advanced drugs such as ARV-110 (targeting AR), ARV-471 (targeting ER), NX-2127 (targeting BTK), and FHD-609 (targeting BRD9) are all bifunctional protein degradative agents designed using phthalimide-based CRBN ligands. However, these ligands have problems such as poor solubility and weak CRBN binding force. Therefore, there is an urgent need to develop a series of novel CRBN ligands with high CRBN binding force and drug-like properties to design and synthesize corresponding bifunctional protein degraders for different targets, so as to treat and / or prevent target protein-mediated or related diseases or conditions.

[0004] Furthermore, after lithiamine-based CRBN E3 ubiquitin ligase ligands bind to CRBN, they themselves can act as molecular glues to induce CRBN to recognize new substrate proteins, leading to their ubiquitination and degradation, thereby producing pharmacological effects including antitumor and immunomodulatory effects. Molecular glue degraders directly target and degrade target proteins, offering potential advantages such as targeting "undruggable" targets. Moreover, molecular glue degraders typically have small molecular weights and good drug-like properties, making the development of such drugs highly valued. In addition to marketed lithiamine drugs, a series of molecular glue compounds based on CRBN E3 ubiquitin ligases have been developed, such as Bristol-Myers Squibb's (BMS) CC-122, CC-220, CC-90009, CC-99282, and CC-92480, which are currently undergoing clinical trials; Novartis' DKY709; and C4 Therapeutics' CFT7455. The degradation substrates of these molecular gels have expanded from the initially discovered transcription factors IKZF1 / 3 to casein kinase 1α (CK1α), zinc finger protein 91 (ZFP91), and translation factor GSPT1, etc. The degradation of these substrate proteins enables the molecular gels to exert immunomodulatory, anti-inflammatory, and anti-tumor pharmacological activities in different indications.

[0005] In summary, CRBN ligands can be used as part of bifunctional protein-degrading drugs to achieve effective degradation of specific pathogenic proteins, and they can also act as molecular glue degraders to induce the degradation of different substrate proteins. Therefore, the design of diversified scaffolds, the development of more novel druggable CRBN ligands, and their application in the development of bifunctional protein-degrading agents have become research hotspots in this field.

[0006] Invention Overview

[0007] In view of the above, the purpose of this disclosure is to provide novel small molecule ligands for E3 ubiquitin ligases, bifunctional protein degraders designed based on novel small molecule ligands for E3 ubiquitin ligases and various target protein ligands, their uses, and their methods of use. The E3 ligands provided herein possess stronger CRBN binding affinity and druggability, and their activity as molecular colloids in inducing substrate protein degradation is stronger and / or more selective. Based on the E3 ligands provided herein, bifunctional degraders designed for different targets exhibit stronger degradation / inhibition effects and favorable pharmacokinetic properties against various pathogenic protein classes or families, thereby generating broad pharmacological activity.

[0008] To achieve the above and other related objectives, in one aspect, this disclosure provides a novel CRBN E3 ubiquitin ligase ligand that can serve as a molecular gel-bound CRBN E3 ligase. The novel E3 ubiquitin ligase ligand of this disclosure possesses CRBN binding affinity, exhibits antitumor activity, and can further be applied to bifunctional degradation of small molecules.

[0009] In some embodiments, the novel E3 ubiquitin ligase ligand of this disclosure may be a compound of formula (II) or a salt thereof, a stereoisomer (including enantiomers), a solvate, an isotope-enriched analog, a prodrug, or a polymorph:

[0010] in

[0011] A represents N or CH;

[0012] R a1 R a2 R a3 and R a4 The same or different and each independently represents hydrogen, deuterium, halogen, and carbon. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, deuterated C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0013] Ring W 1 The ring W represents a heteroaryl group. 1 Optionally, it can be divided into m R a5 Replace, each R a5 The same or different and each independently represents halogen, hydroxyl, mercapto, nitro, amino, cyano, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 alkenyl, or C 2-6 alkynyl group;

[0014] m represents an integer 0, 1, 2, 3, or 4;

[0015] X indicates a key or -R b1 -N(R a6 )-R b2 -, where R a6 Indicates hydrogen or C 1-6 Alkyl groups, and R b1 and R b2 Each independently represents an optional substitution of C. 0-2 Alkylene;

[0016] LIN represents an optional substituted methylene group, or an optional substituted straight-chain or branched C group. 2-15 Alkylene, wherein the straight-chain or branched C 2-15 One or more pairs of adjacent carbon atoms in the main carbon chain skeleton of an alkylene group may optionally be interrupted by one or more groups selected from the following: R a R b And any combination thereof, each group R a Each is independently selected from O, C(O), OC(O), S, S(O), S(O)2, and S(O)2N(R). a7 ), N(R a7 S(O)2、C(O)N(R) a7 ), N(R a7 C(O), N(R) a7 ) and N(R a7 )C(O)N(R a7 ), where each R a7 Each can be represented independently as H or C. 1-3 Alkyl groups, and when the straight-chain or branched C... 2-30 Two or more R groups are inserted into the main carbon chain backbone of the alkylene group. a At that time, each group R a They are not directly connected to each other; each group R b Each is independently selected from optionally substituted cycloalkylene, optionally substituted arylene, optionally substituted heterocyclic, optionally substituted heteroaryl, ynylene, alkenylene, and any combination thereof; and

[0017] R w It represents hydrogen, deuterium, leaving group, halogen, hydroxyl, COOH, NH2, N3, CHO, methanesulfonyloxy, trifluoromethanesulfonyloxy, or p-toluenesulfonyloxy.

[0018] On the other hand, the protein degradation molecules designed based on novel E3 ubiquitin ligase ligands and various target protein ligands disclosed herein can be compounds of formula (I) or their salts, stereoisomers (including enantiomers), solvates, isotope-enriched analogs, prodrugs, or polymorphs: PBM-LIN-ULM Formula (I)

[0019] PBM represents the target portion of a protein that can bind to it, and PBM is covalently linked to ULM via the LIN group;

[0020] ULM represents the ligand moiety capable of binding to E3 ubiquitin ligases, and is represented by the following formula (ULM):

[0021] in

[0022] A represents N or CH;

[0023] R a1 R a2 R a3 and R a4 The same or different and each independently represents hydrogen, deuterium, halogen, and carbon. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, deuterated C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0024] Ring W 1 The ring W represents a aryl or heteroaryl group. 1 Optionally, it can be divided into m R a5 Replace, each R a5 The same or different and each independently represents halogen, hydroxyl, mercapto, nitro, amino, cyano, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 alkenyl, or C 2-6 alkynyl group;

[0025] m represents an integer 0, 1, 2, 3, or 4;

[0026] X indicates a key or -R b1 -N(R a6 )-R b2 -, where R a6 Indicates hydrogen or C 1-6 Alkyl groups, and R b1and R b2 Each independently represents an optional substitution of C. 0-2 Alkylene;

[0027] LIN stands for linker, representing a bond, an optional substituted methylene group, or an optional substituted straight or branched C-chain. 2-15 Alkylene, wherein the straight-chain or branched C 2-15 One or more pairs of adjacent carbon atoms in the main carbon chain skeleton of an alkylene group may optionally be interrupted by one or more groups selected from the following: R a R b And any combination thereof, each group R a Each is independently selected from O, C(O), OC(O), S, S(O), S(O)2, and S(O)2N(R). a7 ), N(R a7 S(O)2、C(O)N(R) a7 ), N(R a7 C(O), N(R) a7 ) and N(R a7 )C(O)N(R a7 ), where each R a7 Each can be represented independently as H or C. 1-3 Alkyl groups, and when the straight-chain or branched C 2-30 Two or more R groups are inserted into the main carbon chain backbone of the alkylene group. a At that time, each group R a They are not directly connected to each other; each group R b Each is independently selected from optionally substituted cycloalkylene, optionally substituted arylene, optionally substituted heterocyclic, optionally substituted heteroaryl, alkynylene, alkenylene, and any combination thereof.

[0028] In another aspect, this disclosure provides a pharmaceutical composition comprising a compound of formula (I) or a salt thereof, a stereoisomer (including enantiomers), a solvate, an isotope-enriched analog, a prodrug or polymorph, and at least one pharmaceutically acceptable carrier.

[0029] In another aspect, this disclosure also provides a kit or reagent kit containing a compound of formula (I) or a pharmaceutically acceptable salt thereof or a pharmaceutical composition containing the same.

[0030] On the other hand, this disclosure provides a compound of formula (I) or a salt thereof, stereoisomer (including enantiomers), solvate, isotope-enriched analog, prodrug or polymorph, or a pharmaceutical composition containing such compound as an active ingredient, which is used as a medicament.

[0031] On the other hand, the compounds of formula (I) provided in this disclosure, or their salts, stereoisomers (including enantiomers), solvates, isotope-enriched analogs, prodrugs or polymorphs, or pharmaceutical compositions containing them as active ingredients, may be used to treat and / or prevent diseases or conditions selected from: tumors, infectious diseases, autoinflammatory diseases, inflammatory diseases, autoimmune diseases, neurological diseases, respiratory diseases, anemia, hemorrhagic shock, transplant rejection, multiple organ dysfunction syndrome (MODS), sarcoidosis, adult respiratory distress syndrome, Onvelicht syndrome, Richter syndrome (RS), acute liver failure, diabetes, Kennedy disease, seborrheic alopecia, hirsutism, skin diseases, cardiovascular diseases, dysfunctional uterine bleeding, anemia, childhood aplastic anemia, endometriosis, transplant rejection, polycystic ovary syndrome, or thyroid diseases.

[0032] In another aspect, this disclosure also provides a method for treating or preventing a disease or condition in a subject, the method comprising administering to the subject a therapeutically effective amount of a compound of formula (I) or a salt thereof, enantiomer, stereoisomer, solvate, isotope-enriched analog, prodrug, or polymorph, or a pharmaceutical composition comprising the thereof, wherein the disease or condition includes tumors, infectious diseases, autoinflammatory diseases, inflammatory diseases, autoimmune diseases, neurological diseases, respiratory diseases, anemia, hemorrhagic shock, transplant rejection, multiple organ dysfunction syndrome (MODS), sarcomatoid diseases, adult respiratory distress syndrome, Unverricht syndrome, Richter syndrome (RS), acute liver failure, diabetes, Kennedy disease, seborrheic alopecia, hirsutism, skin diseases, cardiovascular diseases, dysfunctional uterine bleeding, anemia, childhood aplastic anemia, endometriosis, transplant rejection, polycystic ovary syndrome, and thyroid diseases.

[0033] In another aspect, this disclosure provides the use of compounds of formula (II) or their salts, stereoisomers (including enantiomers), solvates, isotope-enriched analogs, prodrugs or polymorphs for the preparation of Cereblon protein (CRBN) binders.

[0034] On the other hand, this disclosure provides the use of a compound of formula (II) or a salt thereof, stereoisomer (including enantiomers), solvate, isotope-enriched analog, prodrug or polymorph thereof for the preparation of a compound of formula (I) or a salt thereof, enantiomer, stereoisomer, solvate, isotope-enriched analog, prodrug or polymorph thereof.

[0035] In another aspect, this disclosure also provides a method for preparing the compound of formula (I) of this disclosure, or its salt, enantiomer, stereoisomer, solvate, isotope-enriched analog, prodrug, or polymorph using a compound of formula (II) or its salt, stereoisomer (including enantiomer), solvate, isotope-enriched analog, prodrug, or polymorph.

[0036] On the other hand, the compounds of formula (II) provided in this disclosure, or their salts, stereoisomers (including enantiomers), solvates, isotope-enriched analogs, prodrugs or polymorphs, or pharmaceutical compositions containing them as active ingredients, may be used as medicines for the treatment and / or prevention of diseases or conditions related to cereblon protein.

[0037] In another aspect, this disclosure also provides a method for treating or preventing a disease or condition related to cereblon protein in a subject, the method comprising administering to the subject a therapeutically effective amount of a compound of formula (II) or a salt thereof, an enantiomer, a stereoisomer, a solvate, an isotope-enriched analog, a prodrug or a polymorph, or a pharmaceutical composition comprising thereto. Attached Figure Description

[0038] Figure 1 shows the Western Blot results of the degradation of the target substrate protein by the compounds of the present invention in cells.

[0039] Invention Details

[0040] The following detailed description is provided as exemplary embodiments to assist those skilled in the art in understanding and implementing the present disclosure. However, it should be understood that such description is not intended to limit the scope of the disclosure, and various modifications and variations may be made to the specific embodiments described herein without departing from the spirit and scope of the disclosure, all of which fall within the claimed scope of the disclosure.

[0041] I. Compounds

[0042] Compound of formula (I)

[0043] The compounds of formula (I) disclosed herein, or their salts (including pharmaceutically acceptable salts), stereoisomers (including enantiomers), solvates, isotope-enriched analogs, prodrugs, or polymorphs, can bind to target proteins, recruiting them to E3 ubiquitin ligases for ubiquitination and degradation. The compounds of formula (I) disclosed herein can specifically target specific classes or families of target proteins, exhibiting broad pharmacological activity through the degradation / inhibition of various target protein classes or families. PBM-LIN-ULM Formula (I)

[0044] PBM, LIN, and ULM are as defined in compound (I) above.

[0045] In some implementations, the PBM can be a small molecule ligand that binds to a specific target protein, including but not limited to epidermal growth factor receptor (EGFR), cyclin-dependent kinase 4 / 6 (CDK4 / 6), cyclin-dependent kinase 2 (CDK2), anaplastic lymphoma kinase (ALK), activin receptor-like kinase 2 (ALK2), fibroblast growth factor receptors (FGFRs), proto-oncogene tyrosine-protein kinase receptor (RET), focal adhesion kinase (FAK), breakpoint cluster region (BCR)-Abelson leukemia virus. Virus ABL (BCR-ABL) tyrosine kinase, Bruton tyrosine kinase (BTK), androgen receptor (AR), estrogen receptor (ER), bromodomain and extra-terminal domain protein (BET), interleukin-1 receptor-associated kinase 4 (IRAK4), cyclin-dependent kinase 9 (CDK9), histone-lysine N-methyltransferase EZH2 (EZH2), neurotrophic receptor tyrosine kinase,NTRK), Src homology 2 domain-containing protein tyrosine phosphatase (SHP2), poly(ADP-ribose) polymerase (PARP), signal transducers and activators of transcription 3 (STAT3), FMS-like tyrosine kinase 3 (FLT3), BCL-2 (B cell lymphoma-2) family proteins, SOS Ras / Rac guanine nucleotide exchange factor 1 (SOS1) or GTPase Kras (KRAS), and SWI / SNF-related matrix-associated actin-dependent chromatin regulator subfamily a members 2 / 4. 2 / 4; SMARCA2 / 4) and ribosomal protein S6 kinase (RSK).

[0046] In some implementations, the PBM includes a structure selected from the following formula:

[0047] in

[0048] In formula (PBM-1), (R) 1a ) p1a This indicates that the benzene ring it is attached to is connected to p1a R 1a Replace, each R 1a The same or different and each independently represents deuterium, halogen, hydroxyl, NH2, NO2, cyano, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0049] p1a represents the integer 1, 2, 3, 4 or 5;

[0050] R 1b Indicates a key or optionally selected from C 1-3 Alkyl, deuterated C 1-3 Alkyl, Halogenated C 1-3 Alkyl and halogen substituents of C 1-2 Alkylene;

[0051] (R 1c ) p1b The quinazoline ring in the expression (PBM-1) is surrounded by p1b R 1c Replace, each R 1c The same or different and each independently represents deuterium, halogen, NO2, cyano, and halogenated C. 1-6 Alkyl, C 1-10 Alkyl, deuterated C 1-10 Alkyl, C 1-10 Alkoxy, halogenated C 1- 10 alkoxy, -O-optionally substituted heterocyclic group, or -NHC(O)R 1e , where R 1e Indicate C 1-10 Alkyl, deuterated C 1-10 Alkyl or C 2-10 alkenyl groups, such as R 1c Indicates methyl, methoxy, For example

[0052] p1b represents the integer 1, 2, or 3;

[0053] R 1d Indicates hydrogen, deuterium, or C 1-3 alkyl;

[0054] In formula (PBM-2), (R) 2a ) p2a This indicates that the benzene ring it is attached to is surrounded by p2a R atoms. 2a Replace, each R 2a The same or different and each independently represents deuterium, halogen, nitro, cyano, and halogenated C. 1-6 Alkyl, C 1-10 Alkyl, deuterated C 1-10 Alkyl, C 1-10 Alkyl group or -NHC(O)R 2d , where R 2d Indicate C 1-10 Alkyl, deuterated C 1-10 Alkyl or C 2-10 alkenyl groups, such as R 2a Indicates methyl, methoxy, nitro or

[0055] p2a represents the integer 1, 2, 3 or 4;

[0056] (R 2b ) p2b In the expression (PBM-2), the 1H-indole ring is surrounded by p2b R... 2b Replace, p2b represents the integer 0, 1, 2 or 3, and each R 2b The same or different and each independently represents deuterium, deuterated C. 1-10 Alkyl, C 1-10 Alkyl, halogen or halogenated C 1-10 alkyl;

[0057] R 2c Indicates hydrogen, C 1-10 Alkyl, deuterated C 1-10 Alkyl, halogen or halogenated C 1-10 alkyl;

[0058] In formula (PBM-3), (R) 3a ) p3a This indicates that the benzene ring it is attached to is surrounded by p3a R atoms. 3a Replace, each R 3a The same or different and each independently represents deuterium, halogen, hydroxyl, C. 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkyl, NO2, NH2, or cyano groups;

[0059] p3a represents the integer 0, 1, 2, 3, 4 or 5;

[0060] R 3b C indicates whether it is substituted or not substituted. 3-15 Cycloalkyl groups, such as cyclopentyl;

[0061] R in equation (PBM-4) 4a Indicate C 6-10 Aryl or 5- to 20-membered heteroaryl, wherein C 6-10 The aryl group and the 5- to 20-membered heteroaryl group are each independently and optionally selected by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) independently selected from deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Substitution with alkoxy groups or any combination thereof;

[0062] R 4bIndicate C 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), wherein the C 6-10 The aryl group and the 5- to 20-membered heteroaryl group are each independently and optionally surrounded by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) R groups. 4d Replacement, and each R 4d The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, nitro, and C. 1-6 Alkyl, Halogenated C 1- 6-alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0063] (R 4c ) p4a The isoindoline ring in the expression (PBM-4) is optionally replaced by p4a R 4c Replace, each R 4c The same or different and each independently represents deuterium, halogen, hydroxyl, C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, NO2, NH2, C 1-6 Alkoxy, halogenated C 1-6 alkoxy or cyano groups;

[0064] p4a represents the integer 0, 1, 2 or 3;

[0065] R in equation (PBM-5) 5a Indicates hydrogen, C 1-10 Alkyl (e.g.) ), deuterated C 1-10 Alkyl or halogenated C 1-10 alkyl;

[0066] R 5b express Or a 4- to 12-membered nitrogen-containing heterocyclic group, wherein the 4- to 12-membered nitrogen-containing heterocyclic group is optionally selected by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3 or 2-5) each independently selected from deuterium, halogen, hydroxyl, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6Substitution with alkoxy, NO2, NH2, cyano, or any combination thereof;

[0067] In equation (PBM-6), ring A represents C. 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), wherein ring A is optionally surrounded by one or more (e.g., 1 to 10, 1 to 8, 2 to 6, 1 to 5, 1 to 4, 1 to 3, or 2 to 5) R 6a Replacement, and each R 6a The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, nitro, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 alkenyl, or C 2-6 alkynyl group;

[0068] In equation (PBM-6), ring B represents C. 3-15 Cycloalkyl or 4- to 20-membered heterocyclic groups (e.g., 4- to 20-membered heterocyclic groups containing 1 to 4 heteroatoms selected from N, O, and S), wherein the ring B is optionally surrounded by one or more (e.g., 1 to 10, 1 to 8, 2 to 6, 1 to 5, 1 to 4, 1 to 3, or 2 to 5) R 6b Replacement, and each R 6b The same or different and independent of each other are deuterium, halogens, and carbon. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0069] In formula (PBM-6), the ring C represents a 5- to 20-membered heteroaryl group (e.g., a 5- to 20-membered monocyclic or bicyclic heteroaryl group containing 1-4 heteroatoms selected from N, O, and S), wherein the ring C is optionally surrounded by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) R atoms. 6c Replacement, and each R 6c The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, nitro, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0070] R in equation (PBM-7) 7a The term refers to a 4- to 20-membered heterocyclic group (e.g., a 4- to 20-membered heterocyclic group containing 1-4 heteroatoms selected from N, O, and S), wherein the 4- to 20-membered heterocyclic group is optionally surrounded by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) R 7c Replacement, and each R 7c The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, nitro, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1- 6-alkoxy;

[0071] In formula (PBM-7), (R) 7b ) p7a This indicates that the benzene ring connected to it is surrounded by p7a R 7b Replace, each R 7b The same or different and each independently represents deuterium, halogen, and carbon. 1-6 Alkyl, Halogenated C 1-6 Alkyl or deuterated C 1-6 Alkyl group, p7a indicates the integer 1, 2, 3 or 4;

[0072] In formula (PBM-8), X1 represents N or CR 8f , where R 8f X2 represents hydrogen, deuterium, or amino, and X2 represents N or CR. 8g , where R 8g X3 represents hydrogen or a bond, and X3 represents CH or N;

[0073] R 8a and R 8b Each can independently represent hydrogen or a bond;

[0074] In formula (PBM-8), (R) 8c ) p8a This indicates that the benzene ring connected to it is surrounded by p8a R 8c Replace, each R 8c The same or different and each independently represents -O-aryl, -O-heteroaryl, 4- to 20-membered heterocyclic groups, -C 1-3 Alkylene-NHC(O)-heteroaryl, -C 1-3 alkylene-C(O)NH-heteroaryl, C 1-6 Alkyl, deuterium, deuterated C 1-6 Alkyl, halogen, or halogenated C 1-6The alkyl group, wherein the 4- to 20-membered heterocyclic group, aryl group, and heteroaryl group are each optionally and independently surrounded by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) R groups. 8h Replacement, and each R 8h The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0075] p8a represents the integer 1, 2, 3 or 4;

[0076] R 8d Represents bond, hydrogen, halogen, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 alkoxy, or C 1-6 Alkoxy;

[0077] R 8e Represents hydrogen, halogen, cyano, C 1-6 Alkyl, Halogenated C 1-6 Alkyl or amino;

[0078] Where R 8g R 8a R 8b and R 8d Not both are hydrogen, and R 8g R 8a R 8b and R 8d There is one and only one key, where

[0079] When R 8a When representing a key, it is related to R. 8a The linked ring carbon atoms are directly connected to R c X2 represents CH or N, and R 8b It is hydrogen, and R 8d Not a key;

[0080] When X2 represents CR 8g , where R 8g When representing a key, it is related to R. 8g The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, and R 8d Not a key;

[0081] When R8b When representing a key, it is related to R. 8b The linked cyclic nitrogen atom is directly connected to R c X2 represents N or CH, and R 8a It is hydrogen, and R 8d Not a key; and

[0082] When R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And X2 represents N or CH, and R 8a and R 8b They are all hydrogen;

[0083] In formula (PBM-9), X4 represents CR 9e or fragments Where the symbol # represents the connection point of N adjacent to X4, the symbol ## represents the connection point of X5, and each R 9e Each can be used independently to represent deuterium, hydrogen, halogen, and carbon. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, -C(O)-C 1-6 Alkyl, -C(O)-deuterated C 1-6 Alkyl or -C(O)NR 9f R 9g , where R 9f R 9g The same or different and each independently represents hydrogen and C. 1-6 Alkyl or deuterated C 1-6 alkyl;

[0084] In formula (PBM-9), X5 represents N or CR 9h , where R 9h Represents hydrogen, deuterium, halogens, and carbon. 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0085] X6 and X7 each independently represent CH or N;

[0086] R 9a Indicates a heteroaryl group with a bond or optional substitution (e.g., a halogenated or deuterium-substituted heteroaryl group);

[0087] R 9b Indicates hydrogen, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, or optionally substituted C 3-12 cycloalkyl;

[0088] In formula (PBM-9) (R) 9c ) p9a This indicates that the pyridine ring connected to it may optionally be p9a R 9c Replace, each R 9c The same or different and each independently represents deuterium, halogen, and carbon. 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl group, p9a indicates the integer 0, 1, 2 or 3;

[0089] In formula (PBM-9) (R) 9d ) p9b This indicates that the bicyclic nitrogen-containing heteroaryl ring connected to it may optionally be p9b R 9d Replace, each R 9d The same or different and each independently represents deuterium, halogen, and carbon. 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl group, p9b indicates the integer 0 or 1;

[0090] In formula (PBM-10), (R) 10a ) p10a This indicates that the benzene ring connected to it may optionally be p10a R 10a Replace, each R 10a The same or different and each independently represents deuterium, cyano, halogen, and C. 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl or deuterated C 1-6 Alkyl group, p10a represents the integer 0, 1, 2 or 3;

[0091] (R 10b ) p10b This indicates that the benzene ring connected to it may optionally be p10b R 10b Replace, each R 10b The same or different and each independently represents deuterium, cyano, halogen, and C. 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl or deuterated C 1- 6-alkyl, p10b represents the integer 0, 1, 2, 3 or 4;

[0092] Each R 10c and R 10dThe same or different and independent of each other are deuterium and C. 1-6 Alkyl, halogen, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0093] In formula (PBM-11), (R) 11a ) p11a This indicates that the benzene ring connected to it is surrounded by p11a R 11a Replace, each R 11a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl or deuterated C 1-6 alkyl;

[0094] p11a represents the integer 1, 2, 3, 4 or 5;

[0095] R 11b Indicates NR 11d R 11e , where R 11d R 11e The same or different and each independently represents hydrogen and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl or deuterated C 1-6 alkyl;

[0096] R 11c This indicates deuterium, hydrogen, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl or deuterated C 1-6 alkyl;

[0097] In formula (PBM-12), X8, X9, X 10 X 11 and X 12 The same or different and each independently represents N or CH;

[0098] R 12a The methylene group represents a bonded or optionally substituted methylene group (e.g., a halogen-substituted methylene group);

[0099] R 12b -C(O)N(R) 12f )R 12e -N(R) 12f )C(O)R 12e-S(O)2N(R) 12f )R 12e -N(R) 12f )S(O)2R 12e -S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C. 1-6 Alkyl or deuterated C 1-6 Alkyl, R 12f Indicates hydrogen or C 1-6 alkyl;

[0100] In formula (PBM-12), (R) 12c ) p12a It indicates that it is connected to contain X9 and X 10 The six-membered ring can be optionally p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0101] p12a represents the integer 0, 1, 2, 3 or 4;

[0102] R 12d This indicates deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0103] In formula (PBM-13), each (R) 13a ) p13a Each independently represents the benzene ring to which it is connected, optionally represented by p13a R. 13a Replace, each R 13a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0104] Each p13a may be the same or different and each independently represents the integer 0, 1, 2, 3 or 4;

[0105] In formula (PBM-14), (R) 14a ) p14a This indicates that the benzene ring connected to it is surrounded by p14a R 14a Replacement, p14a represents the integers 0, 1, 2, 3, 4, or 5, each R 14a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0106] Each R 14b The same or different and each independently represents halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0107] In formula (PBM-15), (R) 15a ) p15a This indicates that the benzene ring connected to it may optionally be p15a R 15a Replace, each R 15a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0108] p15a represents the integer 0, 1, 2, 3 or 4;

[0109] (R 15b ) p15b This indicates that the 4-oxo-3,4-dihydroquinazoline ring attached to it is surrounded by p15b R 15b Replace, each R 15b The same or different and each independently represents halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0110] p15b represents the integers 1, 2, 3, or 4;

[0111] R in equation (PBM-16) 16a Indicate C6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), wherein the C 6-10 The aryl and 5- to 20-membered heteroaryl groups are each independently and optionally surrounded by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) R groups. 16d Replacement, and each R 16d The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, nitro, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 alkenyl, or C 2-6 alkynyl group;

[0112] In formula (PBM-16), (R) 16b ) p16a This indicates that the 1,2,3,4-tetrahydroquinoline ring connected to it is surrounded by p16a R 16b Replace, each R 16b The same or different and each independently represents deuterium, halogen, and carbon. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0113] p16a represents the integer 0, 1, 2, 3 or 4;

[0114] In formula (PBM-16), (R) 16c ) p16b This indicates that the benzene ring connected to it is surrounded by p16b R 16c Replace, each R 16c The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0115] p16b represents the integers 0, 1, 2, 3, or 4;

[0116] In formula (PBM-17), (R) 17a ) p17a This indicates that the benzene ring connected to it is surrounded by p17a R 17a Replace, each R17a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0117] p17a represents the integers 1, 2, 3, 4, or 5;

[0118] R 17b Indicates halogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0119] In formula (PBM-18), (R) 18a ) p18a This indicates that the quinoline ring connected to it is p18a R 18a Replace, each R 18a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0120] p18a represents the integers 1, 2, 3, or 4;

[0121] In formula (PBM-18), (R) 18b ) p18b This indicates that the benzene ring connected to it is surrounded by p18b R 18b Replace, each R 18b The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0122] p18b represents the integer 1, 2, 3, 4, or 5;

[0123] R in equation (PBM-19) 19a It represents -NHC(O)- or -C(O)NH-;

[0124] R 19b Represents -NH-, -N(C 1-6 alkyl)- or ethynyl group;

[0125] In formula (PBM-19), ring D represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1-4 heteroatoms selected from N, O, and S. 19c ) p19a This indicates that the ring D can be optionally divided by p19a R. 19c Replacement, and each R 19c The same or different, and each independently, represent optional substituted 5- to 15-membered heteroaryl, deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0126] p19a represents the integers 0, 1, 2, or 3;

[0127] In formula (PBM-19), each (R) 19d ) p19b Each independently represents the benzene ring to which it is attached, and each can be optionally represented by a p19b R. 19d Replace, each R 19d The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0128] Each p19b may be the same or different and each represents an integer 0, 1, 2, 3 or 4 independently;

[0129] R in formula (PBM-20) 20a R 20b R 20c and R 20d Each independently represents a bond, hydrogen, deuterium, halogen, hydroxyl, cyano, amino, and C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl, wherein R 20a R 20b R 20c and R 20d There is one and only one bond, and the remaining three are the same or different and each independently represents hydrogen, halogen, or hydroxyl, where R 20a R 20b R 20c and R 20dWhen one of the terms represents a bond, the benzene ring or methylene group in formula (PBM-20) connected to it is directly linked to R. c ;

[0130] The symbol connecting the double bond in formula (PBM-20) This indicates a bond that can be in a stereo configuration (cis or trans, or E- or Z-configuration);

[0131] In formula (PBM-20), each (R) 20e ) p20a Each independently represents the benzene ring to which it is attached, and each can be optionally represented by a p20a R. 20e Replace, each R 20e The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0132] Each p20a may be the same or different and each independently represents the integer 0, 1, 2, 3 or 4;

[0133] R in equation (PBM-21) 21d Indicates O, S, or CH2;

[0134] (R 21c ) p21a This represents p21a R 21c Substituents, each R 21c The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0135] p21a represents the integer 0, 1, 2, 3 or 4;

[0136] R 21a and R 21b There is one and only one bond, and the other represents hydrogen, halogen, hydroxyl, cyano, amino, C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl, wherein when R 21a and R 21bWhen one of the atoms represents a bond, the carbon atom of the benzene ring to which it is attached in formula (PBM-21) is directly attached to R. c ;

[0137] In formula (PBM-22), ring E represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O, and S;

[0138] R 22b This indicates optional substituted 5- to 15-membered heteroaryl, optional substituted 5- to 15-membered heterocyclic, deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0139] R 22a Indicates hydrogen, halogen, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0140] R in equation (PBM-23) 23a This indicates optional substituted 5- to 15-membered heterocyclic groups, optional substituted 5- to 15-membered heteroaryl groups, deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0141] R 23b This indicates a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1-4 heteroatoms selected from N, O, and S, wherein the heteroaryl group is optionally surrounded by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) selected from deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Substitution with alkoxy groups or any combination thereof;

[0142] (R 24a ) p24a The isoquinoline ring in the expression (PBM-24) is optionally replaced by p24a R 24a Replace, each R24a The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy group, -C(O)NH2, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0143] p24a represents the integer 0, 1, 2, 3 or 4;

[0144] (R 24b ) p24b The pyrrolidone ring in the expression (PBM-24) is optionally replaced by p24b R 24b Replace, each R 24b The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy group, -C(O)NH2, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0145] p24b represents the integers 0, 1, 2, 3, or 4;

[0146] In equation (PBM-24), y represents the integer 1, 2, or 3;

[0147] R in formula (PBM-25) 25g Indicates N or CR 25h , where R 25h R represents hydrogen or halogen. 25i Indicates N or CR 25j , where R 25j Indicates hydrogen or halogen;

[0148] R 25f The following are represented bonds: -C(O)NH-, -NHC(O)-, -S(O)2NH-, or -NHS(O)2-.

[0149] (R 25a ) p25a The expression (PBM-25) containing R 25g and R 25i The six-membered ring can be optionally p25a R 25a Replace, each R 25a The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C1-6 alkyl;

[0150] p25a represents the integer 0, 1, or 2;

[0151] R 25b Indicates hydrogen, halogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl or -C 1-3 Alkylene-C 3-6 cycloalkyl;

[0152] R 25c Indicates hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl; or

[0153] R 25b and R 25c Together with the corresponding nitrogen and carbon atoms to which they are attached, they form optional substituted 5- to 7-membered nitrogen-containing heterocycles;

[0154] R 25d R represents hydrogen or a bond. 25e Represents hydrogen or a bond, where R 25d and R 25e Not both are hydrogen, and R 25d and R 25e There is one and only one bond, and the other represents hydrogen, where R 25d When representing a key, it is related to R. 25d The linked ring carbon atoms are directly connected to R c , and when R 25e When representing a key, it is related to R. 25e The linked ring carbon atoms are directly connected to R c ;

[0155] R in equation (PBM-26) 26a Indicates key, C 1-3 Alkylene or halogenated C 1-3 Alkylene;

[0156] R 26b Indicates optional substitution of halogens, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, optional substituted C 3-6 cycloalkyl, or optionally substituted C 1-6 Alkyl groups (e.g., C14 groups optionally substituted with aryl groups) 1-6 alkyl);

[0157] (R 26c ) p26a The benzene ring in the expression (PBM-26) may optionally be replaced by p26a R 26c Replace, each R 26c The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0158] p26a represents the integer 0, 1, 2, 3 or 4;

[0159] R in equation (PBM-27) 27a Indicate C 1-3 Alkylene or halogenated C 1-3 Alkylene;

[0160] R 27b Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, or optionally substituted C 3-6 cycloalkyl;

[0161] R 27c and R 27d Each can be represented independently as S or O;

[0162] R in equation (PBM-28) 28a Indicate C 1-3 Alkylene or halogenated C 1-3 Alkylene;

[0163] (R 28b ) p28a The pyrazolo[1,5-a]pyrimidine ring to which it is attached is optionally replaced by a p28a R 28b Replace, each R 28b The same or different and each independently represents hydroxyl, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0164] p28a represents the integer 0, 1, 2, or 3;

[0165] R 28c and R 28d The same or different and each independently represents hydrogen, and the C with optional substitution. 1-10 Alkyl or optionally substituted C3-15 cycloalkyl;

[0166] (R 28e ) p28b This indicates that the benzene ring connected to it may optionally be p28b R 28e Replace, each R 28e The same or different and each independently represents halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0167] p28b represents the integers 0, 1, 2, 3, or 4;

[0168] R in equation (PBM-29) 29a Indicates -S- or fragment Where R 29a When -S- is represented, R is included in equation (PBM-29). 29a The heteroaryl group of the nitrogen atom is a thiazolyl group, and when R 29a Representing fragments When, in equation (PBM-29) R is included 29a The heteroaryl group containing the nitrogen atom is a pyridyl group;

[0169] R 29b Indicates N or CH;

[0170] R 29c C represents hydrogen or optional substitution 1-10 alkyl;

[0171] R 29d Indicates hydrogen, -C 1-3 Alkylene-optionally substituted 4- to 10-membered heterocyclic groups, or optionally substituted 4- to 10-membered heterocyclic groups;

[0172] R 29e Indicates hydroxyl, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0173] R in formula (PBM-30) 30a Indicates O or S;

[0174] R 30b Indicates N or CH;

[0175] R 30c and R 30dThe same or different and each independently represents hydroxyl, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0176] (R 30e ) p30a This indicates that the benzene ring connected to it may optionally be p30a R 30e Replace, each R 30e The same or different and each independently represents deuterium, hydroxyl, halogen, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl groups, -S(O)2NH2, or -C(O)NH2;

[0177] p30a represents the integer 0, 1, 2, 3, 4 or 5;

[0178] R in equation (PBM-31) 31a Represents C(O)NH, NHC(O), and (CH2) 1-2 C(O)NH, (CH2) 1-2 NHC(O), C(O)NH(CH2) 1-2 ,NHC(O)(CH2) 1-2 S(O)₂NH or NHS(O)₂;

[0179] R 31b Represents hydrogen, hydroxyl, halogen, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0180] R 31c Indicates hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl; or

[0181] R 31b and R 31c Together with their respective attached carbon and nitrogen atoms, as well as the carbon atom on the benzene ring attached to the nitrogen atom, they form optional substituted 4- to 6-membered heteroaromatic rings or optional substituted 4- to 6-membered heterocycles;

[0182] R 31d C represents an optional substitution3-6 cycloalkyl, C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl or optionally substituted 4- to 20-membered heterocyclic groups;

[0183] (R 31e ) p31a This indicates that the pyridine-2(1H)-ketone ring connected to it is occupied by p31a R 31e Replace, each R 31e The same or different and each independently represents hydroxyl, halogen, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0184] p31a represents the integer 0, 1, 2 or 3;

[0185] In formula (PBM-31), ring F represents an arylene or a 5- to 20-membered monocyclic or bicyclic heteroarylene containing 1-4 heteroatoms selected from N, O, and S; (R 31f ) p31b This indicates that the ring F can be optionally divided by p31b R. 31f Replacement, and each R 31f The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1- 6-alkoxy or halogenated C 1-6 Alkoxy;

[0186] p31b represents the integer 0, 1, 2, 3 or 4;

[0187] R in equation (PBM-32) 32c C represents an optional substitution 1-3 Alkylene;

[0188] (R 32a ) p32a This indicates that the benzene ring connected to it is surrounded by p32a R 32a Replace, each R 32a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0189] p32a represents the integers 0, 1, 2, 3, 4, or 5;

[0190] (R 32b ) p32b This indicates that the 1H-indazole ring connected to it is bounded by p32b R 32b Replace, each R 32b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0191] p32b represents the integers 0, 1, 2, 3, 4, or 5;

[0192] R 32d It represents C(O)NH, NHC(O), S(O)2NH or NHS(O)2;

[0193] R 32e Indicates NR 32f R 32g , where R 32f R 32g The same or different and each independently represents hydrogen and C. 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, optional substituted C 3-6 Cycloalkyl or optionally substituted 4- to 8-membered heterocyclic groups;

[0194] X in equation (PBM-33) 13 X 14 and X 15 The same or different and each independently represents CH or N, where X 13 X 14 and X 15 Not both N, and including X 13 X 14 and X 15 The six-membered ring may optionally be further composed of one or two groups selected from halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl groups or any combination thereof are substituted;

[0195] In formula (PBM-33), ring G represents pyrrole, imidazole, pyrazole, benzene ring, pyridine, pyrimidine, or pyrazine;

[0196] (R33a ) p33a This indicates that the benzene ring connected to it may optionally be p33a R 33a Replace, each R 33a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0197] p33a represents the integers 0, 1, 2, 3, 4, or 5;

[0198] (R 33b ) p33b This indicates that the tetrahydropyrrole ring connected to it is optionally replaced by p33b R 33b Replace, each R 33b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0199] p33b represents the integers 0, 1, 2, 3, 4, 5, or 6;

[0200] R 33c and R 33d The same or different and each independently represents hydrogen, halogen, hydroxyl, amino, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0201] (R 33e ) p33c This indicates that the ring G connected to it can optionally be p33c R. 33e Replace, each R 33e The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0202] p33c represents the integer 0 or 1;

[0203] X in equation (PBM-34) 16X 17 and X 18 Each can be represented independently as CH or N;

[0204] R 34a Indicates a bond, S, or NH;

[0205] R 34b The symbol represents a bond, an optional substituted cycloalkyl group, or an optional substituted 4- to 15-membered nitrogen-containing heterocyclic group;

[0206] R 34c Indicates bond, halogen, amino, hydroxyl, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, optionally substituted cycloalkyl, or optionally substituted 4- to 15-membered nitrogen-containing heterocyclic groups;

[0207] Where R 34b and R 34c Not both are keys, and R 34b and R 34c There is one and only one key in R, where R is the key. 34b When representing a key, it is related to R. 34b The linked ring carbon atoms are directly connected to R c , and when R 34c When representing a key, it is related to R. 34c The linked ring carbon atoms are directly connected to R c ;

[0208] (R 34d ) p34a This indicates that the six-membered ring connected to it can optionally be p34a R 34d Replace, each R 34d The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0209] p34a represents the integer 0, 1, 2, 3 or 4;

[0210] (R 34e ) p34b This indicates that the nitrogen-containing six-membered heteroaryl ring connected to it is optionally replaced by p34b R 34e Replace, each R 34e The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1- 6-alkyl or halogenated C 1-6 alkyl;

[0211] p34b represents the integer 0, 1, or 2;

[0212] In formula (PBM-35), (R) 35a ) p35a This indicates that the phthalazinone ring connected thereto is optionally replaced by a p35a R 35a Replace, each R 35a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0213] p35a represents the integer 0, 1, 2, 3 or 4;

[0214] R 35b C represents an optional substitution 1-3 Alkylene;

[0215] (R 35c ) p35b This indicates that the benzene ring connected to it is optionally replaced by p35b R 35c Replace, each R 35c The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0216] p35b represents the integer 0, 1, 2, 3 or 4;

[0217] In formula (PBM-36), (R) 36a ) p36a This indicates that the 2H-indazole ring connected thereto is optionally replaced by p36a R 36a Replace, each R 36a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0218] p36a represents the integer 0, 1, 2, or 3;

[0219] (R 36b ) p36b This indicates that the benzene ring connected to it is optionally replaced by p36b R 36b Replace, each R 36b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0220] p36b represents the integers 0, 1, 2, 3, or 4;

[0221] In formula (PBM-37), (R) 37a ) p37a The benzofuran ring connected thereto is optionally represented by p37a R 37a Replace, each R 37a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0222] p37a represents the integer 0, 1, 2 or 3;

[0223] (R 37b ) p37b This indicates that the benzene ring connected to it may optionally be replaced by p37b R 37b Replace, each R 37b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0224] p37b represents the integer 0, 1, 2, or 3;

[0225] In formula (PBM-38), (R) 38a ) p38a This indicates that the benzene ring connected to it may optionally be replaced by p38a R 38a Replace, each R 38a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0226] p38a represents the integer 0, 1, 2, 3 or 4;

[0227] R 38b R 38c R 38d The same or different and each independently represents hydrogen, deuterium, hydroxyl, amino, cyano, halogen, and C. 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0228] R in equation (PBM-39) 39a R 39b The same or different and each independently represents hydrogen, halogen, and C. 1-3 Alkyl or halogenated C 1-3 alkyl;

[0229] R 39c Represents bond, hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0230] y1 represents the integer 1, 2, or 3;

[0231] R 39d The structure of the following expression is represented as:

[0232] Where R 39e Indicates a bond or hydrogen; (R) 39f ) p39a This indicates that the benzene ring connected to it may optionally be replaced by p39a R 39f Replace, each R 39f The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl groups, and p39a represent integers 0, 1, 2, 3, or 4; y2 represents integers 1, 2, or 3; or

[0233] R 39d The structure of the following expression is represented as:

[0234] Among them (R) 39g ) p39bEach independently represents the benzene ring connected to it, optionally represented by p39b R. 39g Replace, each R 39g The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl groups, and p39b represent integers 0, 1, 2, 3, 4, or 5;

[0235] Where R 39c and R 39e Not both are keys, and R 39c and R 39e There is one and only one key, where R 39c When representing a key, it is related to R. 39c The linked cyclic nitrogen atom is directly connected to R c , and when R 39e When representing a key, it is related to R. 39e The linked ring carbon atoms are directly connected to R c ;

[0236] In formula (PBM-40), (R) 40a ) p40a This indicates that the benzene ring connected to it may optionally be p40a R 40a Replace, each R 40a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0237] p40a represents the integer 0, 1, 2, 3 or 4;

[0238] R in formula (PBM-40) x3 Represents a bond or C(O);

[0239] R in equation (PBM-41) 41a Indicates hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, optional substituted C 3-15 Cycloalkyl or optionally substituted 4- to 15-membered nitrogen-containing heterocyclic groups;

[0240] R 41b Indicates hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C1-6 Alkyl, optional substituted C 3-15 Cycloalkyl, optionally substituted 4- to 15-membered nitrogen-containing heterocyclic groups or NR 41e R 41f , where R 41e R 41f The same or different and each independently represents hydrogen and C. 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl or optionally substituted 4- to 15-membered heterocyclic groups;

[0241] R 41c Indicates N or CH;

[0242] (R 41d ) p41a This indicates that the benzene ring connected to it may optionally be p41a R 41d Replace, each R 41d The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0243] p41a represents the integer 0, 1, 2, 3 or 4;

[0244] In formula (PBM-42), (R) 42a ) p42a This indicates that the benzene ring connected to it may optionally be replaced by p42a R 42a Replace, each R 42a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0245] p42a represents the integers 0, 1, 2, 3, 4, or 5;

[0246] R 42b Representing O, S, C 1-3 Alkylene or halogenated C 1-3 Alkylene;

[0247] (R 42c ) p42b This indicates that the benzene ring connected to it may optionally be replaced by p42b R 42c Replace, each R 42cThe same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0248] p42b represents the integer 0, 1, 2, 3 or 4;

[0249] In equation (PBM-43), the ring H represents C. 6-15 arylene or 5- to 15-membered monocyclic, bicyclic, or polycyclic heteroarylene, (R 43a ) p43a This indicates that the ring H is optionally divided by p43a R 43a Replacement, and each R 43a The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, nitro, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1- 6-alkoxy;

[0250] p43a represents the integer 0, 1, 2, 3 or 4;

[0251] R 43b This indicates a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group with optional substitutions, containing 1-4 heteroatoms selected from N, O, and S, optionally substituted with hydroxyl, amino, cyano, halogen, nitro, C... 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl substituents;

[0252] R in equation (PBM-44) 44a R 44b R 44c Each can be represented independently as CH or N;

[0253] R 44d -C(O)NHR 44h -NHC(O)R 44h -S(O)2NHR 44h -NHS(O)2R 44h -S(O)2R 44h or -P(O)(R 44h )2, where each R 44h The same or different and each independently represents C.1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0254] (R 44e ) p44a This indicates p44a substituents R 44e Each R 44e The same or different and each independently represents halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0255] p44a represents the integer 0, 1, 2, 3 or 4;

[0256] (R 44f ) p44b This indicates p44b substituents R 44f Each R 44f The same or different and each independently represents halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy;

[0257] p44b represents the integer 0, 1, or 2;

[0258] (R 44g ) p44c This indicates that the benzene ring connected to it may optionally be p44c R 44g Replacement, and each R 44g Each can be independently represented by halogen, hydroxyl, cyano, amino, nitro, or C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1- 6-alkoxy;

[0259] p44c represents the integer 0, 1, 2, 3 or 4;

[0260] R in formula (PBM-45) c1 Represents a key, or R c1 Indicates -NH-R c2 -C(O)-***, where the symbol *** indicates that it is related to R c The connection point, and R c2 C represents an optional substitution3-15 cycloalkyl;

[0261] (R 45a ) p45a This indicates that the 1H-pyrrolo[2,3-b]pyridine ring connected thereto is optionally replaced by a p45a R 45a Replacement, and each R 45a Each of these groups independently consists of cyano, halogen, hydroxyl, amino, nitro, and C groups. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1- 6-alkoxy or halogenated C 1-6 Alkoxy groups and p45a represent integers 0, 1, 2, 3, 4, or 5;

[0262] (R 45b ) p45b This indicates that the pyridine ring connected to it is optionally replaced by p45b R 45b Replacement, and each R 45b Each of these groups independently consists of cyano, halogen, hydroxyl, nitro, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkoxy or NR 45c R 45d , where R 45c R 45d The same or different and each independently represents hydrogen and C. 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, optional substituted C 3-15 Cycloalkyl or optionally substituted 4- to 15-membered heterocyclic groups, and p45b represents the integer 0, 1, 2 or 3;

[0263] R in equation (PBM-46) 46a It represents NHC(O), C(O)NH, NHS(O)2 or S(O)2NH;

[0264] (R 46b ) p46a This indicates that the benzene ring connected to it may optionally be replaced by p46a R 46b Replacement, and each R 46b Each of these groups independently represents a halogen, hydroxyl, cyano, amino, nitro, or C group. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6The alkoxy group and p46a represent integers 0, 1, 2, 3, 4, or 5;

[0265] (R 46c ) p46b This indicates that the 1H-pyrazole ring connected thereto is optionally replaced by p46b R 46c Replacement, and each R 46c Each of these groups independently represents a halogen, hydroxyl, cyano, amino, nitro, or C group. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 The alkoxy group and p46b represent integers 0, 1, or 2;

[0266] R in equation (PBM-47) 47a Represents N or CH, R 47b It represents O, S, NH, CH2, CH(F) or C(F)2;

[0267] R 47c The methylene group represents a bonded or optionally substituted methylene group (e.g., a halogen-substituted methylene group);

[0268] Ring I represents C 6-15 aryl, 4- to 15-membered heterocyclic or 5- to 15-membered heteroaryl, (R 47d ) p47a This indicates that the ring I connected to it can optionally be p47a R 47d Replacement, and each R 47d The same or different, and each independently, are deuterium, halogen, hydroxyl, cyano, amino, nitro, oxo, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 The alkoxy group and p47a represent integers 0, 1, 2, 3, or 4;

[0269] (R 47e ) p47b It indicates that the one connected to it contains R 47a The six-membered nitrogen-containing heteroaryl ring is optionally replaced by a p47b R 47e Replace, each R 47e Each can be independently represented as deuterium, halogen, hydroxyl, cyano, amino, nitro, or C. 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl groups, and p47b represent integers 0, 1, or 2;

[0270] (R 47f ) p47c This indicates that the benzene ring connected to it may optionally be replaced by p47c R 47f Replace, each R 47f The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1- 6-alkyl or halogenated C 1-6 Alkyl groups, and p47c represent integers 0, 1, 2, 3, or 4;

[0271] R in equation (PBM-48) 48a R 48b and R 48c Each can be represented independently as N or CH;

[0272] (R 48d ) p48a This indicates that the naphthyl group linked to it is optionally replaced by a p48a R group. 48d Replace, each R 48d Each can independently represent halogen, hydroxyl, amino, mercapto, nitro, cyano, and C. 2-6 alkynyl group, C 2-6 alkenyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl groups, and p48a represent integers 0, 1, 2, 3, 4, 5, 6, or 7;

[0273] R 48e C represents an optional substitution 3-15 Cycloalkyl or optionally substituted 4-15 membered heterocyclic groups containing 1-4 heteroatoms selected from N, O and S;

[0274] R 48f Represents hydrogen, halogen, hydroxyl, cyano, amino, mercapto, nitro, C 2-6 alkynyl group, C 2-6 alkenyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl;

[0275] R in equation (PBM-49) 49a Indicates N or CH;

[0276] R 49bIt represents NHC(O), C(O)NH, NHS(O)2 or S(O)2NH;

[0277] (R 49c ) p49a Indicates that it is connected to R 49a The six-membered ring can be optionally p49a R 49c Replace, each R 49c The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p49a represents an integer 0, 1, 2, 3 or 4;

[0278] Cyclic J represents 5 to 15-membered heteroaryl groups, (R 49d ) p49b This indicates that the ring J connected to it can optionally be p49b R. 49d Replace, each R 49d The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, hydroxyl substituted C 1-6 alkyl and amino substituted C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy or optional substituted C 3-15 Cycloalkyl, and p49b represents the integer 0, 1, 2 or 3;

[0279] In formula (PBM-50), (R) 50a ) p50a This indicates that the benzene ring connected to it is p50a R 50a Replace, each R 50a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkyl-S(O)2, Halogenated C 1-6 Alkyl-S(O)2, Halogenated C 1-6 Alkyl-NHC(O), Halogenated C 1-6 Alkyl-C(O)NH, Halogenated C 1-6 Alkyl-NHS(O)2, Halogenated C 1-6 Alkyl-S(O)2NH, C 1-6 alkoxy or halogenated C1-6 Alkyl group, and p50a represents an integer 0, 1, 2, 3 or 4;

[0280] R 50b Indicates hydrogen, C 1-6 Alkyl, Halogenated C 1-6 Alkyl or deuterated C 1-6 alkyl;

[0281] In formula (PBM-51), (R) 51a ) p51a This indicates that the benzene ring connected to it is surrounded by p51a R 51a Replace, each R 51a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optional substituted C 3-15 Cycloalkyl or optionally substituted 4-15 membered heterocyclic groups containing 1-4 heteroatoms selected from N, O and S, where p51a represents an integer 0, 1, 2, 3, 4 or 5;

[0282] (R 51b ) p51b This indicates that the benzene ring connected to it is surrounded by p51b R 51b Replace, each R 51b The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optional substituted C 3-15 Cycloalkyl or optionally substituted 4-15 membered heterocyclic groups containing 1-4 heteroatoms selected from N, O and S, where p51b represents an integer 0, 1, 2, 3 or 4;

[0283] (R 51c ) p51c This indicates that the isoxazole ring connected to it is optionally replaced by p51c R 51c Replace, each R 51c The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p51c represents the integer 0, 1 or 2;

[0284] The dashed lines in formula (PBM-52) indicate the optional presence of double bonds;

[0285] (R 52a ) p52a The six-membered cycloalkyl group connected thereto is optionally represented by a p52a R group. 52a Replace, each R 52a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, oxo, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p52a represents an integer 0, 1, 2, 3, 4, 5, 6, 7 or 8;

[0286] (R 52b ) p52b This indicates that the benzene ring connected to it may optionally be p52b R 52b Replace, each R 52b The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p52b represents an integer 0, 1, 2, 3, 4 or 5;

[0287] (R 52c ) p52c The six-membered cycloalkyl group connected thereto is optionally represented by a p52c R. 52c Replace, each R 52c The same or different and each independently represents halogen, cyano, oxo, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p52c represents an integer 0, 1, 2, 3, 4, 5, 6, 7 or 8;

[0288] (R 52d ) p52d This indicates that the benzene ring connected to it may optionally be p52d R 52d Replace, each R 52d The same or different and each independently represents halogen, hydroxyl, mercapto, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C1-6 Alkoxy, halogenated C 1-6 alkoxy or And p52d represents the integer 0, 1, or 2;

[0289] (R 52e ) p52e This indicates that the benzene ring connected to it may optionally be p52e R 52e Replace, each R 52e The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, -SO2CF3, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p52e represents an integer 0, 1, 2, 3 or 4;

[0290] R 52f This indicates hydrogen, deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 alkoxy or Where y3 represents the integer 1, 2 or 3;

[0291] In formula (PBM-53), (R) 53a ) p53a This indicates p53a substituents R 53a Each R 53a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p53a represents an integer 0, 1, 2, 3, 4 or 5;

[0292] (R 53b ) p53b This indicates that the benzene ring connected to it may optionally be p53b R 53b Replace, each R 53b The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6Alkyl group, and p53b represents an integer 0, 1, 2, 3, or 4; and

[0293] R 53c Indicate C 1-6 Alkylene or halogenated C 1-6 Alkylene;

[0294] In formula (PBM-54), (R) 54a ) p54a This indicates p54a substituents R 54a Each R 54a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p54a represents an integer 0, 1, 2, 3 or 4;

[0295] (R 54b ) p54b This indicates that the benzene ring connected to it may optionally be p54b R 54b Replace, each R 54b The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p54b represents an integer 0, 1, 2, 3 or 4;

[0296] In formula (PBM-55), (R) 55a ) p55a This indicates p55a substituent R 55a Each R 55a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 alkoxy or halogenated C 1-6 Alkyl group, and p55a represents an integer 0, 1, 2, 3 or 4;

[0297] R 55b R 55c The same or different and each independently represents hydrogen and C. 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, or optionally substituted aryl;

[0298] R in formula (PBM-55) 55d Representing fragments Where the symbol ### represents the junction with a carbon atom in the ring, the symbol **** represents the junction with a nitrogen atom in the ring, and R 55e Indicates an optionally substituted aryl group or an optionally substituted heteroaryl group, and R 55f Indicates hydrogen, halogen, C 1-6 Alkyl, Halogenated C 1-6 Alkyl or deuterated C 1-6 Alkyl groups; and

[0299] R in each general formula c Each independently represents a bond, -O-, -N(R) d )-, -NHC(O)-*, -C(O)NH-*, -N(R d )-R f -N(R e -*、-R f -C(O)NH-*、-R f -NHC(O)-*、-R f -C(O)O-*、-R f -OC(O)-*, -C(O)O-*, -OC(O)-*, -R f -、-R f -N(R d -*、-OR f -N(R d )-*、

[0300] Among them, each ring W 2 The same or different and independent groups represent nitrogen-containing subheterocyclic groups, t1 represents the integer 1 or 2, (R c1 ) m2 Indicates each ring W 2 Each can be independently and optionally assigned to m2 R c1 Group substitution, each R c1 Independent of deuterium and C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogen, amino, hydroxyl, mercapto, cyano, carboxyl, C 2-6 alkynyl group, C 2-6 Alkenyl, optional deuterated C 3-6 cycloalkyl, or R c4 -R c3 -, where R c3 It is an optional replacement for C 1-6Alkylene or optionally substituted C 2-6 Ideonyl, R c4 Indicates halogen, R c5 R c6 N-, hydroxyl, carboxyl, ethynyl, or vinyl, wherein R c5 and R c6 The same or different and each independently represents hydrogen or C. 1-3 Alkyl groups, and m2 represents integers from 0 to 20;

[0301] Each ring W 3 The same or different and each independently represents a heterocyclic group, a cycloalkyl group, an aryl group, or a heteroaryl group, t2 represents an integer 0 or 1, (R c2 ) m3 Indicates each ring W 3 Independently and optionally by m3 R c2 Group substitution, each R c2 Independent of deuterium and C 1-6 Alkyl, deuterated C 1-6 Alkyl, Halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogen, amino, hydroxyl, mercapto, cyano, carboxyl, C 2-6 alkynyl group, C 2-6 Alkenyl, optional deuterated C 3-6 cycloalkyl, or R c8 -R c7 -, where R c7 It is an optional replacement for C 1-6 Alkylene or optionally substituted C 2-6 Ideonyl, R c8 Indicates halogen, R c9 R c10 N-, hydroxyl, carboxyl, ethynyl, or vinyl, wherein R c9 and R c10 The same or different and each independently represents hydrogen or C. 1-3 Alkyl groups, and m3 represent integers from 0 to 20; and

[0302] R d and R e Each can be independently represented as hydrogen or C. 1-6 Alkyl, R f and R g Each independently represents an optional substitution of C. 1-6 Alkylene or optionally substituted C 2-6 The subalkenyl group, and the symbol * indicates the connection point with LIN.

[0303] In embodiments of this disclosure, the number of substituents is not limited in principle, or is automatically limited by the size of the building block (i.e., the total number of hydrogen atoms that can be replaced in the building block), or as expressly defined herein.

[0304] In some implementations, PBM represents a small molecule ligand of EGFR.

[0305] In some implementations, PBM represents the structure of the following formulas (PBM-1-1A), (PBM-1-1B), (PBM-1-1C), or (PBM-1-1D):

[0306] In equations (PBM-1-1A), (PBM-1-1B), (PBM-1-1C), and (PBM-1-1D),

[0307] (R 1a ) p1a This indicates that the benzene ring it is attached to is connected to p1a R 1a Replace, each R 1a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, NH2, NO2, cyano, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0308] p1a represents the integer 1, 2, 3, 4 or 5;

[0309] R 1b Indicates a key or optionally selected from C 1-3 Alkyl, deuterated C 1-3 Alkyl, Halogenated C 1-3 Alkyl and halogen substituents of C 1-2 Alkylene;

[0310] (R 1c ) p1b The quinazoline ring in the expression (PBM-1) is surrounded by p1b R 1c Replace, each R 1c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), NO2, cyano, halogenated C. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-), C 1-10 Alkyl (e.g., C10) 1-6 Alkyl or C 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-10 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-10 Alkoxy groups (e.g., C) 1-6 Alkoxy or C 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-10 Alkoxy groups (e.g., halogenated C) 1-6 alkoxy or halogenated C 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-; -O-optionally substituted heterocyclic groups (e.g., -O-optionally substituted 4- to 20-membered heterocyclic groups); or -NHC(O)R 1e , where R 1e Indicate C 1-10 Alkyl (e.g., C10) 1-8 Alkyl, C 1-6 Alkyl or C 1-4Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, or octyl), and deuterated C. 1-10 Alkyl groups (e.g., fully deuterated C) 1-8 Alkyl, fully deuterated C 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or C 2-10 alkenyl (e.g., C) 2-6 alkenyl or C 2-4 Alkenyl groups, such as vinyl, propenyl, butenyl, or pentenyl, for example, R 1c Indicates methyl, methoxy, For example

[0311] p1b represents the integer 1, 2, or 3; and

[0312] R 1d Indicates hydrogen, deuterium, or C 1-3 alkyl.

[0313] In some implementation schemes, (R 1c ) p1b The quinazoline ring in the expression (PBM-1) is surrounded by p1b R 1c Replace, where p1b represents the integer 1, 2, or 3, R 1c The designation indicates an optional -O-substituted heterocyclic group, wherein the heterocyclic group is a 4- to 20-membered (e.g., 4 to 15-, 4-12-, 4-10-, 4-7-, or 4-6-membered) monocyclic, bicyclic, or polycyclic heterocyclic group containing one or more (e.g., 1-4 or 1, 2, 3, or 4) heteroatoms selected from nitrogen, oxygen, and sulfur, including but not limited to aziridine, oxacyclobutyl, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxacyclohexyl, aziridine, and diaziridine. The heterocyclic group (e.g., 1,4-diazacycloheptan-1-yl), azircyclic octyl, azircyclic octyl, azirbicyclo[3.1.1]heptyl, azirbicyclo[2.2.1]heptyl, azirbicyclo[3.2.1]octyl, azirbicyclo[2.2.2]octyl, azirbicyclo[3.1.1]heptyl, azirbicyclo[2.2.1]heptyl, azirbicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), azirbicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl). In some embodiments, the heterocyclic group is optionally selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, and optionally deuterated C. 1-6 Alkyl, Halogenated C1-6 Alkyl, optional deuterated C 3-6 cycloalkyl, optional deuterated C 1-6 Alkoxy, optional deuterated C 1-6 Alkyl-NH-, NH2-C 1-6 Alkylene, optional deuterated C 1-6 Alkyl-NHC(O)-, optionally deuterated C 1-6 Substituents of alkyl-C(O)NH- or any combination thereof. In some embodiments, p1b represents the integer 1.

[0314] In some implementation schemes, R 1c express:

[0315] Fluorine, chlorine, bromine, or iodine;

[0316] Methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, or octyl;

[0317] Methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy;

[0318] -NHC(O)-C 2-10 Alkenyl groups, such as -NHC(O)-vinyl (i.e. -NHC(O)-propenyl or -NHC(O)-butenyl; or

[0319] For example

[0320] In some implementation schemes, R 1b Indicates a key or optionally selected from C 1-3 Alkyl, deuterated C 1-3 Alkyl, Halogenated C 1-3 Alkyl and halogen substituents of C 1-2 Alkylene. In some embodiments, R 1b Indicates a key or optionally selected from C 1-3 Alkyl, deuterated C 1-3 Alkyl, Halogenated C 1-3 The alkyl and halogen substituents are substituted with methylene or ethylene. In some embodiments, R 1b Indicates a key.

[0321] In some implementations, PBM represents the structure of the following formulas (PBM-1-1), (PBM-1-2), (PBM-1-3), (PBM-1-4), or (PBM-1-5):

[0322] In some implementations, PBM represents the structure of the following formulas (PBM-2-1A), (PBM-2-1B), (PBM-2-1C), (PBM-2-1D), or (PBM-2-1E):

[0323] In equations (PBM-2-1A), (PBM-2-1B), (PBM-2-1C), (PBM-2-1D), and (PBM-2-1E),

[0324] (R 2a ) p2a This indicates that the benzene ring it is attached to is surrounded by p2a R atoms. 2a Replace, each R 2a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), nitro, cyano, halogenated C. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-), C 1-10 Alkyl (e.g., C10) 1-8 Alkyl, C 1-6 Alkyl or C 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, or octyl), and deuterated C. 1-10 Alkyl groups (e.g., fully deuterated C) 1- 8-alkyl, fully deuterated C 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-10 Alkoxy groups (e.g., C) 1-8 Alkoxy, C 1-6 Alkoxy or C 1-4 Alkyl groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy) or -NHC(O)R 2d , where R 2d Indicate C 1-10 Alkyl (e.g., C10) 1-8 Alkyl, C 1-6 Alkyl or C 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, or octyl), and deuterated C. 1-10 Alkyl groups (e.g., fully deuterated C) 1-8 Alkyl, fully deuterated C 1-6 Alkyl or fully deuterated C 1-4Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or C 2-10 alkenyl (e.g., C) 2-6 alkenyl or C 2-4 Alkenyl groups, such as vinyl, propenyl, butenyl, or pentenyl, for example, R 2a Indicates methyl, methoxy, nitro or

[0325] p2a represents the integer 1, 2, 3 or 4;

[0326] (R 2b ) p2b This indicates that the 1H-indole ring it is attached to is bound by p2b R atoms. 2b Replace, p2b represents the integer 0, 1, 2 or 3, and each R 2b The same or different and each independently represents deuterium, deuterated C. 1-10 Alkyl groups (e.g., fully deuterated C) 1-8 Alkyl, fully deuterated C 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-10 Alkyl (e.g., C10) 1-8 Alkyl, C 1-6 Alkyl or C 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, or octyl; halogens (such as fluorine, chlorine, bromine, or iodine); or halogenated C. 1-10 Alkyl groups (e.g., halogenated C) 1-6 Alkyl or halogenated C 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0327] R 2c Indicates hydrogen, C 1-10 Alkyl (e.g., C10) 1-8 Alkyl, C 1-6 Alkyl or C 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl, or octyl), and deuterated C. 1-10 Alkyl groups (e.g., fully deuterated C) 1- 8-alkyl, fully deuterated C 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.; halogens (such as fluorine, chlorine, bromine, or iodine); or halogenated C atoms. 1-10 Alkyl groups (e.g., halogenated C)1-6 Alkyl or halogenated C 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0328] In some implementations, PBM represents the structure of the following formula (PBM-2-1) or formula (PBM-2-2):

[0329] In some implementations, PBM represents the structure of the following formula (PBM-3):

[0330] in,

[0331] (R 3a ) p3a This indicates that the benzene ring it is attached to is surrounded by p3a R atoms. 3a Replace, each R 3a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), NO2, NH2 or cyano groups;

[0332] p3a represents the integer 0, 1, 2, 3, 4 or 5;

[0333] R 3b C indicates whether it is substituted or not substituted. 3-15 Cycloalkyl (e.g., substituted or unsubstituted C) 3-10 cycloalkyl or C 3-6 Cycloalkyl groups, such as cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl. In some embodiments, the C... 3-15 The cycloalkyl group is optionally selected from one or more (e.g., 1-3, 1, 2, or 3) groups selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen (e.g., fluorine, chlorine, bromine, or iodine), cyano, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-, optionally halogenated C 3-6 cycloalkyl, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl-NH-, NH2-C 1-6 Alkylene, C 1-6 Alkyl-NHC(O)-, C 1-6 Alkyl-C(O)NH- or any combination thereof are substituted.

[0334] In some implementations, PBM represents the structure of the following formula (PBM-3-1):

[0335] In some implementations, PBM represents the structure of the following formulas (PBM-4-1A), (PBM-4-1B), (PBM-4-1C), or (PBM-4-1D):

[0336] In equations (PBM-4-1A), (PBM-4-1B), (PBM-4-1C), and (PBM-4-1D),

[0337] R 4a Indicate C 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), wherein the C 6-10 The aryl group and the 5- to 20-membered heteroaryl group are each independently and optionally selected by one or more (e.g., 1 to 6, e.g., 1, 2, 3, 4, 5, or 6) independently from deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-6 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-5 Alkoxy or C 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, or any combination thereof, are substituted with substituents.

[0338] R4b Indicate C 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), wherein the C 6-10 The aryl group and the 5- to 20-membered heteroaryl group are each independently and optionally selected by one or more (e.g., 1 to 6, e.g., 1, 2, 3, 4, 5, or 6) independently from deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy) and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Substitution of alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-; and

[0339] (R 4c ) p4a This indicates that the isoindoline ring connected to it is optionally replaced by p4a R 4c Replace, each R 4c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1- 3 alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), halogenated C1- 6-alkyl (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), NO2, NH2, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-, or cyano groups; and

[0340] p4a represents the integer 0, 1, 2 or 3.

[0341] In some implementation schemes, R 4a Indicate C 6-10 Aryl, such as, but not limited to, phenyl or naphthyl, wherein each of the phenyl or naphthyl groups is optionally selected by one or more (e.g., 1-6, e.g., 1, 2, 3, 4, 5, or 6) independently selected from deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, or any combination thereof, are substituted.

[0342] In some implementation schemes, R 4a The term represents a 5- to 20-membered heteroaryl group, for example, a 5- to 20-membered heteroaryl group comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S. In one sub-implementation, R 4a This refers to an aromatic ring group consisting of one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur, comprising a 5- to 14-membered monocyclic or bicyclic aromatic ring. In one embodiment, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiophene, thiazolyl, isothiazolyl, thiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, isindolyl, benzofuranyl, isobenzofuranyl, benzothiophene, indolyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3]oxadiazolyl, benzo[2,1,3]thiazolyl, Benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridinyl, cyclolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, imidazo[2,1-b]thiazolyl, imidazo[1,2-b]pyridazinyl, or 6,7-dihydro-5H-pyrrolo[1,2-c]imidazolyl. The heteroaryl group is optionally selected by one or more (e.g., 1-6, e.g., 1, 2, 3, 4, 5 or 6) independently selected from deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, or any combination thereof, are substituted.

[0343] In some implementation schemes, R 4b Indicate C 6-10 Aryl, such as, but not limited to, phenyl or naphthyl, wherein each of the phenyl or naphthyl groups is optionally surrounded by one or more (e.g., 1-6, such as 1, 2, 3, 4, 5, or 6) R as defined above. 4d replace.

[0344] In some implementation schemes, R 4b This indicates a heteroaryl group comprising one or two 5- to 7-membered rings and one to four heteroatoms selected from N, O, and S. In one sub-implementation, R 4bThis refers to an aromatic ring group comprising one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur, consisting of a 5- to 14-membered monocyclic or bicyclic ring. In one embodiment, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thienyl, thiazolyl, isothiazolyl, thiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indoleyl, isindoleyl, benzofuranyl, isobenzofuranyl, benzothiopheneyl, indoleyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3]oxadiazolyl, benzyl... [2,1,3]thiadiazolyl, benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridyl, cyclolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridyl, 1H-pyrrolo[3,2-b]pyridyl, 1H-pyrrolo[2,3-b]pyridyl, pyrrolo[2,1-b]thiazolyl, imidazo[2,1-b]thiazolyl, or imidazo[1,2-b]pyridazine. The heteroaryl group is optionally replaced by one or more (e.g., 1-6, e.g., 1, 2, 3, 4, 5, or 6) R as defined above. 4d replace.

[0345] In some implementations, PBM represents the structure of the following formulas (PBM-4-1), (PBM-4-2), (PBM-4-3), (PBM-4-4), or (PBM-4-5):

[0346] In some implementations, PBM represents the structure of the following formula (PBM-5):

[0347] in

[0348] R 5a Indicates hydrogen, C 1-10 Alkyl (e.g., C10) 1-8 Alkyl, C 1-6 Alkyl or C 1-4 Alkyl groups, such as methyl, ethyl, propyl, and isopropyl. Butyl, sec-butyl, tert-butyl, pentyl, hexyl, heptyl or octyl), deuterated C 1-10 Alkyl groups (e.g., fully deuterated C) 1-8 Alkyl, fully deuterated C 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-10 Alkyl groups (e.g., halogenated C) 1-8Alkyl or halogenated C 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0349] R 5b express Or a 4- to 12-membered nitrogen-containing heterocyclic group, wherein the 4- to 12-membered nitrogen-containing heterocyclic group is optionally selected by one or more independently selected from deuterium, halogens (e.g., fluorine, chlorine, bromine or iodine), hydroxyl groups, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-5 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), deuterated C 1-6 Alkoxy groups (e.g., fully deuterated C) 1-4Alkoxy groups, such as CD3-O-, CD3CD2-O-, or CD3CD2CD2-O-), NO2, NH2, cyano, or any combination thereof, are substituents. In some sub-implants, examples of 4- to 12-membered nitrogen-containing heterocyclic groups include, but are not limited to, aziridine, pyrrolidinyl, imidazoalkyl, pyrazolyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxacyclohexyl, aziridine heptyl, diazacycloheptyl (e.g., 1,4-diazacycloheptane-1-yl), aziridine octyl, diazacyclo octyl, aziridine-bicyclo[3.1.1]heptyl, aziridine-bicyclo[2. 2.1] Heptyl, azabicyclo[3.2.1] octyl, azabicyclo[2.2.2] octyl, diazabicyclo[3.1.1] heptyl, diazabicyclo[2.2.1] heptyl, diazabicyclo[3.2.1] octyl (e.g., 3,8-diazabicyclo[3.2.1] octane-3-yl), diazabicyclo[2.2.2] octyl (e.g., 2,5-diazabicyclo[2.2.2] octane-2-yl).

[0350] In some implementations, PBM represents the structure of the following formula (PBM-5-1) or formula (PBM-5-2):

[0351] In some implementations, PBM represents the structure of the following formula (PBM-44):

[0352] in

[0353] R 44a R 44b R 44c Each can be represented independently as CH or N;

[0354] R 44d -C(O)NHR 44h -NHC(O)R 44h -S(O)2NHR 44h -NHS(O)2R 44h -S(O)2R 44h or -P(O)(R 44h )2, where each R 44h The same or different and each independently represents C. 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-5 Alkyl, fully deuterated C 1-4 Alkyl or fully deuterated C 1-3Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-5 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0355] (R 44e ) p44a This indicates p44a substituents R 44e Each R 44e The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-5 Alkyl, fully deuterated C 1-4 Alkyl or fully deuterated C 1- 3 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-5 Alkoxy, C 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as trifluoromethoxy groups;

[0356] p44a represents the integer 0, 1, 2, 3 or 4;

[0357] (R 44f ) p44b This indicates p44b substituents R 44f Each R 44f The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-5 Alkyl, fully deuterated C 1-4 Alkyl or fully deuterated C 1- 3 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-5 Alkoxy, C 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as trifluoromethoxy groups;

[0358] p44b represents the integer 0, 1, or 2;

[0359] (R 44g ) p44c This indicates that the benzene ring connected to it may optionally be p44c R 44g Replacement, and each R 44g Each can be independently represented by a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, or C. 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-5 Alkyl, fully deuterated C 1-4 Alkyl or fully deuterated C 1-3 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-5 Alkoxy, C 1-4 Alkoxy or C 1-3Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as trifluoromethoxy groups; and

[0360] p44c represents the integer 0, 1, 2, 3, or 4.

[0361] In some implementation schemes, R 44a and R 44b Each can be represented independently as CH or N. In some sub-implementations, R 44a Represents CH, R 44b N represents N. In some sub-implementations, R represents N. 44a Represents CH, R 44b CH is indicated. In some sub-implementations, R... 44a Represents N, R 44b CH is indicated. In some sub-implementations, R... 44a Represents N, R 44b N represents N.

[0362] In some implementation schemes, R 44c Indicates CH or N. In some sub-implementations, R 44c N represents N. In some sub-implementations, R represents N. 44c It represents CH.

[0363] In some implementation schemes, R 44d -C(O)NHR 44h -NHC(O)R 44h -S(O)2NHR 44h -NHS(O)2R 44h -S(O)2R 44h or -P(O)(R 44h )2, where each R 44h The same or different and each independently represents C. 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-5 Alkyl, fully deuterated C 1-4 Alkyl or fully deuterated C 1-3 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-5 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-. In some sub-implementations, R 44d Represents -P(O)(R) 44h )2, where each R 44h The same or different and each independently represents C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-5 Alkyl, fully deuterated C 1-4 Alkyl or fully deuterated C 1-3 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-5 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-. In some sub-implementations, R 44d It represents -P(O)(CH3)2.

[0364] In some implementations, p44c represents the integer 0, 1, 2, 3, or 4. In some sub-implementations, p44c represents the integer 2.

[0365] In some implementations, PBM represents the structure of the following formulas (PBM-44-1), (PBM-44-2), (PBM-44-3), (PBM-44-4), or (PBM-44-5):

[0366] In some implementations, PBM represents a small molecule ligand for AR.

[0367] In some implementations, PBM represents the structure of the following formula (PBM-6):

[0368] in

[0369] Ring A represents C 6-10aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), ring A optionally surrounded by one or more (e.g., 1 to 10, 1 to 8, or 1 to 6, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) R 6a Replacement, and each R 6a The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 2-6 alkenyl (e.g., vinyl, propenyl, or butenyl), or C 2-6 Alkyne group (e.g., ethynyl, propynyl, or butynyl);

[0370] Ring B represents C 3-15 Cycloalkyl or 4- to 20-membered heterocyclic groups (e.g., 4- to 20-membered heterocyclic groups containing 1 to 4 heteroatoms selected from N, O, and S), wherein ring B is optionally surrounded by one or more (e.g., 1 to 10, 1 to 8, or 1 to 6, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) R 6b Replacement, and each R 6bThe same or different and independent of each other are deuterium, halogens (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-); and

[0371] The ring C represents a 5- to 20-membered heteroaryl group (e.g., a 5- to 20-membered monocyclic or bicyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O, and S), wherein the ring C is optionally surrounded by one or more (e.g., 1 to 10, 1 to 8, or 1 to 6, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) R groups. 6c Replacement, and each R 6c The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0372] In some implementations, PBM represents the structure of the following formula (PBM-6-1A):

[0373] in

[0374] In formula (PBM-6-1A), the benzene ring is optionally surrounded by one or more (e.g., 1-10, 1-8, or 1-6, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) R 6a Replacement, and each R 6a The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 2-6 alkenyl (e.g., vinyl, propenyl, or butenyl), or C 2-6 Alkyne group (e.g., ethynyl, propynyl, or butynyl);

[0375] Ring B represents C 3-15 Cycloalkyl or 4- to 20-membered heterocyclic groups (e.g., 4- to 20-membered heterocyclic groups containing 1 to 4 heteroatoms selected from N, O, and S), wherein ring B is optionally surrounded by one or more (e.g., 1 to 10, 1 to 8, or 1 to 6, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) R 6b Replacement, and each R 6b The same or different and independent of each other are deuterium, halogens (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0376] Q1 represents N or CH; and

[0377] In formula (PBM-6-1A), the heteroaryl group containing Q1 and a nitrogen atom is optionally surrounded by one or more (e.g., 1-3, e.g., 1, 2 or 3) R 6c Replacement, and each R 6c The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0378] In some implementations, ring B in equations (PBM-6) and (PBM-6-1A) independently represents C. 3-15 Cycloalkyl or 4- to 20-membered heterocyclic groups (e.g., 4- to 20-membered heterocyclic groups containing 1 to 4 heteroatoms selected from N, O, and S). C 3-15Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, decahydronaphthyl, octahydrocyclopentadienyl, octahydro-1H-indenyl, 2,3-dihydro-1H-indenyl, and spirocyclic (e.g., C14) 5-15 Spirocyclic), adamantyl, noradamantyl, and norbornel. C 3-15 The optional substituents of the cycloalkyl group are optionally selected from deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-). Examples of the 4- to 20-membered heterocyclic groups include, but are not limited to, azirrobutyl, oxacyclobutyl, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxacyclohexyl, azirrohepyl, diazacyclohepyl (e.g., 1,4-diazacycloheptan-1-yl), azirrooctyl, diazacyclooctyl, azirbicyclo[3.1.1]heptyl. Alkyl, azabicyclo[2.2.1]heptyl, azabicyclo[3.2.1]octyl, azabicyclo[2.2.2]octyl, diazabicyclo[3.1.1]heptyl, diazabicyclo[2.2.1]heptyl, diazabicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), diazabicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl). Optional substituents for the 4- to 20-membered heterocyclic groups are optionally selected from deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0379] In some implementations, PBM represents the structure of the following formulas (PBM-6-1), (PBM-6-2), (PBM-6-3), or (PBM-6-4):

[0380] In some implementations, PBM represents the structure of the following formula (PBM-7):

[0381] in

[0382] R 7a The designation represents a 4- to 20-membered heterocyclic group (e.g., a 4- to 20-membered heterocyclic group containing 1 to 4 heteroatoms selected from N, O, and S), wherein the 4- to 20-membered heterocyclic group is optionally surrounded by one or more (e.g., 1 to 10, 1 to 8, or 1 to 6, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) R 7c Replacement, and each R 7c The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-; and

[0383] (R 7b ) p7a This indicates that the benzene ring connected to it is surrounded by p7a R 7b Replace, each R 7b The same or different and each independently represents deuterium, halogens (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., p7a represents the integer 1, 2, 3 or 4.

[0384] In some implementation schemes, R 7aThe term refers to a 4- to 20-membered heterocyclic group (e.g., a 4- to 20-membered heterocyclic group containing 1 to 4 heteroatoms selected from N, O, and S), wherein examples of the 4- to 20-membered heterocyclic group include, but are not limited to, aziridine, oxacyclobutyl, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxacyclohexyl, aziridineheptyl, diazacycloheptyl (e.g., 1,4-diazacycloheptane-1-yl), aziridineheptane, and aziridineheptyl. Cyclooctyl, diazacyclooctyl, azabicyclo[3.1.1]heptyl, azabicyclo[2.2.1]heptyl, azabicyclo[3.2.1]octyl, azabicyclo[2.2.2]octyl, diazabicyclo[3.1.1]heptyl, diazabicyclo[2.2.1]heptyl, diazabicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), diazabicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl). In some embodiments, the 4- to 20-membered heterocyclic group is optionally replaced by one or more (e.g., 1-10, 1-8, or 1-6, e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) R 7c Replacement, and each R 7c Same or different and as defined above.

[0385] In some implementations, PBM represents the structure of the following formulas (PBM-7-1), (PBM-7-2), (PBM-7-3), or (PBM-7-4):

[0386] In some implementations, PBM represents the structure of the following formula (PBM-50):

[0387] in

[0388] (R 50a ) p50a This indicates that the benzene ring connected to it is surrounded by p50a R 50a Replace, each R 50a The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkyl-S(O)2, Halogenated C 1-6 Alkyl-S(O)2, Halogenated C 1-6 Alkyl-NHC(O), Halogenated C 1-6 Alkyl-C(O)NH, Halogenated C 1-6 Alkyl-NHS(O)2, Halogenated C 1-6 Alkyl-S(O)2NH, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), and p50a represents an integer 0, 1, 2, 3, or 4; and

[0389] R 50b Indicates hydrogen, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.

[0390] In some implementations, PBM represents the structure of the following formula (PBM-50-1):

[0391] In some implementations, PBM represents the structure of the following formula (PBM-51):

[0392] in

[0393] (R 51a ) p51a This indicates that the benzene ring connected to it is surrounded by p51a R 51a Replace, each R 51a The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, with optional substituted C groups. 3-15 Cycloalkyl or optionally substituted 4-15 membered heterocyclic groups containing 1-4 heteroatoms selected from N, O and S, where p51a represents an integer 0, 1, 2, 3, 4 or 5;

[0394] (R 51b ) p51bThis indicates that the benzene ring connected to it is surrounded by p51b R 51b Replace, each R 51b The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, with optional substituted C groups. 3-15 Cycloalkyl or optionally substituted 4-15 membered heterocyclic groups containing 1-4 heteroatoms selected from N, O and S, where p51b represents an integer 0, 1, 2, 3 or 4;

[0395] (R 51c ) p51c This indicates that the isoxazole ring connected to it is optionally replaced by p51c R 51c Replace, each R 51c The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C)1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, and p51c represents the integer 0, 1, or 2.

[0396] In some implementation schemes, R 51a and R 51b The same or different and each independently represents an alternative substitution C 3-15 Cycloalkyl or optionally substituted 4-15 membered heterocyclic groups containing 1-4 heteroatoms selected from N, O, and S. C 3-15 Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, decahydronaphthyl, octahydrocyclopentadienyl, octahydro-1H-indenyl, 2,3-dihydro-1H-indenyl, and spirocyclic (e.g., C14) 5-15 Spirocyclic), adamantyl, noradamantyl, and norbornel. C 3-15 The optional substituents of the cycloalkyl group are optionally selected from halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-). Examples of the 4- to 15-membered heterocyclic groups include, but are not limited to, azirrobutyl, oxacyclobutyl, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxacyclohexyl, azirrohepyl, diazacyclohepyl (e.g., 1,4-diazacycloheptan-1-yl), azirrooctyl, diazacyclooctyl, azirbicyclo[3.1.1]heptyl. Alkyl, azabicyclo[2.2.1]heptyl, azabicyclo[3.2.1]octyl, azabicyclo[2.2.2]octyl, diazabicyclo[3.1.1]heptyl, diazabicyclo[2.2.1]heptyl, diazabicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), diazabicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl). Optional substituents for the 4- to 15-membered heterocyclic group are optionally selected from halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups, such as methoxy, CD3-O-, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0397] In some implementations, PBM represents the structure of the following formula (PBM-51-1):

[0398] In some implementations, PBM represents the structure of the following formula (PBM-54):

[0399] in

[0400] In formula (PBM-54), (R) 54a ) p54a This indicates p54a substituents R 54a Each R 54a The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-5 Alkoxy or C 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), and p54a represents an integer 0, 1, 2, 3, or 4;

[0401] (R 54b ) p54b This indicates that the benzene ring connected to it may optionally be p54b R 54b Replace, each R 54b The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-5 Alkoxy or C 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, and p54b represents the integer 0, 1, 2, 3, or 4.

[0402] In some implementations, PBM represents the structure of the following formula (PBM-54-1):

[0403] In some implementations, PBM represents a small molecule ligand of BTK.

[0404] In some implementations, PBM represents the structure of the following formula (PBM-8):

[0405] in

[0406] In formula (PBM-8), X1 represents N or CR 8f , where R 8f X2 represents hydrogen, deuterium, or amino, and X2 represents N or CR. 8g , where R 8g X3 represents hydrogen or a bond, and X3 represents CH or N;

[0407] R 8a and R 8b Each can independently represent hydrogen or a bond;

[0408] (R 8c ) p8a This indicates that the benzene ring connected to it is surrounded by p8a R 8c Replace, each R 8c The same or different and each independently represents -O-aryl, -O-heteroaryl, 4- to 20-membered heterocyclic groups, -C 1-3 Alkylene-NHC(O)-heteroaryl, -C 1-3 alkylene-C(O)NH-heteroaryl, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; deuterium; deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.; halogens (such as fluorine, chlorine, bromine, or iodine); or halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-), wherein the 4- to 20-membered heterocyclic, aryl, and heteroaryl groups are each optionally and independently surrounded by one or more (e.g., 1 to 5, e.g., 1, 2, 3, 4, or 5) R groups. 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0409] p8a represents the integer 1, 2, 3 or 4;

[0410] R 8d Indicates bonds, hydrogen, halogens (e.g., fluorine, chlorine, bromine, or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), or C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy;

[0411] R 8e Indicates hydrogen, halogen (e.g., fluorine, chlorine, bromine, or iodine), cyano, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or amino groups;

[0412] Where R 8g R 8a R 8b and R 8d Not both are hydrogen, and R 8g R 8a R 8b and R 8dThere is one and only one key, where

[0413] When R 8a When representing a key, it is related to R. 8a The linked ring carbon atoms are directly connected to R c X2 represents CH or N, and R 8b It is hydrogen, and R 8d Not a key;

[0414] When X2 represents CR 8g , where R 8g When representing a key, it is related to R. 8g The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, and R 8d Not a key;

[0415] When R 8b When representing a key, it is related to R. 8b The linked cyclic nitrogen atom is directly connected to R c X2 represents N or CH, and R 8a It is hydrogen, and R 8d Not a key; or

[0416] When R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And X2 represents N or CH, and R 8a and R 8b Both are hydrogen.

[0417] In some implementations, R in formula (PBM-8) 8c It represents -O-aryl, -O-heteroaryl, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3 Alkylene-C(O)NH-heteroaryl, wherein the aryl group may be optionally substituted C 6-10 Aryl groups, including but not limited to phenyl or naphthyl groups, and heteroaryl groups, can be optionally substituted aromatic ring groups containing one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur, comprising 5- to 14-membered monocyclic, bicyclic, or polycyclic aromatic rings. In one embodiment, R 8c Represents -O-phenyl or -O-naphthyl, wherein the phenyl or naphthyl group is optionally surrounded by one or more (e.g., 1-5, such as 1, 2, 3, 4, or 5) R groups. 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10)1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implementation, R 8c Indicates -O-heteroaryl, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3 Alkylene-C(O)NH-heteroaryl, wherein the heteroaryl group is optionally surrounded by one or more (e.g., 1-5, e.g., 1, 2, 3, 4 or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implementation, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiophenyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indoleyl, isindoleyl, benzofuranyl, isobenzofuranyl, benzothiophenyl, indoleyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3] Oxadiazole, benzo[2,1,3]thiadiazole, benzo[1,2,3]thiadiazole, quinolinyl, isoquinolinyl, naphridinyl, cinolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, or imidazo[2,1-b]thiazolyl.

[0418] In some implementations, R in formula (PBM-8) 8c This refers to a 4- to 20-membered (e.g., 4- to 15-membered, 4- to 12-membered, 4- to 10-membered, 4- to 7-membered, or 4- to 6-membered) monocyclic, bicyclic, or polycyclic heterocyclic group, wherein the 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic group may be optionally substituted. In one sub-implementation, R 8cThis indicates a 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic group, which may optionally be surrounded by one or more (e.g., 1-5, such as 1, 2, 3, 4, or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implantation, examples of 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic groups include, but are not limited to, aziridine, oxazoridine, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxazolidinyl, aziridine-heptyl, diazacycloheptyl (e.g., 1,4-diazacycloheptane-1-yl), aziridine-octyl, diazacyclooctyl, and aziridine-bicyclic. [3.1.1]Heptyl, azabicyclo[2.2.1]Heptyl, azabicyclo[3.2.1]Octyl, azabicyclo[2.2.2]Octyl, diazabicyclo[3.1.1]Heptyl, diazabicyclo[2.2.1]Heptyl, diazabicyclo[3.2.1]Octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), diazabicyclo[2.2.2]Octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl).

[0419] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d It is not a key, and X2 represents N or CH.

[0420] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d Not a key, and X2 represents N, X1 represents CR 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0421] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d Not a key, and X2 represents N, X1 represents CR 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH.

[0422] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d It is not a key, and X2 represents N, X1 represents N, and X3 represents CH.

[0423] In some implementation schemes, R8b Indicates key, R 8a It is hydrogen, R 8d These are not keys, and X2 represents N, X1 represents N, and X3 represents N.

[0424] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d It is not a key, and X2 represents CH, X1 represents CR. 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0425] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d It is not a key, and X2 represents CH, X1 represents CR. 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH.

[0426] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d It is not a bond, and X2 represents CH, X1 represents N, and X3 represents CH.

[0427] In some implementation schemes, R 8b Indicates key, R 8a It is hydrogen, R 8d These are not keys, and X2 represents CH, X1 represents N, and X3 represents N.

[0428] In some implementations, when R 8a When representing a key, it is related to R. 8a The linked ring carbon atoms are directly connected to R c X2 represents CH or N, and R 8b It is hydrogen, and R 8d It's not a key.

[0429] In some implementation schemes, R 8a Indicates key, R 8b It is hydrogen, R 8d These are not keys, and X2 represents CH, X1 represents N, and X3 represents N.

[0430] In some implementation schemes, R 8a Indicates key, R 8b It is hydrogen, R 8d It is not a bond, and X2 represents CH, X1 represents N, and X3 represents CH.

[0431] In some implementation schemes, R8a Indicates key, R 8b It is hydrogen, R 8d It is not a key, and X2 represents CH, X1 represents CR. 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0432] In some implementation schemes, R 8a Indicates key, R 8b It is hydrogen, R 8d It is not a key, and X2 represents CH, X1 represents CR. 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH.

[0433] In some implementation schemes, R 8a Indicates key, R 8b It is hydrogen, R 8d Not a key, and X2 represents N, X1 represents CR 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0434] In some implementation schemes, R 8a Indicates key, R 8b It is hydrogen, R 8d Not a key, and X2 represents N, X1 represents CR 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH.

[0435] In some implementation schemes, R 8a Indicates key, R 8b It is hydrogen, R 8d It is not a key, and X2 represents N, X1 represents N, and X3 represents CH.

[0436] In some implementation schemes, R 8a Indicates key, R 8b It is hydrogen, R 8d These are not keys, and X2 represents N, X1 represents N, and X3 represents N.

[0437] In some implementations, when X2 represents CR 8g , where R 8g When representing a key, it is related to R. 8g The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, and R 8d It's not a key.

[0438] In some implementations, when X2 represents CR8g , where R 8g When representing a key, it is related to R. 8g The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, R 8d It is not a key, and X1 represents N, and X3 represents CH.

[0439] In some implementations, when X2 represents CR 8g , where R 8g When representing a key, it is related to R. 8g The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, R 8d It is not a key, and X1 represents N, and X3 represents N.

[0440] In some implementations, when X2 represents CR 8g , where R 8g When representing a key, it is related to R. 8g The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, R 8d It is not a key, and X1 represents CR. 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH.

[0441] In some implementations, when X2 represents CR 8g , where R 8g When representing a key, it is related to R. 8g The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, R 8d It is not a key, and X1 represents CR. 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0442] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And X2 represents N or CH, and R 8a and R 8b Both are hydrogen.

[0443] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to Rc And R 8a and R 8b All are hydrogen, and X2 represents N, X1 represents N, and X3 represents CH.

[0444] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And R 8a and R 8b All are hydrogen, and X2 represents N, X1 represents N, and X3 represents N.

[0445] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, and X2 represents N, X1 represents CR. 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0446] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, and X2 represents N, X1 represents CR. 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH.

[0447] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And R 8a and R 8b All are hydrogen, and X2 represents CH, X1 represents N, and X3 represents CH.

[0448] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And R 8a and R 8b All are hydrogen, and X2 represents CH, X1 represents N, and X3 represents N.

[0449] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to Rc And R 8a and R 8b Both are hydrogen, and X2 represents CH and X1 represents CR. 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH.

[0450] In some implementations, when R 8d When representing a key, it is related to R. 8d The linked ring carbon atoms are directly connected to R c And R 8a and R 8b Both are hydrogen, and X2 represents CH and X1 represents CR. 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0451] In some implementations, PBM represents the structure of the following formula (PBM-8-1A):

[0452] in

[0453] In formula (PBM-8-1A), X1 represents N or CR. 8f , where R 8f X1 represents hydrogen or amino, X2 represents N or CH, and X3 represents CH or N;

[0454] In formula (PBM-8-1A) (R) 8c ) p8a This indicates that the benzene ring connected to it is surrounded by p8a R 8c Replace, each R 8c The same or different and each independently represents -O-aryl, -O-heteroaryl, 4- to 20-membered heterocyclic groups, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3 alkylene-C(O)NH-heteroaryl, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; deuterium; deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.; halogens (such as fluorine, chlorine, bromine, or iodine); or halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-, wherein the 4- to 20-membered heterocyclic, aryl, and heteroaryl groups are each independently and optionally surrounded by one or more (e.g., 1 to 5, e.g., 1, 2, 3, 4, or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0455] p8a represents the integer 1, 2, 3 or 4;

[0456] R 8d Indicates hydrogen, halogens (e.g., fluorine, chlorine, bromine, or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), or C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy; for example, R 8d Indicates hydrogen or methyl; and

[0457] R 8e Indicates hydrogen, halogen (e.g., fluorine, chlorine, bromine, or iodine), cyano, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or amino groups.

[0458] In some implementations, the R of formula (PBM-8-1A) 8c It represents -O-aryl, -O-heteroaryl, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3Alkylene-C(O)NH-heteroaryl, wherein the aryl group may be optionally substituted C 6-10 Aryl groups, including but not limited to phenyl or naphthyl groups, and heteroaryl groups, can be optionally substituted aromatic ring groups containing one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur, of a 5- to 14-membered monocyclic or bicyclic aromatic ring. In one embodiment, R 8c Represents -O-phenyl or -O-naphthyl, wherein the phenyl or naphthyl group is optionally surrounded by one or more (e.g., 1-5, such as 1, 2, 3, 4, or 5) R groups. 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implementation, R 8c Indicates -O-heteroaryl, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3Alkylene-C(O)NH-heteroaryl, wherein the heteroaryl group is optionally surrounded by one or more (e.g., 1-5, e.g., 1, 2, 3, 4 or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implementation, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiophenyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indoleyl, isindoleyl, benzofuranyl, isobenzofuranyl, benzothiophenyl, indoleyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3] Oxadiazole, benzo[2,1,3]thiadiazole, benzo[1,2,3]thiadiazole, quinolinyl, isoquinolinyl, naphridinyl, cinolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, or imidazo[2,1-b]thiazolyl.

[0459] In some implementations, R in formula (PBM-8-1A) 8c This refers to a 4- to 20-membered (e.g., 4- to 15-membered, 4- to 12-membered, 4- to 10-membered, 4- to 7-membered, or 4- to 6-membered) monocyclic, bicyclic, or polycyclic heterocyclic group, wherein the 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic group may be optionally substituted. In one sub-implementation, R 8c This indicates a 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic group, which may optionally be surrounded by one or more (e.g., 1-5, such as 1, 2, 3, 4, or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implantation, examples of 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic groups include, but are not limited to, aziridine, oxazoridine, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxazolidinyl, aziridine-heptyl, diazacycloheptyl (e.g., 1,4-diazacycloheptane-1-yl), aziridine-octyl, diazacyclooctyl, and aziridine-bicyclic. [3.1.1]Heptyl, azabicyclo[2.2.1]Heptyl, azabicyclo[3.2.1]Octyl, azabicyclo[2.2.2]Octyl, diazabicyclo[3.1.1]Heptyl, diazabicyclo[2.2.1]Heptyl, diazabicyclo[3.2.1]Octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), diazabicyclo[2.2.2]Octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl).

[0460] In some implementations, X1 in formula (PBM-8-1A) represents N, X2 represents N, and X3 represents CH.

[0461] In some implementations, X1 in formula (PBM-8-1A) represents N, X2 represents N, and X3 represents N.

[0462] In some implementations, X1 in formula (PBM-8-1A) represents N, X2 represents CH, and X3 represents CH.

[0463] In some implementations, X1 in formula (PBM-8-1A) represents N, X2 represents CH, and X3 represents N.

[0464] In some implementations, X1 in formula (PBM-8-1A) represents CR 8f , where R 8f X1 represents hydrogen or amino, X2 represents N, and X3 represents N.

[0465] In some implementations, X1 in formula (PBM-8-1A) represents CR 8f , where R 8f X1 represents hydrogen or amino, X2 represents N, and X3 represents CH.

[0466] In some implementations, X1 in formula (PBM-8-1A) represents CR 8f , where R 8f X1 represents hydrogen or amino, X2 represents CH, and X3 represents N.

[0467] In some implementations, X1 in formula (PBM-8-1A) represents CR 8f , where R 8f X1 represents hydrogen or amino group, X2 represents CH, and X3 represents CH.

[0468] In some implementations, PBM represents the structure of the following formula (PBM-8-1):

[0469] In some implementations, PBM represents the structure of the following formula (PBM-8-1B):

[0470] in

[0471] In formula (PBM-8-1B), X1 represents N or CR. 8f , where R 8f X3 represents hydrogen or amino, and X3 represents CH or N;

[0472] In formula (PBM-8-1B) (R) 8c ) p8a This indicates that the benzene ring connected to it is surrounded by p8a R 8c Replace, each R 8c The same or different and each independently represents -O-aryl, -O-heteroaryl, 4- to 20-membered heterocyclic groups, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3alkylene-C(O)NH-heteroaryl, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; deuterium; deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.; halogens (such as fluorine, chlorine, bromine, or iodine); or halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-, wherein the 4- to 20-membered heterocyclic, aryl, and heteroaryl groups are each independently and optionally surrounded by one or more (e.g., 1 to 5, e.g., 1, 2, 3, 4, or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0473] p8a represents the integer 1, 2, 3 or 4;

[0474] R 8d Indicates hydrogen, halogens (e.g., fluorine, chlorine, bromine, or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C- groups. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), or C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy, for example, R 8d Indicates hydrogen or methyl; and

[0475] R 8e Indicates hydrogen, halogen (e.g., fluorine, chlorine, bromine, or iodine), cyano, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or amino groups.

[0476] In some implementations, the R of formula (PBM-8-1B) 8c It represents -O-aryl, -O-heteroaryl, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3 Alkylene-C(O)NH-heteroaryl, wherein the aryl group may be optionally substituted C 6-10 Aryl groups, including but not limited to phenyl or naphthyl groups, and heteroaryl groups, can be optionally substituted aromatic ring groups containing one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur, of a 5- to 14-membered monocyclic or bicyclic aromatic ring. In one embodiment, R 8c Represents -O-phenyl or -O-naphthyl, wherein the phenyl or naphthyl group is optionally surrounded by one or more (e.g., 1-5, such as 1, 2, 3, 4, or 5) R groups. 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implementation, R 8c Indicates -O-heteroaryl, -C 1-3 alkylene-NHC(O)-heteroaryl, or -C 1-3 Alkylene-C(O)NH-heteroaryl, wherein the heteroaryl group is optionally surrounded by one or more (e.g., 1-5, e.g., 1, 2, 3, 4 or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implementation, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiophenyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indoleyl, isindoleyl, benzofuranyl, isobenzofuranyl, benzothiophenyl, indoleyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3] Oxadiazole, benzo[2,1,3]thiadiazole, benzo[1,2,3]thiadiazole, quinolinyl, isoquinolinyl, naphridinyl, cinolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, or imidazo[2,1-b]thiazolyl.

[0477] In some implementations, R in formula (PBM-8-1B) 8c This refers to a 4- to 20-membered (e.g., 4- to 15-membered, 4- to 12-membered, 4- to 10-membered, 4- to 7-membered, or 4- to 6-membered) monocyclic, bicyclic, or polycyclic heterocyclic group, wherein the 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic group may be optionally substituted. In one sub-implementation, R 8c This indicates a 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic group, which may optionally be surrounded by one or more (e.g., 1-5, such as 1, 2, 3, 4, or 5) R 8h Replacement, and each R 8h The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In one sub-implantation, examples of 4- to 20-membered monocyclic, bicyclic, or polycyclic heterocyclic groups include, but are not limited to, aziridine, oxazoridine, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxazolidinyl, aziridine-heptyl, diazacycloheptyl (e.g., 1,4-diazacycloheptane-1-yl), aziridine-octyl, diazacyclooctyl, and aziridine-bicyclic. [3.1.1]Heptyl, azabicyclo[2.2.1]Heptyl, azabicyclo[3.2.1]Octyl, azabicyclo[2.2.2]Octyl, diazabicyclo[3.1.1]Heptyl, diazabicyclo[2.2.1]Heptyl, diazabicyclo[3.2.1]Octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), diazabicyclo[2.2.2]Octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl).

[0478] In some implementations, X1 in formula (PBM-8-1B) represents N, and X3 represents CH.

[0479] In some implementations, X1 in formula (PBM-8-1B) represents N, and X3 represents N.

[0480] In some implementations, X1 in formula (PBM-8-1B) represents CR 8f , where R8f X3 represents hydrogen or amino, and X3 represents CH.

[0481] In some implementations, X1 in formula (PBM-8-1B) represents CR 8f , where R 8f X is hydrogen or represents amino, and X3 represents N.

[0482] In some implementations, PBM represents the structure of the following formula (PBM-8-2):

[0483] In some implementations, PBM represents the structure of the following formula (PBM-41):

[0484] in

[0485] R 41a Indicates hydrogen, C 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-, with optional substituted C- groups. 3-15 Cycloalkyl (e.g., optionally substituted C) 3-11 Cycloalkyl) or optionally substituted 4- to 15-membered nitrogen-containing heterocyclic groups;

[0486] R 41b Indicates hydrogen, C1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-, with optional substituted C- groups. 3-15 Cycloalkyl (e.g., optionally substituted C) 3-11 cycloalkyl), optionally substituted 4- to 15-membered nitrogen-containing heterocyclic groups or NR 41e R 41f , where R 41e R 41f The same or different and each independently represents hydrogen and C. 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-) or optionally substituted 4- to 15-membered heterocyclic groups;

[0487] R 41c Indicates N or CH;

[0488] (R 41d ) p41a This indicates that the benzene ring connected to it may optionally be p41a R 41d Replace, each R 41d The same or different and each independently represents hydroxyl, amino, cyano, halogen (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-4Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-5 Alkoxy or C 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0489] p41a represents the integers 0, 1, 2, 3, or 4.

[0490] In some implementation schemes, R 41a Indicate C 1-6 Alkyl groups, such as, but not limited to, methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, and tert-butyl.

[0491] In some implementation schemes, R 41a It represents hydrogen.

[0492] In some implementation schemes, R 41a C represents an optional substitution 3-15 Cycloalkyl (e.g., optionally substituted C) 3-11 Cycloalkyl) or optionally substituted 4- to 15-membered nitrogen-containing heterocyclic groups. C 3-11 Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, decahydronaphthyl, octahydrocyclopentadienyl, octahydro-1H-indenyl, 2,3-dihydro-1H-indenyl, C 5-11 Spirocyclic, adamantyl, noradamantyl, and norbornelyl. C 3-11The optional substituents of the cycloalkyl group are optionally selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optionally C 1-3 Alkyl or halogen-substituted 2-oxoimidazolyl groups (e.g., 3-methyl-2-oxoimidazolyl-1-yl) or any combination thereof. In some embodiments, the optionally substituted 4- to 15-membered nitrogen-containing heterocyclic group is, for example, an optionally substituted monocyclic or bicyclic heterocyclic group containing one or more, e.g., 1-4 or 1, 2, 3 or 4, heteroatoms selected from nitrogen, oxygen and sulfur, of 4- to 8-membered (e.g., 4-7-, 4-6-, 5-7-, or 5-6-membered) heterocyclic groups, including but not limited to the following optionally substituted groups: aziridine, pyrrolidinyl, imidazolyl, pyrazolyl, oxazolyl, thiazolyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, aziridine-heptyl, diazaheptanyl (e.g., 1,4-diazaheptanyl). Alkyl-1-yl), azacyclooctyl, diazacyclooctyl, azabicyclo[3.1.1]heptyl, azabicyclo[2.2.1]heptyl, azabicyclo[3.2.1]octyl, azabicyclo[2.2.2]octyl, diazabicyclo[3.1.1]heptyl, diazabicyclo[2.2.1]heptyl, diazabicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), and diazabicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl). In some embodiments, the 4- to 15-membered nitrogen-containing heterocyclic group is optionally selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optionally C 1-3 Alkyl or halogen-substituted 2-oxoimidazolyl groups (e.g., 3-methyl-2-oxoimidazol-1-yl) or any combination thereof are substituted.

[0493] In some implementation schemes, R 41b C represents optional substitution 3-15 Cycloalkyl (e.g., optionally substituted C) 3-11 Cycloalkyl) or optionally substituted 4- to 15-membered nitrogen-containing heterocyclic groups. C 3-11Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, decahydronaphthyl, octahydrocyclopentadienyl, octahydro-1H-indenyl, 2,3-dihydro-1H-indenyl, C 5-11 Spirocyclic, adamantyl, noradamantyl, and norbornelyl. C 3-11 The optional substituents of the cycloalkyl group are optionally selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optionally C 1-3 Alkyl or halogen-substituted 2-oxoimidazolyl groups (e.g., 3-methyl-2-oxoimidazolyl-1-yl) or any combination thereof. In some embodiments, the optionally substituted 4- to 15-membered nitrogen-containing heterocyclic group is, for example, an optionally substituted monocyclic or bicyclic heterocyclic group containing one or more, e.g., 1-4 or 1, 2, 3 or 4 heteroatoms selected from nitrogen, oxygen and sulfur (e.g., 4-12, 4-10, 4-7, 4-6, 5-7, or 5-6 members), including but not limited to the following optionally substituted groups: aziridine, pyrrolidinyl, imidazolyl, pyrazolyl, oxazolyl, thiazolyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, aziridine heptyl, diaziridine heptyl (e.g., 1,4... -diazacycloheptan-1-yl), azircyclic octyl, azircyclic octyl, azirbicyclo[3.1.1]heptyl, azirbicyclo[2.2.1]heptyl, azirbicyclo[3.2.1]octyl, azirbicyclo[2.2.2]octyl, azirbicyclo[3.1.1]heptyl, azirbicyclo[2.2.1]heptyl, azirbicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), and azirbicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl). In some embodiments, the 4- to 15-membered nitrogen-containing heterocyclic group is optionally selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, C 1-6 Alkyl, Halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optionally C 1-3 Alkyl or halogen-substituted 2-oxoimidazolium alkyl groups (e.g., 3-methyl-2-oxoimidazolidine-1-yl) or any combination thereof are substituted. In some embodiments, R 41bThe label indicates a piperidinyl group, which may optionally be substituted with a 3-methyl-2-oxoimidazol-1-yl group.

[0494] In some implementation schemes, R 41b Indicates NR 41e R 41f , where R 41e R 41f The same or different and each independently represents hydrogen and C. 1-6 Alkyl (e.g., C10) 1-4 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or optionally substituted 4- to 15-membered heterocyclic groups. In some embodiments, the optionally substituted 4- to 15-membered heterocyclic groups are, for example, optionally substituted monocyclic or bicyclic heterocyclic groups containing one or more, such as 1-4 or 1, 2, 3 or 4, heteroatoms selected from nitrogen, oxygen and sulfur (e.g., 4-12, 4-10, 4-7, 4-6, 5-7, or 5-6), including but not limited to the following optionally substituted groups: aziridine, oxacyclobutyl, pyrrolidinyl, imidazolyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazolyl, piperidinyl, piperazine, morpholinyl, thiomorpholinyl, dioxacyclohexyl, etc. Azaheptanyl, diazaheptanyl (e.g., 1,4-diazaheptan-1-yl), azaheptanyl, diazaheptanyl, azabicyclo[3.1.1]heptyl, azabicyclo[2.2.1]heptyl, azabicyclo[3.2.1]octyl, azabicyclo[2.2.2]octyl, diazabicyclo[3.1.1]heptyl, diazabicyclo[2.2.1]heptyl, diazabicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octyl-3-yl), diazabicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octyl-2-yl). In some embodiments, the 4- to 15-membered heterocyclic group is optionally selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, C 1-6 Alkyl, Halogenated C 1-6Alkyl, deuterated C 1-6 Alkyl, C 3-6 cycloalkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optionally C 1-3 Alkyl or halogen-substituted 2-oxoimidazolium alkyl groups (e.g., 3-methyl-2-oxoimidazolidine-1-yl) or any combination thereof are substituted. In some embodiments, R 41b Indicates NR 41e R 41f , where R 41e R represents hydrogen. 41f It represents tetrahydropyranyl.

[0495] In some implementations, p41a represents the integer 0.

[0496] In some implementations, p41a represents 1, and R 41d It indicates methoxy, methyl, or fluorine.

[0497] In some implementations, PBM represents the structure of the following formula (PBM-41-2) or formula (PBM-41-3):

[0498] In some implementations, PBM represents the structure of the following formula (PBM-42-1A), formula (PBM-42-1B), or formula (PBM-42-1C):

[0499] In equations (PBM-42-1A), (PBM-42-1B), and (PBM-42-1C),

[0500] (R 42a ) p42a This indicates that the benzene ring connected to it may optionally be replaced by p42a R 42a Replace, each R 42a The same or different and each independently represents hydroxyl, amino, cyano, halogen (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0501] p42a represents the integers 0, 1, 2, 3, 4, or 5;

[0502] R 42b Representing O, S, C 1-3 Alkylene or halogenated C 1-3 Alkylene;

[0503] (R 42c ) p42b This indicates that the benzene ring connected to it may optionally be replaced by p42b R 42c Replace, each R 42c The same or different and each independently represents hydroxyl, amino, cyano, halogen (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy or C 1-3 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 alkoxy or halogenated C 1-3Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0504] p42b represents the integers 0, 1, 2, 3, or 4.

[0505] In some implementations, R of formula (PBM-42) 42b It represents O.

[0506] In some implementations, R of formula (PBM-42) 42b S represents the symbol S.

[0507] In some implementations, R of formula (PBM-42) 42b C represents 1-3 Alkylene. In some sub-implementations, R 42b It indicates methylene, ethylene, or propylene.

[0508] In some implementations, R of formula (PBM-42) 42b Indicates halogenated C 1-3 Alkylene. In some sub-implementations, R 42b It indicates fluoromethylene or difluoromethylene.

[0509] In some implementations, PBM represents the structure of the following formula (PBM-42-1):

[0510] In some implementations, PBM represents a small molecule ligand for CDK4 / 6.

[0511] In some implementations, PBM represents the structure of the following formulas (PBM-9-1A), (PBM-9-1B), (PBM-9-1C), or (PBM-9-1D):

[0512] in

[0513] Each R 9e Each can be used independently to represent deuterium, hydrogen, halogens (e.g., fluorine, chlorine, bromine, or iodine), or carbon. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., -C(O)-C 1-6 Alkyl groups (e.g., -C(O)-C) 1-5 Alkyl or -C(O)-C 1-3 Alkyl groups, such as -C(O)-CH3, -C(O)-CH2CH3, and -C(O)-deuterated C 1-6 Alkyl groups (e.g., -C(O)-deuterated C) 1-5 Alkyl or -C(O)-deuterated C 1-3 Alkyl groups, such as -C(O)-CD3) or -C(O)NR 9f R 9g , where R 9f R 9g The same or different and each independently represents hydrogen and C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups (such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl) or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., and R 9f R 9g They are not both hydrogen;

[0514] Each X5 represents N or CR independently. 9h , where R 9h It represents hydrogen, deuterium, halogens (such as fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl or halogenated C 1-3 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0515] X6 and X7 each independently represent CH or N;

[0516] R in equations (PBM-9-1B) and (PBM-9-1D) 9a Each independently represents an optionally substituted heteroaryl group (e.g., an optionally substituted 5- to 20-membered monocyclic, bicyclic, or polycyclic aromatic ring group containing one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur), wherein the heteroaryl group is optionally derived from one or two independently selected halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, or any combination thereof, are substituted with substituents.

[0517] Each R 9b Each independently represents hydrogen and C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or optionally substituted C4 groups. 3-12 Cycloalkyl groups (e.g., cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, or cycloheptyl, optionally selected, for example, from halogens, C 1-6 Alkyl, Halogenated C 1-6 Alkyl or deuterated C 1-6 Alkyl substituents);

[0518] Each (R) 9c ) p9a Each independently represents the pyridine ring to which it is connected, optionally represented by p9a R 9c Replace, each R 9c The same or different and each independently represents deuterium, halogens (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-), where p9a represents the integer 0, 1, 2, or 3; and

[0519] Each (R) 9d ) p9b Each independently represents the bicyclic nitrogen-containing heteroaryl ring connected to it, optionally represented by p9b R. 9d Replace, each R 9d The same or different and each independently represents deuterium, halogens (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1- 4-alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), deuterated C 1-6Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-), p9b represents the integer 0 or 1.

[0520] In some implementations, R in formulas (PBM-9-1B) and (PBM-9-1D) 9a Each independently represents an optionally substituted heteroaryl group, such as an optionally substituted 5- to 14-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur. Examples of heteroaryl groups include, but are not limited to, iminofuranyl, imoxazolyl, imoxazolyl, imoxadiazolyl, iminophenyl, imoxazolyl, imoxazolyl, imoxazolyl, imoxadiazolyl, iminopyrroleyl, iminoimidazolyl, iminopyridinyl, iminopyridinyl, iminopyridinyl, iminopyridyl, iminopyridyl, iminopyridyl, iminopyridyl, iminopyridyl, iminopyrrolyl, iminofuranyl, iminopyrrolyl, iminothiophenyl, iminopyridyl, iminoimidazolyl, iminoxazolyl, iminopyridyl, iminopyridyl, iminopyridyl, iminopyridyl, iminopyridyl, iminopyridyl[2,1,3]oxadiazolyl. Benzo[2,1,3]thiadiazolyl, Benzo[1,2,3]thiadiazolyl, Quinolinyl, Isoquinolinyl, Naphthidyl, Azolinyl, Quinolinyl, Quinoxalinyl, Phthaloazinyl, Pyrazolo[1,5-a]pyridinyl, Pyrazolo[1,5-a]pyrimidineyl, Imidazolo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, 4H-fluoro[3,2-b]pyrroleyl, Pyrrolo[2,1-b]thiazoleyl and Imidazolo[2,1-b]thiazoleyl. The heteroaryl group may optionally be substituted by one or more (e.g., 1-4, such as 1, 2, 3, or 4) substituents selected from the following: halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0521] In some implementations, PBM represents the structure of the following formula (PBM-9-1), formula (PBM-9-2), or formula (PBM-9-3):

[0522] In some implementations, PBM represents a small molecule ligand of ALK.

[0523] In some implementations, PBM represents the structure of the following formula (PBM-10):

[0524] in

[0525] In formula (PBM-10), (R) 10a ) p10a This indicates that the benzene ring connected to it may optionally be p10a R 10a Replace, each R 10a Each can be independently represented by deuterium, cyano, halogen (e.g., fluorine, chlorine, bromine, or iodine), or C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., p10a represents the integer 0, 1, 2, or 3; and

[0526] (R 10b ) p10b This indicates that the benzene ring connected to it may optionally be p10b R 10b Replace, each R 10b Each can be independently represented by deuterium, cyano, halogen (e.g., fluorine, chlorine, bromine, or iodine), or C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C)1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., p10b represents the integer 0, 1, 2, 3, or 4; and

[0527] Each R 10c and R 10d The same or different and independent of each other are deuterium and C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; halogens (such as fluorine, chlorine, bromine, or iodine); and halogenated C groups. 1-6 Alkyl groups (e.g., fluorine, chlorine, bromine, or iodine), deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0528] In some implementations, PBM represents the structure of the following formula (PBM-10-1):

[0529] In some implementations, PBM represents the structure of the following formula (PBM-11):

[0530] in

[0531] In formula (PBM-11), (R) 11a ) p11a This indicates that the benzene ring connected to it is surrounded by p11a R 11a Replace, each R 11a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkyl (e.g., C10) 1-5Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.

[0532] p11a represents the integer 1, 2, 3, 4, or 5; or

[0533] R 11b Indicates NR 11d R 11e , where R 11d R 11e The same or different and each independently represents hydrogen and C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.; and

[0534] R 11c This indicates deuterium, hydrogen, halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, amino, cyano, and C. 1-6 Alkyl (e.g., C10) 1- 5-alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.

[0535] In some implementations, PBM represents the structure of the following formula (PBM-11-1), (PBM-11-2), or (PBM-11-3):

[0536] In some implementations, PBM represents the structure of the following formula (PBM-12):

[0537] in

[0538] In formula (PBM-12), X8, X9, X 10 X 11 and X 12 The same or different and each independently represents N or CH;

[0539] R 12aThe methylene group represents a bonded or optionally substituted methylene group (e.g., a halogen-substituted methylene group);

[0540] R 12b Represents -C(O)N(R) 12f )R 12e -N(R) 12f )C(O)R 12e -S(O)2N(R) 12f )R 12e -N(R) 12f )S(O)2R 12e -S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., R 12f Indicates hydrogen or C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl);

[0541] In formula (PBM-12), (R) 12c ) p12a It indicates that the part connected to it contains X9 and X. 10 The six-membered ring can be optionally p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0542] p12a represents the integers 0, 1, 2, 3, or 4; and

[0543] R 12d This indicates deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, amino, cyano, and C. 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0544] In some implementations, R in formula (PBM-12) 12a This represents a bond. In other words, the X-containing bonds in equation (PBM-12) 11 and X 12 The six-membered ring is directly connected to -NH-.

[0545] In some implementations, R in formula (PBM-12) 12a This indicates an optional substituted methylene group (e.g., a halogen-substituted methylene group).

[0546] In some implementations, PBM represents the structure of the following formula (PBM-12-1A):

[0547] in

[0548] X8, X9 and X 10 The same or different and each independently represents N or CH;

[0549] R 12b Represents -C(O)N(R) 12f )R 12e -N(R) 12f )C(O)R 12e -S(O)2N(R) 12f )R 12e -N(R) 12f )S(O)2R 12e -S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., R 12f Indicates hydrogen or C 1-6Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl);

[0550] (R 12c ) p12a It indicates that the part connected to it contains X9 and X. 10 The six-membered ring can be optionally p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0551] p12a represents the integers 0, 1, 2, 3, or 4; and

[0552] R 12d This indicates deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, amino, cyano, and C. 1-6 Alkoxy groups (e.g., C) 1-4Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0553] In some implementations, PBM represents the structure of the following formula (PBM-12-1B):

[0554] in

[0555] X9 and X 10 The same or different and each independently represents N or CH;

[0556] R 12b Represents -C(O)N(R) 12f )R 12e -N(R) 12f )C(O)R 12e -S(O)2N(R) 12f )R 12e -N(R) 12f )S(O)2R 12e -S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., R 12f Indicates hydrogen or C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl);

[0557] (R 12c ) p12a It indicates that the part connected to it contains X9 and X. 10 The six-membered ring can be optionally p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0558] p12a represents the integers 0, 1, 2, 3, or 4.

[0559] In some implementations, PBM represents the structure of the following formula (PBM-12-1) or formula (PBM-12-2):

[0560] In some implementations, PBM represents a small molecule ligand for RET.

[0561] In some implementations, PBM represents the structure of the following formula (PBM-12-1C):

[0562] in

[0563] X9 and X 10 The same or different and each independently represents N or CH;

[0564] R 12b Represents -C(O)N(R) 12f )R 12e -N(R) 12f )C(O)R 12e -S(O)2N(R) 12f )R 12e -N(R) 12f )S(O)2R 12e -S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., R 12f Indicates hydrogen or C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl);

[0565] (R 12c ) p12a It indicates that the part connected to it contains X9 and X. 10 The six-membered ring can be optionally p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0566] p12a represents the integers 0, 1, 2, 3, or 4.

[0567] In some implementations, PBM represents the structure of the following formula (PBM-12-3), formula (PBM-12-4), or formula (PBM-12-5):

[0568] In some implementations, PBM represents the structure of the following formula (PBM-13):

[0569] in

[0570] Each (R) 13a ) p13a Each independently represents the benzene ring to which it is connected, optionally represented by p13a R. 13a Replace, each R 13a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0571] Each p13a may be the same or different and each represents an integer 0, 1, 2, 3 or 4 independently.

[0572] In some implementations, PBM represents the structure of the following formula (PBM-13-1), (PBM-13-2), or (PBM-13-3):

[0573] In some implementations, PBM represents a small molecule ligand of BET.

[0574] In some implementations, PBM represents the structure of the following formula (PBM-14):

[0575] in

[0576] In formula (PBM-14), (R) 14a ) p14a This indicates that the benzene ring connected to it is surrounded by p14a R 14a Replacement, p14a represents the integers 0, 1, 2, 3, 4, or 5, each R 14a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0577] Each R 14b The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0578] In some implementations, R in formula (PBM-14) x Indicates a key.

[0579] In some implementations, R in formula (PBM-14) x Indicates -C 1-3 Alkylene-C(O)-.

[0580] In some implementations, PBM represents the structure of the following formula (PBM-14-1) or (PBM-14-2):

[0581] In some implementations, PBM represents the structure of the following formula (PBM-15):

[0582] in

[0583] In formula (PBM-15), (R) 15a ) p15a This indicates that the benzene ring connected to it may optionally be p15a R 15a Replace, each R 15a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0584] p15a represents the integer 0, 1, 2, 3 or 4;

[0585] (R 15b ) p15b This indicates that the 4-oxo-3,4-dihydroquinazoline ring attached to it is surrounded by p15b R 15b Replace, each R 15b The same or different and each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0586] p15b represents the integers 1, 2, 3, or 4.

[0587] In some implementations, PBM represents the structure of the following formula (PBM-15-1):

[0588] In some implementations, PBM represents the structure of the following formula (PBM-16):

[0589] in

[0590] R in equation (PBM-16) 16a C represents 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising one or two 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), wherein the C 6-10 The aryl and 5- to 20-membered heteroaryl groups are each independently and optionally surrounded by one or more (e.g., 1-10, 1-8, 2-6, 1-5, 1-4, 1-3, or 2-5) R groups. 16d Replacement, and each R 16d The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 2-6 alkenyl, or C 2-6 alkynyl group;

[0591] In formula (PBM-16), (R) 16b ) p16a This indicates that the 1,2,3,4-tetrahydroquinoline ring connected to it is surrounded by p16a R 16b Replace, each R 16b The same or different and each independently represents deuterium, halogens (e.g., fluorine, chlorine, bromine or iodine), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0592] p16a represents the integer 0, 1, 2, 3 or 4;

[0593] In formula (PBM-16), (R) 16c ) p16b This indicates that the benzene ring connected to it is surrounded by p16b R 16c Replace, each R 16c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0594] p16b represents the integers 0, 1, 2, 3, or 4.

[0595] In some implementations, PBM represents the structure of the following formula (PBM-16-1):

[0596] In some implementations, PBM represents a small molecule ligand of BCR-ABL.

[0597] In some implementations, PBM represents the structure of the following formula (PBM-17):

[0598] in

[0599] In formula (PBM-17), (R) 17a ) p17a This indicates that the benzene ring connected to it is surrounded by p17a R 17a Replace, each R 17a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0600] p17a represents the integers 1, 2, 3, 4, or 5; and

[0601] R 17bIndicates halogens (e.g., fluorine, chlorine, bromine, or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0602] In some implementations, PBM represents the structure of the following formula (PBM-17-1):

[0603] In some implementations, PBM represents the structure of the following formula (PBM-18):

[0604] in

[0605] In formula (PBM-18), (R) 18a ) p18a This indicates that the quinoline ring connected to it is p18a R 18a Replace, each R 18a The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups (e.g., methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated carbon groups. 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0606] p18a represents the integers 1, 2, 3, or 4;

[0607] In formula (PBM-18), (R) 18b ) p18b This indicates that the benzene ring connected to it is surrounded by p18b R 18b Replace, each R 18b The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0608] p18b represents the integers 1, 2, 3, 4, or 5.

[0609] In some implementations, PBM represents the structure of the following formula (PBM-18-1):

[0610] In some implementations, the structure of the PBM representation (PBM-19) is as follows:

[0611] in

[0612] R 19a It represents -NHC(O)- or -C(O)NH-;

[0613] R 19b Represents -NH-, -N(C 1-6 alkyl)- or ethynyl group;

[0614] Ring D represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1-4 heteroatoms selected from N, O, and S. 19c ) p19a This indicates that the ring D can be optionally divided by p19a R. 19c Replacement, and each R 19c The same or different, and each independently, represent optional substituted 5- to 15-membered heteroaryl, deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C)1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0615] p19a represents the integers 0, 1, 2, or 3;

[0616] In formula (PBM-19), each (R) 19d ) p19b Each independently represents the benzene ring to which it is attached, and each can be optionally represented by a p19b R. 19d Replace, each R 19d The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0617] Each p19b may be the same or different and each represents an integer 0, 1, 2, 3 or 4 independently.

[0618] In some embodiments, ring D in formula (PBM-19) represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O, and S. In one sub-implantation, examples of 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thienyl, thiazolyl, isothiazolyl, thiazolyl, pyrroloyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, isindolyl, benzofuranyl, isobenzofuranyl, benzothiophene, indolyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3] [Oxadiazolyl, benzo[2,1,3]thiadiazolyl, benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridyl, cenolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridyl, 1H-pyrrolo[3,2-b]pyridyl, 1H-pyrrolo[2,3-b]pyridyl, pyrrolo[2,1-b]thiazolyl, imidazo[2,1-b]thiazolyl, or imidazo[1,2-b]pyridazinyl. The heteroaryl group is optionally surrounded by a p19a R. 19c Replacement, p19a represents the integers 0, 1, 2, or 3, and each R 19c The same or different and each independently represented: optionally substituted 5- to 15-membered heteroaryl, deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0619] In some implementations, R in formula (PBM-19) 19c The 5- to 15-membered heteroaryl group is optionally substituted. In some embodiments, the 5- to 15-membered heteroaryl group is an aromatic ring group of 5- to 14-membered monocyclic or bicyclic groups containing one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur. In some sub-implementations, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiophenyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indoleyl, isindoleyl, benzofuranyl, isobenzofuranyl, benzothiophenyl, indoleyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3]oxadiazolyl, benzyl [2,1,3]thiadiazolyl, benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridyl, cyclolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, imidazo[2,1-b]thiazolyl, or imidazo[1,2-b]pyridazinyl. The heteroaryl group is optionally substituted with one or more (e.g., 1-6, e.g., 1, 2, 3, 4, 5, or 6) substituents, wherein the substituents are optionally selected from: halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, or any combination thereof.

[0620] In some implementations, R in formula (PBM-19) 19b It represents -NH-.

[0621] In some implementations, R in formula (PBM-19) 19b It indicates ethynylene group.

[0622] In some implementations, PBM represents the structure of the following formula (PBM-19-1A):

[0623] in

[0624] R 19a It represents -NHC(O)- or -C(O)NH-;

[0625] (R 19c ) p19a This indicates that the pyrimidine group connected thereto is optionally replaced by p19a R 19c Replacement, and each R 19c The same or different, and each independently, represent optional substituted 5- to 15-membered heteroaryl, deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0626] p19a represents the integers 0, 1, 2, or 3;

[0627] In formula (PBM-19-1A), each (R) 19d ) p19b Each independently represents the benzene ring to which it is attached, and each can be optionally represented by a p19b R. 19d Replace, each R 19d The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0628] Each p19b may be the same or different and each represents an integer 0, 1, 2, 3 or 4 independently.

[0629] In some implementations, R in formula (PBM-19-1A) 19c The 5- to 15-membered heteroaryl group is optionally substituted. In some embodiments, the 5- to 15-membered heteroaryl group is an aromatic ring group of 5- to 14-membered monocyclic or bicyclic groups containing one or more (e.g., 1 to 6, 1 to 5, 1 to 4, or 1 to 3) heteroatoms independently selected from oxygen, nitrogen, and sulfur. In some sub-implementations, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiophenyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indoleyl, isindoleyl, benzofuranyl, isobenzofuranyl, benzothiophenyl, indoleyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3]oxadiazolyl, benzyl [2,1,3]thiadiazolyl, benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridyl, cyclolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, imidazo[2,1-b]thiazolyl, or imidazo[1,2-b]pyridazinyl. The heteroaryl group is optionally substituted with one or more (e.g., 1-6, e.g., 1, 2, 3, 4, 5, or 6) substituents, wherein the substituents are optionally selected from: halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C)1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C- groups. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, or any combination thereof.

[0630] In some implementations, PBM represents the structure of the following formula (PBM-19-1):

[0631] In some implementations, PBM represents the structure of the following formula (PBM-19-1B):

[0632] in

[0633] R 19a It represents -NHC(O)- or -C(O)NH-;

[0634] Ring D represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1-4 heteroatoms selected from N, O, and S. 19c ) p19a This indicates that the ring D can be optionally divided by p19a R. 19c Replacement, and each R 19c The same or different, and each independently, represent optional substituted 5- to 15-membered heteroaryl, deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C)1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0635] p19a represents the integers 0, 1, 2, or 3;

[0636] In formula (PBM-19-1B), each (R) 19d ) p19b Each independently represents the benzene ring to which it is attached, and each can be optionally represented by a p19b R. 19d Replace, each R 19d The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C)1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0637] Each p19b may be the same or different and each represents an integer 0, 1, 2, 3 or 4 independently.

[0638] In some embodiments, ring D in formula (PBM-19-1B) represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O, and S. In one sub-implantation, examples of 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thienyl, thiazolyl, isothiazolyl, thiazolyl, pyrroloyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, isindolyl, benzofuranyl, isobenzofuranyl, benzothiophene, indolyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3] [Oxadiazolyl, benzo[2,1,3]thiadiazolyl, benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridyl, cenolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridyl, 1H-pyrrolo[3,2-b]pyridyl, 1H-pyrrolo[2,3-b]pyridyl, pyrrolo[2,1-b]thiazolyl, imidazo[2,1-b]thiazolyl, or imidazo[1,2-b]pyridazinyl. The heteroaryl group is optionally surrounded by a p19a R. 19c Replacement, p19a represents the integers 0, 1, 2, or 3, and each R 19c The same or different and each independently represented: optionally substituted 5- to 15-membered heteroaryl, deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0639] In some implementations, R in formula (PBM-19-1B) 19cThe 5- to 15-membered heteroaryl group is optionally substituted. In some embodiments, the 5- to 15-membered heteroaryl group is a 5- to 14-membered monocyclic, bicyclic, or polycyclic aromatic ring group containing one or more (e.g., one to six, one to five, one to four, or one to three) heteroatoms independently selected from oxygen, nitrogen, and sulfur. In some sub-implementations, examples of heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thiophenyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indoleyl, isindoleyl, benzofuranyl, isobenzofuranyl, benzothiophenyl, indoleyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3]oxadiazolyl, benzyl [2,1,3]thiadiazolyl, benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridyl, cyclolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, imidazo[2,1-b]thiazolyl, or imidazo[1,2-b]pyridazinyl. The heteroaryl group is optionally substituted with one or more (e.g., 1-6, e.g., 1, 2, 3, 4, 5, or 6) substituents, wherein the substituents are optionally selected from: halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, or any combination thereof.

[0640] In some implementations, PBM represents the structure of the following formula (PBM-19-2):

[0641] In some implementations, PBM represents the structure of the following formula (PBM-46):

[0642] in

[0643] R in equation (PBM-46) 46a It represents NHC(O), C(O)NH, NHS(O)2 or S(O)2NH;

[0644] (R 46b ) p46a This indicates that the benzene ring connected to it may optionally be replaced by p46a R 46b Replacement, and each R 46b Each of these groups is independently a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, or C group. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy) or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-), and p46a represent integers 0, 1, 2, 3, 4, or 5; and

[0645] (R 46c ) p46b This indicates that the 1H-pyrazole ring connected thereto is optionally replaced by p46b R 46c Replacement, and each R 46c Each of these groups is independently a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, or C group. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C- groups. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy) or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, and p46b represent integers 0, 1, or 2.

[0646] In some implementations, p46a in equation (PBM-46) represents the integer 1, and R 46b It is a halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkyl (e.g., C10)1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy) or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-. In some embodiments, R 46b It is F2ClC-O-.

[0647] In some implementation schemes, R 46a Represents NHC(O). In some implementations, R 46a It represents C(O)NH.

[0648] In some implementations, p46b represents the integer 0.

[0649] In some implementations, PBM represents the structure of the following formula (PBM-46-1):

[0650] In some implementations, PBM represents a small molecule ligand of FAK.

[0651] In some implementations, PBM represents the structure of the following formula (PBM-12-1D):

[0652] in

[0653] In formula (PBM-12-1D), X8 and X 11 and X12 The same or different and each independently represents N or CH;

[0654] R 12a The methylene group represents a bonded or optionally substituted methylene group (e.g., a halogen-substituted methylene group);

[0655] R 12b Represents -C(O)N(R) 12f )R 12e -N(R) 12f )C(O)R 12e -S(O)2N(R) 12f )R 12e -N(R) 12f )S(O)2R 12e -S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, or deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., R 12f Indicates hydrogen or C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl);

[0656] In formula (PBM-12-1D), (R) 12c ) p12a This indicates that the benzene ring connected to it may optionally be p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0657] p12a represents the integers 0, 1, 2, 3, or 4; and

[0658] R 12d This indicates deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, amino, cyano, and C. 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0659] In some implementations, R in formula (PBM-12-1D) 12a This represents a bond. In other words, the X-containing bonds in equation (PBM-12-1D) are... 11 and X 12 The six-membered ring is directly connected to -NH-.

[0660] In some implementations, R in formula (PBM-12-1D) 12a This indicates an optional substituted methylene group (e.g., a halogen-substituted methylene group).

[0661] In some implementations, PBM represents the structure of the following formula (PBM-12-1E) or formula (PBM-12-1F):

[0662] in

[0663] X8, X 11 and X 12 The same or different and each independently represents N or CH;

[0664] Each R 12g They may be the same or different and each can independently represent hydrogen or halogen;

[0665] R 12b Represents -C(O)N(R) 12f )R 12e -N(R) 12f )C(O)R 12e -S(O)2N(R) 12f )R 12e -N(R) 12f )S(O)2R 12e -S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, or deuterated C1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., R 12f Indicates hydrogen or C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl);

[0666] (R 12c ) p12a This indicates that the benzene ring connected to it may optionally be p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, amino, cyano, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0667] p12a represents the integers 0, 1, 2, 3, or 4; and

[0668] R 12d This indicates deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, amino, cyano, and C. 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0669] In some implementations, PBM represents the structure of the following formulas (PBM-12-6), (PBM-12-7), (PBM-12-8), (PBM-12-9), (PBM-12-10), or (PBM-12-11):

[0670] In some implementations, PBM represents the structure of the following formula (PBM-47):

[0671] Where R 47a Indicates N or CH;

[0672] R 47b It represents O, S, NH, CH2, CH(F) or C(F)2;

[0673] R 47cThe methylene group represents a bonded or optionally substituted methylene group (e.g., a halogen-substituted methylene group);

[0674] Ring I represents C 6-15 aryl, 4- to 15-membered heterocyclic or 5- to 15-membered heteroaryl, (R 47d ) p47a This indicates that the ring I connected to it can optionally be p47a R 47d Replacement, and each R 47d The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, oxo, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, and p47a represent integers 0, 1, 2, 3, or 4;

[0675] (R 47e ) p47b It indicates that the one connected to it contains R 47a The six-membered nitrogen-containing heteroaryl ring is optionally replaced by a p47b R 47e Replace, each R 47e This indicates deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkoxy groups (e.g., C) 1-4Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-), and p47b represents the integers 0, 1 or 2;

[0676] (R 47f ) p47c This indicates that the benzene ring connected to it may optionally be replaced by p47c R 47f Replace, each R 47f The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, F2ClC-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-), and p47c represents the integers 0, 1, 2, 3 or 4.

[0677] In some implementation schemes, R 47a N represents N.

[0678] In some implementation schemes, R 47a It represents CH.

[0679] In some implementation schemes, R 47c Indicates a key.

[0680] In some implementation schemes, R 47c This indicates an optionally substituted methylene group (e.g., a methylene group optionally substituted with a halogen (e.g., fluorine, chlorine, bromine, or iodine)).

[0681] In some implementations, ring I represents C 6-15 Aryl, 4- to 15-membered heterocyclic, or 5- to 15-membered heteroaryl. C 6-15Examples of aryl groups include, but are not limited to, phenyl and naphthyl. Examples of 4- to 15-membered heterocyclic groups include, but are not limited to, azirrobutyl, oxacyclobutyl, pyrrolidinyl, imidazoalkyl, pyrazolyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiophenyl, tetrahydrothiaranyl, oxazolyl, thiazoalkyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dioxacyclohexyl, azirrohepyl, diazacyclohepyl (e.g., 1,4-diazacycloheptan-1-yl), azirrooctyl, diazacyclooctyl, azirbicyclo[3.1.1]heptyl , azabicyclo[2.2.1]heptyl, azabicyclo[3.2.1]octyl, azabicyclo[2.2.2]octyl, diazabicyclo[3.1.1]heptyl, diazabicyclo[2.2.1]heptyl, diazabicyclo[3.2.1]octyl (e.g., 3,8-diazabicyclo[3.2.1]octane-3-yl), diazabicyclo[2.2.2]octyl (e.g., 2,5-diazabicyclo[2.2.2]octane-2-yl). Examples of 5 to 15-membered heteroaryl groups include, but are not limited to, furanyl, oxazolyl, isoxazolyl, oxadiazolyl, thienyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrroleyl, imidazolyl, pyrazolyl, triazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, isindolyl, isindolinlinyl, benzofuranyl, isobenzofuranyl, benzothiopheneyl, inazolyl, benzimidazolyl, benzooxazolyl, benzoisooxazolyl, benzothiazolyl, benzotriazolyl, benzo[2,1,3]oxadiazolyl, benzyl [2,1,3]thiadiazolyl, benzo[1,2,3]thiadiazolyl, quinolinyl, isoquinolinyl, naphridyl, cenolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyrazolo[1,5-a]pyridyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridyl, 1H-pyrrolo[3,2-b]pyridyl, 1H-pyrrolo[2,3-b]pyridyl, 4H-fluoro[3,2-b]pyrrolyl, pyrrolo[2,1-b]thiazolyl and imidazo[2,1-b]thiazolyl.

[0682] In some implementations, (R) in formula (PBM-47) 47d ) p47a This indicates that the ring I can be optionally divided by p47a R 47d Replacement, and each R 47d The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, oxo, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, and p47a represent integers 0, 1, 2, 3, or 4.

[0683] In some embodiments, cycloI represents an isoindolinyl group, which is optionally further surrounded by a p47a R group. 47d Replacement, and each R 47d The same or different and independent of each other are deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, oxo, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1- 4 alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkoxy groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-, and p47a represent integers 0, 1, 2, 3, or 4. In some embodiments, p47a represents integers 0, 1, 2, 3, or 4. In some embodiments, ring I represents an isoindoline group, which may optionally be further converted by a halogen (e.g., fluorine, chlorine, bromine, or iodine), an oxo group, and C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, are substituted.

[0684] In some implementation schemes, (R 47e ) p47b It indicates that the one connected to it contains R 47a The six-membered nitrogen-containing heteroaryl ring is optionally replaced by a p47b R 47e Replace, each R 47e This indicates deuterium, halogens (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-), and p47b represent integers 0, 1, or 2. In some embodiments, each R... 47e Each can be independently represented as deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, nitro, or C. 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups (such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl) or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-), and p47b represents the integers 0, 1, or 2.

[0685] In some implementation schemes, (R 47f ) p47c This indicates that the benzene ring connected to it may optionally be replaced by p47c R 47f Replace, each R 47f The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, nitro, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-), and p47c represents the integers 0, 1, 2, 3, or 4. In some embodiments, each R 47f Each independently represents a halogen (e.g., fluorine, chlorine, bromine, or iodine) or C. 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and p47c represent integers 0, 1, 2, 3, or 4.

[0686] In some implementations, PBM represents the structure of the following formulas (PBM-47-1A), (PBM-47-1B), (PBM-47-1C), (PBM-47-2A), (PBM-47-2B), or (PBM-47-2C):

[0687] Among them, R 47a R 47c 、(R 47d ) p47a 、(R 47e ) p47b and (R) 47f ) p47c As defined in the various implementation schemes and sub-implementations of formula (PBM-47).

[0688] In some implementations, PBM represents the structure of the following formulas (PBM-47-1), (PBM-47-2), (PBM-47-3), or (PBM-47-4):

[0689] In some implementations, PBM represents a small molecule ligand for ER.

[0690] In some implementations, PBM represents the structure of the following formulas (PBM-20-1A), (PBM-20-1B), (PBM-20-1C), or (PBM-20-1D):

[0691] in

[0692] R 20a R 20b R 20c and R 20dThe same or different and each independently represents hydrogen, deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0693] In formulas (PBM-20-1A), (PBM-20-1B), (PBM-20-1C), and (PBM-20-1D), the symbol “” connecting the double bond indicates that the bond can be a stereo configuration (cis or trans, or E- or Z- configuration);

[0694] Each (R) 20e ) p20a Each independently represents the benzene ring to which it is attached, and each can be optionally represented by a p20a R. 20e Replace, each R 20e The same or different and each independently represents deuterium, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-; and

[0695] Each p20a may be the same or different and each independently represents the integer 0, 1, 2, 3 or 4.

[0696] In some implementations, PBM represents the structure of the following formulas (PBM-20-1), (PBM-20-2), (PBM-20-3), (PBM-20-4), (PBM-20-5), (PBM-20-6), (PBM-20-7), (PBM-20-8), (PBM-20-9), or (PBM-20-10):

[0697] In some implementations, PBM represents the structure of the following formula (PBM-21-1A) or formula (PBM-21-1B):

[0698] in

[0699] Each R 21d Each can independently represent O, S, or CH2;

[0700] (R 21c ) p21a This represents p21a R 21c Substituents, i.e., those containing R in formula (PBM-21) 21d The ten-element ring can be optionally p21a R 21c Replace, each R21c The same or different and each independently represents hydrogen, hydroxyl, halogen (e.g., fluorine, chlorine, bromine or iodine), hydroxyl, cyano, amino, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-);

[0701] p21a represents the integers 0, 1, 2, 3, or 4; and

[0702] R 21a and R 21b Each can independently represent hydrogen, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkoxy groups (e.g., C) 1-4 Alkoxy groups, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), and halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O- or CH2ClCH2-O-), C 1-6 Alkyl (e.g., C10)1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; deuterated C 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc., or halogenated C 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2-, or CH2ClCH2-.

[0703] In some implementations, PBM represents the structure of the following formulas (PBM-21-1), (PBM-21-2), (PBM-21-3), (PBM-21-4), (PBM-21-5), (PBM-21-6), (PBM-21-7), (PBM-21-8), (PBM-21-9), (PBM-21-10), (PBM-21-11), or (PBM-21-12):

[0704] In some implementations, PBM represents a small molecule ligand of IRAK4.

[0705] In some implementations, PBM represents the structure of the following formula (PBM-22):

[0706] in

[0707] In formula (PBM-22), ring E represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O, and S;

[0708] R 22b This indicates optional substituted 5- to 15-membered heteroaryl, optional substituted 5- to 15-membered heterocyclic, deuterium, halogen (e.g., fluorine, chlorine, bromine, or iodine), hydroxyl, cyano, amino, C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-);

[0709] R 22a Indicates hydrogen, halogens (e.g., fluorine, chlorine, bromine, or iodine), C 1-6 Alkyl (e.g., C10) 1-5 Alkyl, C 1-4 Alkyl or C 1-3 Alkyl groups, such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tert-butyl, pentyl, or hexyl; and halogenated C groups. 1-6 Alkyl groups (e.g., halogenated C) 1-4 Alkyl groups, such as F3C-, FCH2-, F2CH-, ClCH2-, Cl2CH-, CF3CF2-, CF3CHF-, CHF2CF2-, CHF2CHF-, CF3CH2- or CH2ClCH2-, and deuterated C. 1-6 Alkyl groups (e.g., fully deuterated C) 1-6 Alkyl, fully deuterated C 1-5 Alkyl or fully deuterated C 1-4 Alkyl groups, such as CD3, CD3CD2-, CD3CD2CD2-, etc.), C 1-6 Alkoxy groups (e.g., C) 1-4 Alkyl groups (such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butyloxy, or tert-butyloxy), or halogenated C 1-6 Alkoxy groups (e.g., halogenated C) 1-4Alkyl groups, such as F3C-O-, FCH2-O-, F2CH-O-, ClCH2-O-, Cl2CH-O-, CF3CF2-O-, CF3CHF-O-, CHF2CF2-O-, CHF2CHF-O-, CF3CH2-O-, or CH2ClCH2-O-.

[0710] In some embodiments, ring E in formula (PBM-22) represents a 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O, and S. In some embodiments, the 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl group is a divalent aromatic ring group containing 1 to 4 (e.g., 1 to 4, 1 to 3, 1 to 2, or 1) heteroatoms independently selected from oxygen, nitrogen, and sulfur. In some sub-implementations, examples of 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl groups include, but are not limited to, imidazolyl, imidazolyl, imidazolyl, imidadiazolyl, imidaphenyl, imidazolyl, imidazolyl, imidadiazolyl, imidaroxyl, imidazoly ... [2,1,3]oxadiazole subunit, benzo[2,1,3]thiadiazole subunit, benzo[1,2,3]thiadiazole subunit, quinoline, isoquinoline, naphthidyl, cinnamoline, quinoline, quinoline, quinoline, phthalazinyl, pyrazolo[1,5-a]pyridine subunit, pyrazolo[1,5-a]pyrimidine subunit, imidazo[1,2-a]pyridine subunit, 1H-pyrrolo[3,2-b]pyridine subunit, 1H-pyrrolo[2,3-b]pyridine subunit, pyrrolo[2,1-b]thiazolium subunit, imidazo[2,1-b]thiazolium subunit, or imidazo[1,2-b]pyridazinium subunit. 5- to 20-membered monocyclic, bicyclic, or polycyclic heteroaryl groups may optionally be further substituented by...

Claims

1. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof: PBM-LIN-ULM Formula (I) Wherein PBM represents a targeting moiety capable of binding to a protein, and PBM is covalently linked to ULM via the group LIN; ULM represents a ligand moiety capable of binding to an E3 ubiquitin ligase and represents a structure of the following formula (ULM): in A represents N or CH; R a1 、R a2 、R a3 and R a4 The same or different and each independently represents hydrogen, deuterium, halogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, deuterated C 1-6 Alkoxy or halogenated C 1-6 alkoxy; Ring W 1 represents an arylene group or a heteroarylene group, the ring W 1 Optionally, m R a5 Replace, each R a5 The same or different and each independently represents halogen, hydroxyl, mercapto, nitro, amino, cyano, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 Alkenyl, or C 2-6 Alkynyl; m represents an integer 0, 1, 2, 3 or 4; X represents a bond or -R b1 -N(R a6 )-R b2 -, where R a6 Represents hydrogen or C 1-6 Alkyl, and R b1 and R b2 Each independently represents an optionally substituted C 0-2 alkylene; LIN is a linking moiety, representing a bond, an optionally substituted methylene group, or an optionally substituted linear or branched C 2-15 Alkylene, wherein the linear or branched C 2-15 One or more adjacent carbon atoms of the main carbon chain skeleton of the alkylene group may be optionally interposed with one or more groups selected from the following: a 、R b and any combination thereof, each group R a Each independently selected from O, C(O), OC(O), S, S(O), S(O)2, S(O)2N(R a7 )、N(R a7 )S(O)2、C(O)N(R a7 )、N(R a7 )C(O), N(R a7 ) and N(R a7 )C(O)N(R a7 ), where each R a7 Each independently represents H or C 1-3 Alkyl, and when the linear or branched C 2-30 There are two or more groups R inserted into the main carbon chain skeleton of the alkylene group a When each group R a Not directly connected to each other; each group R b Each is independently selected from optionally substituted cycloalkylene, optionally substituted arylene, optionally substituted heterocyclylene, optionally substituted heteroarylene, alkynylene, alkenylene, and any combination thereof.

2. The compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof according to claim 1, wherein the PBM represents a small molecule ligand that binds to the following proteins: epidermal growth factor receptor (EGFR), cyclin-dependent kinase 4 / 6 (CDK4 / 6), cyclin-dependent kinase 2 (CDK2), anaplastic lymphoma kinase (ALK), activin receptor-like kinase 2 (ALK2), fibroblast growth factor receptors (FGFRs), proto-oncogene tyrosine-protein kinase receptor RET, focal adhesion kinase (FAK), breakpoint cluster region (BCC), cytokine receptor kinase kinase 2 (CCK ... region, BCR)-Abelson leukemia virus (ABL) (BCR-ABL) tyrosine kinase, Bruton tyrosine kinase (BTK), androgen receptor (AR), estrogen receptor (ER), bromodomain and extra-terminal domain protein (BET), interleukin-1 receptor-associated kinase 4 (IRAK4), cyclin-dependent kinase 9 (CDK9), histone-lysine N-methyltransferase EZH2 (EZH2), neurotrophic receptor tyrosine kinase (NTK), androgen receptor (AR), estrogen receptor (ER), bromodomain and extra-terminal domain protein (BET), interleukin-1 receptor-associated kinase 4 (IRAK4), cyclin-dependent kinase 9 (CDK9), histone-lysine N-methyltransferase EZH2 (EZH2), neurotrophic receptor tyrosine kinase (NTK), androgen receptor (AR), estrogen receptor (ER), bromodomain and extra-terminal domain protein (BET), interleukin-1 receptor-associated kinase 4 (IRAK4), cyclin-dependent kinase 9 (CDK9), histone-lysine N-methyltransferase EZH2 (EZH2), neurotrophic receptor tyrosine kinase (NTK), androgen receptor (AR), estrogen receptor (ER), bromodomain and extra-terminal domain protein (BET), interleukin-1 receptor-associated kinase 4 (IRAK4), cyclin-dependent kinaseNTRK), Src homology 2 domain containing protein tyrosine phosphatase (SHP2), Poly (ADP-ribose) polymerase (PARP), signal transducers and activators of transcription 3 (STAT3), FMS-like tyrosine kinase 3 (FLT3), BCL-2 (B cell lymphoma-2) family proteins, SOS Ras / Rac guanine nucleotide exchange factor 1 (SOS1) or GTPase Kras (KRAS), SWI / SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 / 4 2 / 4; SMARCA2 / 4) or ribosomal protein S6 kinase (RSK).

3. The compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof according to claim 1, wherein the PBM comprises a structure selected from the following formula: in (R 1a ) p1a Indicates that the benzene ring to which it is connected is surrounded by p1a R 1a Replace, each R 1a The same or different and each independently represents deuterium, halogen, hydroxyl, NH2, NO2, cyano, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; p1a represents an integer 1, 2, 3, 4, or 5; R 1b represents a bond or optionally selected from C 1-3 Alkyl, deuterated C 1-3 Alkyl, halogenated C 1-3 Alkyl and halogen substituted C 1-2 alkylene; (R 1c ) p1b The quinazoline ring in formula (PBM-1) is replaced by p1b R 1c Replace, each R 1c The same or different and each independently represents deuterium, halogen, NO2, cyano, halogenated C 1-6 Alkyl, C 1-10 Alkyl, deuterated C 1-10 Alkyl, C 1-10 Alkoxy, halogenated C 1- 10 Alkoxy, -O-optionally substituted heterocyclyl, or -NHC(O)R 1e , where R 1e Indicates C 1-10 Alkyl, deuterated C 1-10 Alkyl or C 2-10 Alkenyl, such as R 1c Represents methyl, methoxy, For example p1b represents an integer 1, 2, or 3; R 1d Represents hydrogen, deuterium or C 1-3 alkyl; (R 2a ) p2a Indicates that the benzene ring to which it is connected is surrounded by p2a R 2a Replace, each R 2a The same or different and each independently represents deuterium, halogen, nitro, cyano, halo C 1-6 Alkyl, C 1-10 Alkyl, deuterated C 1-10 Alkyl, C 1-10 Alkoxy or -NHC(O)R 2d , where R 2d Indicates C 1-10 Alkyl, deuterated C 1-10 Alkyl or C 2-10 Alkenyl, such as R 2a represents methyl, methoxy, nitro or p2a represents an integer 1, 2, 3, or 4; (R 2b ) p2b The 1H-indole ring in formula (PBM-2) is replaced by p2b R 2b substituted, p2b represents an integer of 0, 1, 2 or 3, and each R 2b The same or different and each independently represents deuterium, deuterated C 1-10 Alkyl, C 1-10 Alkyl, halogen or halogenated C 1-10 alkyl; R 2c Represents hydrogen, C 1-10 Alkyl, deuterated C 1-10 Alkyl, halogen or halogenated C 1-10 alkyl; (R 3a ) p3a Indicates that the benzene ring to which it is connected is p3a R 3a Replace, each R 3a The same or different and each independently represents deuterium, halogen, hydroxyl, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, NO2, NH2 or cyano; p3a represents an integer 0, 1, 2, 3, 4, or 5; R 3b represents substituted or unsubstituted C 3-15 cycloalkyl groups, such as cyclopentyl; R in formula (PBM-4) 4a Indicates C 6-10 aryl or 5- to 20-membered heteroaryl, the C 6-10 Aryl and 5- to 20-membered heteroaryl are each independently optionally substituted by one or more groups each independently selected from deuterium, halogen, hydroxy, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy or any combination thereof; R 4b Indicates C 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising 1 or 2 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O, and S), wherein the C 6-10 Aryl and the 5- to 20-membered heteroaryl are each independently optionally substituted by one or more R 4d Replace, and each R 4d The same or different and each independently is deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; (R 4c ) p4a The isoindoline ring in formula (PBM-4) is optionally replaced by p4a R 4c Replace, each R 4c The same or different and each independently represents deuterium, halogen, hydroxyl, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, NO2, NH2, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy or cyano; p4a represents an integer 0, 1, 2, or 3; R in formula (PBM-5) 5a Represents hydrogen, C 1-10 Alkyl (e.g. ), deuterated C 1-10 Alkyl or halogenated C 1-10 alkyl; R 5b express or a 4- to 12-membered nitrogen-containing heterocyclic group, wherein the 4- to 12-membered nitrogen-containing heterocyclic group is optionally substituted by one or more independently selected from deuterium, halogen, hydroxyl, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, NO2, NH2, cyano or any combination thereof; Ring A in formula (PBM-6) represents C 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl comprising 1 or 2 5- to 7-membered rings and 1-4 heteroatoms selected from N, O, and S), wherein the ring A is optionally substituted by one or more R 6a Replace, and each R 6a The same or different and each independently is deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 Alkenyl, or C 2-6 Alkynyl; Ring B in formula (PBM-6) represents C 3-15 Cycloalkyl or 4- to 20-membered heterocyclyl (e.g., 4- to 20-membered heterocyclyl containing 1 to 4 heteroatoms selected from N, O, and S), wherein the ring B is optionally substituted by one or more R 6b Replace, and each R 6b The same or different and each independently is deuterium, halogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; Ring C in formula (PBM-6) represents a 5- to 20-membered heteroaryl group (e.g., a 5- to 20-membered monocyclic or bicyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O, and S), and the ring C is optionally substituted by one or more R 6c Replace, and each R 6c The same or different and each independently is deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; R in formula (PBM-7) 7a represents a 4- to 20-membered heterocyclic group (e.g., a 4- to 20-membered heterocyclic group containing 1 to 4 heteroatoms selected from N, O and S), wherein the 4- to 20-membered heterocyclic group is optionally substituted by one or more R 7c Replace, and each R 7c The same or different and each independently is deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; (R 7b ) p7a Indicates that the benzene ring connected to it is p7a R 7b Replace, each R 7b The same or different and each independently represents deuterium, halogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, or deuterated C 1-6 Alkyl, p7a represents an integer of 1, 2, 3 or 4; X1 in formula (PBM-8) represents N or CR 8f , where R 8f represents hydrogen, deuterium or amino, X2 represents N or CR 8g , where R 8g represents hydrogen or represents a bond, and X3 represents CH or N; R 8a and R 8b each independently represents a hydrogen or represents a bond; (R 8c ) p8a Indicates that the benzene ring connected to it is p8a R 8c Replace, each R 8c The same or different and each independently represents -O-aryl, -O-heteroaryl, 4- to 20-membered heterocyclic group, -C 1-3 Alkylene-NHC(O)-heteroaryl, -C 1-3 Alkylene-C(O)NH-heteroaryl, C 1-6 Alkyl, deuterium, deuterated C 1-6 Alkyl, halogen, or halogenated C 1-6 alkyl, the 4- to 20-membered heterocyclyl, aryl and heteroaryl are each independently optionally substituted by one or more R 8h Replace, and each R 8h The same or different and each independently is deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; p8a represents the integer 1, 2, 3 or 4; R 8d Represents bonds, hydrogen, halogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkoxy, or C 1-6 alkoxy; R 8e Represents hydrogen, halogen, cyano, C 1-6 Alkyl, halogenated C 1-6 Alkyl or amino; where R 8g 、R 8a 、R 8b and R 8d are not hydrogen at the same time, and R 8g 、R 8a 、R 8b and R 8d There is only one key in When R 8a When indicating a key, 8a The attached ring carbon atom is directly connected to R c , X2 represents CH or N, and R 8b is hydrogen, and R 8d Not a key; When X2 represents CR 8g , where R 8g When indicating a key, 8g The attached ring carbon atom is directly connected to R c , and R 8a and R 8b are hydrogen, and R 8d Not a key; When R 8b When indicating a key, 8b The attached ring nitrogen atom is directly connected to R c , X2 represents N or CH, and R 8a is hydrogen, and R 8d is not a key; and When R 8d When indicating a key, 8d The attached ring carbon atom is directly connected to R c , and X2 represents N or CH, and R 8a and R 8b All are hydrogen; X4 in the formula (PBM-9) represents CR 9e or fragment The symbol # represents the connection point of N adjacent to X4, the symbol ## represents the connection point with X5, and each R 9e Each independently represents deuterium, hydrogen, halogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, -C(O)-C 1-6 Alkyl, -C(O)-deuterated C 1-6 Alkyl or -C(O)NR 9f R 9g , where R 9f 、R 9g are the same or different and each independently represent hydrogen, C 1-6 Alkyl or deuterated C 1-6 alkyl; X5 in the formula (PBM-9) represents N or CR 9h , where R 9h Represents hydrogen, deuterium, halogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; X6 and X7 each independently represent CH or N; R 9a represents a bond or an optionally substituted heteroarylene (e.g., a halogen- or deuterium-substituted heteroarylene); R 9b Represents hydrogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, or optionally substituted C 3-12 Cycloalkyl; (R 9c ) p9a Indicates that the pyridine ring connected thereto is optionally substituted with p9a R 9c Replace, each R 9c The same or different and each independently represents deuterium, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl, p9a represents an integer of 0, 1, 2 or 3; (R 9d ) p9b represents a bicyclic nitrogen-containing heteroaromatic ring connected thereto which is optionally replaced by p9b R 9d Replace, each R 9d The same or different and each independently represents deuterium, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl, p9b represents an integer of 0 or 1; (R 10a ) p10a The benzene ring connected thereto may be optionally replaced by p10a R 10a Replace, each R 10a The same or different and each independently represents deuterium, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl, or deuterated C 1-6 Alkyl, p10a represents an integer of 0, 1, 2 or 3; (R 10b ) p10b Indicates that the benzene ring connected thereto may be optionally replaced by p10b R 10b Replace, each R 10b The same or different and each independently represents deuterium, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl, or deuterated C 1- 6-alkyl, p10b represents an integer of 0, 1, 2, 3 or 4; Each R 10c and R 10d The same or different and each independently is deuterium, C 1-6 Alkyl, halogen, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; (R 11a ) p11a Indicates that the benzene ring connected to it is p11a R 11a Replace, each R 11a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl, or deuterated C 1-6 alkyl; p11a represents an integer 1, 2, 3, 4, or 5; R 11b Indicates NR 11d R 11e , where R 11d 、R 11e are the same or different and each independently represent hydrogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, or deuterated C 1-6 alkyl; R 11c Deuterium, hydrogen, halogen, hydroxyl, amino, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, halogenated C 1-6 Alkyl, or deuterated C 1-6 alkyl; X8, X9, X in formula (PBM-12) 10 、X 11 and X 12 are the same or different and each independently represent N or CH; R 12a represents a bond or an optionally substituted methylene group (e.g., a halogen-substituted methylene group); R 12b Represents -C(O)N(R 12f )R 12e 、-N(R 12f )C(O)R 12e 、-S(O)2N(R 12f )R 12e 、-N(R 12f )S(O)2R 12e 、-S(O)2R 12e or -P(O)(R 12e )2, where each R 12e The same or different and each independently represents C 1-6 Alkyl or deuterated C 1-6 Alkyl, R 12f Represents hydrogen or C 1-6 alkyl; (R 12c ) p12a Indicates that it is connected to X9 and X 10 The six-membered ring is optionally replaced by p12a R 12c Replace, each R 12c The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p12a represents an integer 0, 1, 2, 3, or 4; R 12d Denotes deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; Each (R 13a ) p13a Each independently represents the benzene ring connected thereto which is optionally replaced by p13a R 13a Replace, each R 13a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; Each p13a is the same or different and independently represents an integer of 0, 1, 2, 3 or 4; (R 14a ) p14a Indicates that the benzene ring connected to it is p14a R 14a substituted, p14a represents an integer of 0, 1, 2, 3, 4 or 5, each R 14a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; Each R 14b The same or different and each independently represents halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; R in formula (PBM-14) x Indicates a key or -C 1-3 Alkylene-C(O)-; (R 15a ) p15a Indicates that the benzene ring connected thereto may be optionally replaced by p15a R 15a Replace, each R 15a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p15a represents an integer 0, 1, 2, 3, or 4; (R 15b ) p15b Indicates that the 4-oxo-3,4-dihydroquinazoline ring connected to it is p15b R 15b Replace, each R 15b The same or different and each independently represents halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p15b represents the integer 1, 2, 3 or 4; R in formula (PBM-16) 16a Indicates C 6-10 aryl or 5- to 20-membered heteroaryl (e.g., 5- to 20-membered heteroaryl containing 1 or 2 5- to 7-membered rings and 1 to 4 heteroatoms selected from N, O and S), wherein C 6-10 Aryl and 5- to 20-membered heteroaryl are each independently optionally substituted by one or more R 16d Replace, and each R 16d The same or different and each independently is deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 Alkenyl, or C 2-6 Alkynyl; (R 16b ) p16a Indicates that the 1,2,3,4-tetrahydroquinoline ring connected to it is p16a R 16b Replace, each R 16b The same or different and each independently represents deuterium, halogen, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p16a represents an integer 0, 1, 2, 3, or 4; (R 16c ) p16b Indicates that the benzene ring connected to it is p16b R 16c Replace, each R 16c The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p16b represents the integer 0, 1, 2, 3 or 4; (R 17a ) p17a Indicates that the benzene ring connected to it is p17a R 17a Replace, each R 17a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p17a represents an integer 1, 2, 3, 4, or 5; R 17b Halogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; (R 18a ) p18a Indicates that the quinoline ring connected to it is p18a R 18a Replace, each R 18a The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p18a represents an integer 1, 2, 3, or 4; (R 18b ) p18b Indicates that the benzene ring connected to it is p18b R 18b Replace, each R 18b The same or different and each independently represents deuterium, halogen, hydroxyl, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p18b represents the integer 1, 2, 3, 4, or 5; R in formula (PBM-19) 19a represents -NHC(O)- or -C(O)NH-; R 19b Indicates -NH-, -N(C 1-6 alkyl)- or ethynylene; Ring D in formula (PBM-19) represents a 5- to 20-membered monocyclic or bicyclic or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O and S, (R 19c ) p19a Indicates that the ring D is optionally replaced by p19a R 19c Replace, and each R 19c Same or different and each Each of the following independently represents an optionally substituted 5- to 15-membered heteroaryl, deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; p19a represents an integer 0, 1, 2, or 3; Each (R 19d ) p19b Each independently represents that the benzene ring connected thereto is each independently optionally replaced by p19b R 19d Replace, each R 19d The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; Each p19b is the same or different and independently represents an integer of 0, 1, 2, 3 or 4; R in formula (PBM-20) 20a 、R 20b 、R 20c and R 20d Each independently represents a bond, hydrogen, deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl, where R 20a 、R 20b 、R 20c and R 20d There is only one bond, and the remaining three are the same or different and each independently represent hydrogen, halogen, or hydroxyl, wherein when R 20a 、R 20b 、R 20c and R 20d When one of them represents a bond, the benzene ring or methylene group in the formula (PBM-20) to which it is connected is directly connected to R c ; Symbols of connecting double bonds in formula (PBM-20) represents a bond that can be in a stereoconfiguration (cis or trans, or E- or Z-configuration); Each (R 20e ) p20a Each independently represents that the benzene ring connected thereto is each independently optionally replaced by p20a R 20e Replace, each R 20e The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; Each p20a is the same or different and independently represents an integer of 0, 1, 2, 3 or 4; R in formula (PBM-21) 21d represents O, S or CH2; (R 21c ) p21a Indicates p21a R 21c Substituents, each R 21c The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p21a represents an integer 0, 1, 2, 3, or 4; R 21a and R 21b There is only one that represents a bond, and the other represents hydrogen, halogen, hydroxyl, cyano, amino, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 Alkyl, where R 21a and R 21b When one of them represents a bond, the benzene ring carbon atom connected thereto in formula (PBM-21) is directly connected to R c ; Ring E in formula (PBM-22) represents a 5- to 20-membered monocyclic or bicyclic or polycyclic heteroarylene group containing 1 to 4 heteroatoms selected from N, O and S; R 22b represents an optionally substituted 5- to 15-membered heteroaryl, an optionally substituted 5- to 15-membered heterocyclyl, deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; R 22a Represents hydrogen, halogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; R in formula (PBM-23) 23a represents an optionally substituted 5- to 15-membered heterocyclic group, an optionally substituted 5- to 15-membered heteroaryl group, deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; R 23b represents a 5- to 20-membered monocyclic or bicyclic or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O and S, said heteroaryl group being optionally substituted by one or more radicals selected from deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy or any combination thereof; (R 24a ) p24a The isoquinoline ring in the formula (PBM-24) is optionally replaced by p24a R 24a Replace, each R 24a The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, -C(O)NH2, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p24a represents an integer 0, 1, 2, 3, or 4; (R 24b ) p24b The pyrrolidone ring in the formula (PBM-24) is optionally replaced by p24b R 24b Replace, each R 24b The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, -C(O)NH2, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p24b represents an integer 0, 1, 2, 3, or 4; In formula (PBM-24), y represents an integer of 1, 2 or 3; R in formula (PBM-25) 25g Indicates N or CR 25h , where R 25h represents hydrogen or halogen, R 25i Indicates N or CR 25j , where R 25j represents hydrogen or halogen; R 25f represents a bond, -C(O)NH-, -NHC(O)-, -S(O)2NH- or -NHS(O)2-; (R 25a ) p25a In the expression (PBM-25), R 25g and R 25i The six-membered ring is optionally replaced by p25a R 25a Replace, each R 25a The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p25a represents an integer 0, 1, or 2; R 25b Represents hydrogen, halogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl or -C 1-3 Alkylene-C 3-6 Cycloalkyl; R 25c Represents hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; or R 25b and R 25c together with the corresponding nitrogen and carbon atoms to which they are respectively attached, form an optionally substituted 5- to 7-membered nitrogen-containing heterocyclic ring; R 25d represents hydrogen or bond, R 25e represents hydrogen or a bond, where R 25d and R 25e are not hydrogen at the same time, and R 25d and R 25e There is only one bond and one hydrogen in the 25d When indicating a key, 25d The attached ring carbon atom is directly connected to R c , and when R 25e When indicating a key, 25e The attached ring carbon atom is directly connected to R c ; R in formula (PBM-26) 26a Indicates key, C 1-3 Alkylene or halogenated C 1-3 alkylene; R 26b represents halogen, optionally substituted C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, or optionally substituted C 3-15 Cycloalkyl; (R 26c ) p26a The benzene ring in the formula (PBM-26) is optionally replaced by p26a R 26c Replace, each R 26c The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p26a represents an integer 0, 1, 2, 3, or 4; R in formula (PBM-27) 27a Indicates C 1-3 Alkylene or halogenated C 1-3 alkylene; R 27b Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, or optionally substituted C 3-6 Cycloalkyl; R 27c and R 27d Each independently represents S or O; R in formula (PBM-28) 28a Indicates C 1-3 Alkylene or halogenated C 1-3 alkylene; (R 28b ) p28a Indicates that the pyrazolo[1,5-a]pyrimidine ring attached thereto is optionally replaced by p28a R 28b Replace, each R 28b The same or different and each independently represents hydroxyl, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p28a represents an integer 0, 1, 2, or 3; R 28c and R 28d The same or different and each independently represents hydrogen, optionally substituted C 1-10 Alkyl or optionally substituted C 3-6 Cycloalkyl; (R 28e ) p28b Indicates that the benzene ring connected thereto may be optionally replaced by p28b R 28e Replace, each R 28e The same or different and each independently represents halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p28b represents an integer 0, 1, 2, 3, or 4; R in formula (PBM-29) 29a Indicates -S- or fragment When R 29a When -S- is represented, the formula (PBM-29) contains R 29a and nitrogen atoms is a thiazolyl ring, and when R 29a Representation fragment When the formula (PBM-29) contains R 29a and the heteroaryl ring of the nitrogen atom is a pyridyl ring; R 29b Indicates N or CH; R 29c represents hydrogen or optionally substituted C 1-10 alkyl; R 29d Represents hydrogen, -C 1-3 Alkylene-optionally substituted 4- to 10-membered heterocyclyl, or optionally substituted 4- to 10-membered heterocyclyl; R 29e Represents hydroxyl, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; R in formula (PBM-30) 30a Indicates O or S; R 30b Indicates N or CH; R 30c and R 30d The same or different and each independently represents hydroxyl, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; (R 30e ) p30a Indicates that the benzene ring connected thereto may be optionally replaced by p30a R 30e Replace, each R 30e The same or different and each independently represents deuterium, hydroxyl, halogen, amino, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, -S(O)2NH2 or -C(O)NH2; p30a represents an integer 0, 1, 2, 3, 4, or 5; R in formula (PBM-31) 31a Indicates C(O)NH, NHC(O), (CH2) 1-2 C(O)NH, (CH2) 1-2 NHC(O), C(O)NH(CH2) 1-2 、NHC(O)(CH2) 1-2 , S(O)2NH or NHS(O)2; R 31b Represents hydrogen, hydroxyl, halogen, cyano, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; R 31c Represents hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; or R 31b and R 31c Together with the carbon atom and nitrogen atom to which they are attached and the carbon atom of the benzene ring to which the nitrogen atom is attached, they form an optionally substituted 4- to 6-membered heteroaryl ring or an optionally substituted 4- to 6-membered heterocyclic ring; R 31d represents an optionally substituted C 3-6 Cycloalkyl, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 alkyl or an optionally substituted 4- to 20-membered heterocyclic group; (R 31e ) p31a Indicates that the pyridin-2(1H)-one ring connected to it is replaced by p31a R 31e Replace, each R 31e The same or different and each independently represents hydroxyl, halogen, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p31a represents an integer 0, 1, 2, or 3; Ring F in formula (PBM-31) represents an arylene group or a 5- to 20-membered monocyclic or bicyclic heteroarylene group containing 1 to 4 heteroatoms selected from N, O and S; (R 31f ) p31b Indicates that the ring F is optionally replaced by p31b R 31f Replace, and each R 31f The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1- 6 alkoxy, or halogenated C 1-6 alkoxy; p31b represents an integer 0, 1, 2, 3, or 4; R in formula (PBM-32) 32c represents an optionally substituted C 1-3 alkylene; (R 32a ) p32a Indicates that the benzene ring connected to it is p32a R 32a Replace, each R 32a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p32a represents the integer 0, 1, 2, 3, 4, or 5; (R 32b ) p32b Indicates that the 1H-indazole ring connected to it is separated by p32b R 32b Replace, each R 32b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p32b represents the integer 0, 1, 2, 3, 4, or 5; R 32d represents C(O)NH, NHC(O), S(O)2NH or NHS(O)2; R 32e Indicates NR 32f R 32g , where R 32f 、R 32g are the same or different and each independently represent hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, optionally substituted C 3-6 cycloalkyl or an optionally substituted 4- to 8-membered heterocyclic group; X in formula (PBM-33) 13 、X 14 and X 15 are the same or different and each independently represent CH or N, wherein X 13 、X 14 and X 15 Not N at the same time, and including X 13 、X 14 and X 15 The six-membered ring may be further substituted by 1 or 2 groups selected from halogen, hydroxy, cyano, amino, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl or any combination thereof substituted substituents; Ring G in formula (PBM-33) represents a pyrrole ring, an imidazole ring, a pyrazole ring, a benzene ring, a pyridine ring, a pyrimidine ring or a pyrazine ring; (R 33a ) p33a Indicates that the benzene ring connected thereto may be optionally replaced by p33a R 33a Replace, each R 33a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p33a represents an integer 0, 1, 2, 3, 4, or 5; (R 33b ) p33b Indicates that the tetrahydropyrrole ring connected thereto is optionally replaced by p33b R 33b Replace, each R 33b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p33b represents an integer 0, 1, 2, 3, 4, 5, or 6; R 33c and R 33d The same or different and each independently represents hydrogen, halogen, hydroxyl, amino, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; (R 33e ) p33c Indicates that the ring G connected to it is optionally replaced by p33c R 33e Replace, each R 33e The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p33c represents an integer 0 or 1; X in formula (PBM-34) 16 、X 17 and X 18 Each independently represents CH or N; R 34a represents a bond, S or NH; R 34b represents a bond, an optionally substituted cycloalkyl group or an optionally substituted 4- to 15-membered nitrogen-containing heterocyclic group; R 34c Represents a bond, halogen, amino, hydroxyl, cyano, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl, halogenated C 1-6 an alkyl group, an optionally substituted cycloalkyl group, or an optionally substituted 4- to 15-membered nitrogen-containing heterocyclic group; where R 34b and R 34c are not bonds at the same time, and R 34b and R 34c There is only one bond in R 34b When indicating a key, 34b The attached ring carbon atom is directly connected to R c , and when R 34c When indicating a key, 34c The attached ring carbon atom is directly connected to R c ; (R 34d ) p34a Indicates that the six-membered ring connected thereto may be optionally replaced by p34a R 34d Replace, each R 34d The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p34a represents an integer 0, 1, 2, 3, or 4; (R 34e ) p34b represents a nitrogen-containing six-membered heteroaromatic ring connected thereto, which is optionally replaced by p34b R 34e Replace, each R 34e The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1- 6 alkyl or halogenated C 1-6 alkyl; p34b represents an integer 0, 1, or 2; (R 35a ) p35a Indicates that the phthalazinone ring connected thereto is optionally replaced by p35a R 35a Replace, each R 35a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p35a represents an integer 0, 1, 2, 3, or 4; R 35b represents an optionally substituted C 1-3 alkylene; (R 35c ) p35b Indicates that the benzene ring connected thereto may be optionally replaced by p35b R 35c Replace, each R 35c The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p35b represents an integer 0, 1, 2, 3, or 4; (R 36a ) p36a Indicates that the 2H-indazole ring connected thereto may be optionally replaced by p36a R 36a Replace, each R 36a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p36a represents an integer 0, 1, 2, or 3; (R 36b ) p36b Indicates that the benzene ring connected thereto may be optionally replaced by p36b R 36b Replace, each R 36b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p36b represents an integer 0, 1, 2, 3, or 4; (R 37a ) p37a Indicates that the benzofuran ring connected thereto is optionally replaced by p37a R 37a Replace, each R 37a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p37a represents an integer 0, 1, 2, or 3; (R 37b ) p37b Indicates that the benzene ring connected thereto may be optionally replaced by p37b R 37b Replace, each R 37b The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p37b represents an integer 0, 1, 2, or 3; (R 38a ) p38a Indicates that the benzene ring connected thereto may be optionally replaced by p38a R 38a Replace, each R 38a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p38a represents an integer 0, 1, 2, 3, or 4; R 38b 、R 38c 、R 38d The same or different and each independently represents hydrogen, deuterium, hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; R in formula (PBM-39) 39a 、R 39b The same or different and each independently represents hydrogen, halogen, C 1-3 Alkyl or halogenated C 1-3 alkyl; R 39c Represents bonds, hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; y1 represents an integer 1, 2, or 3; R 39d Represents the following structure: where R 39e represents a bond or hydrogen; (R 39f ) p39a Indicates that the benzene ring connected thereto is optionally replaced by p39a R 39f Replace, each R 39f The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl, and p39a represents an integer of 0, 1, 2, 3 or 4; y2 represents an integer of 1, 2 or 3; or R 39d Represents the following structure: Among them (R 39g ) p39b Each independently represents that the benzene ring connected thereto is optionally replaced by p39b R 39g Replace, each R 39g The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl, and p39b represents an integer of 0, 1, 2, 3, 4 or 5; where R 39c and R 39e are not bonds at the same time, and R 39c and R 39e There is only one key in R 39c When indicating a key, 39c The attached ring nitrogen atom is directly connected to R c , and when R 39e When indicating a key, 39e The attached ring carbon atom is directly connected to R c ; (R 40a ) p40a The benzene ring connected thereto may be optionally replaced by p40a R 40a Replace, each R 40a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p40a represents an integer 0, 1, 2, 3, or 4; R in the formula (PBM-40) x3 represents a bond or C(O); R in formula (PBM-41) 41a Represents hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, optionally substituted C 3-15 cycloalkyl or an optionally substituted 4- to 15-membered nitrogen-containing heterocyclic group; R 41b Represents hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, optionally substituted C 3-15 Cycloalkyl, optionally substituted 4- to 15-membered nitrogen-containing heterocyclic group or NR 41e R 41f , where R 41e 、R 41f are the same or different and each independently represent hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 alkyl or an optionally substituted 4- to 15-membered heterocyclic group; R 41c Indicates N or CH; (R 41d ) p41a Indicates that the benzene ring connected thereto may be optionally replaced by p41a R 41d Replace, each R 41d The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p41a represents an integer 0, 1, 2, 3, or 4; (R 42a ) p42a Indicates that the benzene ring connected thereto may be optionally replaced by p42a R 42a Replace, each R 42a The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p42a represents an integer 0, 1, 2, 3, 4, or 5; R 42b Indicates O, S, C 1-3 Alkylene or halogenated C 1-3 alkylene; (R 42c ) p42b Indicates that the benzene ring connected thereto may be optionally replaced by p42b R 42c Replace, each R 42c The same or different and each independently represents hydroxyl, amino, cyano, halogen, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; p42b represents an integer 0, 1, 2, 3, or 4; Ring H in formula (PBM-43) represents C 6-15 Arylene or 5- to 15-membered monocyclic or bicyclic or polycyclic heteroarylene, (R 43a ) p43a Indicates that the ring H is optionally replaced by p43a R 43a Replace, and each R 43a are the same or different and are each independently deuterium, halogen, Hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1- 6 alkoxy; p43a represents an integer 0, 1, 2, 3, or 4; R 43b represents an optionally substituted 5- to 20-membered monocyclic or bicyclic or polycyclic heteroaryl group containing 1 to 4 heteroatoms selected from N, O and S, which is optionally selected from hydroxy, amino, cyano, halogen, nitro, C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkyl or halogenated C 1-6 Substitution of alkyl groups; R in the formula (PBM-44) 44a 、R 44b 、R 44c Each independently represents CH or N; R 44d Represents -C(O)NHR 44h 、-NHC(O)R 44h 、-S(O)2NHR 44h 、-NHS(O)2R 44h 、-S(O)2R 44h or -P(O)(R 44h )2, where each R 44h The same or different and each independently represents C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; (R 44e ) p44a Indicates p44a substituents R 44e , each R 44e The same or different and each independently represents halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; p44a represents an integer 0, 1, 2, 3, or 4; (R 44f ) p44b Indicates p44b substituents R 44f , each R 44f The same or different and each independently represents halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy; p44b represents an integer 0, 1, or 2; (R 44g ) p44c The benzene ring connected thereto may be optionally replaced by p44c R 44g Replace, and each R 44g Each independently represents halogen, hydroxy, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1- 6 alkoxy; p44c represents the integer 0, 1, 2, 3, or 4; R in the formula (PBM-45) x1 Indicates a bond or C(O), or R x1 Represents -C(O)NH-R x2 -C(O)-***, where the symbol *** represents the c The connection point, and R x2 represents an optionally substituted C 3-15 Cycloalkyl; (R 45a ) p45a Indicates that the 1H-pyrrolo[2,3-b]pyridine ring attached thereto is optionally replaced by p45a R 45a Replace, and each R 45a are independently cyano, halogen, hydroxy, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1- 6 alkoxy, or halogenated C 1-6 alkoxy, and p45a represents an integer of 0, 1, 2, 3, 4 or 5; (R 45b ) p45b Indicates that the pyridine ring connected thereto is optionally replaced by p45b R 45b Replace, and each R 45b are independently cyano, halogen, hydroxyl, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 Alkoxy or NR 45c R 45d , where R 45c 、R 45d are the same or different and each independently represent hydrogen, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, optionally substituted C 3-15 cycloalkyl or optionally substituted 4- to 15-membered heterocyclyl, and p45b represents an integer of 0, 1, 2 or 3; R in formula (PBM-46) 46a represents NHC(O), C(O)NH, NHS(O)2 or S(O)2NH; (R 46b ) p46a Indicates that the benzene ring connected thereto is optionally replaced by p46a R 46b Replace, and each R 46b are independently halogen, hydroxy, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p46a represents an integer of 0, 1, 2, 3, 4 or 5; (R 46c ) p46b Indicates that the 1H-pyrazole ring connected thereto is optionally replaced by p46b R 46c Replace, and each R 46c are independently halogen, hydroxy, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p46b represents an integer of 0, 1 or 2; R in formula (PBM-47) 47a Indicates N or CH, R 47b represents O, S, NH, CH2, CH(F) or C(F)2; R 47c represents a bond or an optionally substituted methylene group (e.g., a halogen-substituted methylene group); Ring I represents C 6-15 aryl, 4- to 15-membered heterocyclic group or 5- to 15-membered heteroaryl, (R 47d ) p47a Indicates that the ring I connected thereto is optionally replaced by p47a R 47d Replace, and each R 47d The same or different and each independently is deuterium, halogen, hydroxyl, cyano, amino, nitro, oxo, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p47a represents an integer of 0, 1, 2, 3 or 4; (R 47e ) p47b Indicates that it contains R 47a The six-membered nitrogen-containing heteroaromatic ring is optionally replaced by p47b R 47e Replace, each R 47e Each independently represents deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl, and p47b represents an integer of 0, 1 or 2; (R 47f ) p47c The benzene ring connected thereto may be optionally replaced by p47c R 47f Replace, each R 47f The same or different and each independently represents deuterium, halogen, hydroxyl, cyano, amino, nitro, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1- 6 alkyl or halogenated C 1-6 alkyl, and p47c represents an integer of 0, 1, 2, 3 or 4; R in formula (PBM-48) 48a 、R 48b and R 48c Each independently represents N or CH; (R 48d ) p48a It indicates that the naphthyl group connected thereto is optionally replaced by p48a R 48d Replace, each R 48d Each independently represents halogen, hydroxyl, amino, mercapto, nitro, cyano, C 2-6 Alkynyl, C 2-6 Alkenyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl, and p48a represents an integer of 0, 1, 2, 3, 4, 5, 6 or 7; R 48e represents an optionally substituted C 3-15 cycloalkyl or an optionally substituted 4-15 membered heterocyclyl containing 1-4 heteroatoms selected from N, O and S; R 48f Represents hydrogen, halogen, hydroxyl, cyano, amino, mercapto, nitro, C 2-6 Alkynyl, C 2-6 Alkenyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 1-6 Alkyl, deuterated C 1-6 Alkyl or halogenated C 1-6 alkyl; R in formula (PBM-49) 49a Indicates N or CH; R 49b represents NHC(O), C(O)NH, NHS(O)2 or S(O)2NH; (R 49c ) p49a Indicates R-containing 49a The six-membered ring of p49a is 49c Replace, each R 49c The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p49a represents an integer of 0, 1, 2, 3 or 4; Ring J represents a 5- to 15-membered heteroarylene group, (R 49d ) p49b Indicates that the ring J connected to it is optionally replaced by p49b R 49d Replace, each R 49d The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, hydroxy substituted C 1-6 Alkyl, amino substituted C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy or optionally substituted C 3-15 cycloalkyl, and p49b represents an integer of 0, 1, 2 or 3; (R 50a ) p50a Indicates that the benzene ring connected to it is p50a R 50a Replace, each R 50a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkyl-S(O)2, halogenated C 1-6 Alkyl-S(O)2, halogenated C 1-6 Alkyl-NHC(O), halogenated C 1-6 Alkyl-C(O)NH, Halogenated C 1-6 Alkyl-NHS(O)2, halogenated C 1-6 Alkyl-S(O)2NH, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p50a represents an integer of 0, 1, 2, 3 or 4; R 50b Represents hydrogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl or deuterated C 1-6 alkyl; (R 51a ) p51a Indicates that the benzene ring connected to it is p51a R 51a Replace, each R 51a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optionally substituted C 3-15 cycloalkyl or an optionally substituted 4-15 membered heterocyclyl containing 1-4 heteroatoms selected from N, O and S, and p51a represents an integer of 0, 1, 2, 3, 4 or 5; (R 51b ) p51b Indicates that the benzene ring connected to it is p51b R 51b Replace, each R 51b The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, optionally substituted C 3-15 cycloalkyl or an optionally substituted 4-15 membered heterocyclyl containing 1-4 heteroatoms selected from N, O and S, and p51b represents an integer of 0, 1, 2, 3 or 4; (R 51c ) p51c Indicates that the isoxazole ring connected thereto is optionally replaced by p51c R 51c Replace, each R 51c The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p51c represents an integer of 0, 1 or 2; The dashed line in formula (PBM-52) indicates the optional presence of a double bond; (R 52a ) p52a The six-membered cycloalkyl group connected thereto is optionally replaced by p52a R 52a Replace, each R 52a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, oxo, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p52a represents an integer of 0, 1, 2, 3, 4, 5, 6, 7 or 8; (R 52b ) p52b Indicates that the benzene ring connected thereto may be optionally replaced by p52b R 52b Replace, each R 52b The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p52b represents an integer of 0, 1, 2, 3, 4 or 5; (R 52c ) p52c The six-membered cycloalkyl group connected thereto is optionally replaced by p52c R 52c Replace, each R 52c The same or different and each independently represents halogen, cyano, oxo, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p52c represents an integer of 0, 1, 2, 3, 4, 5, 6, 7 or 8; (R 52d ) p52d Indicates that the benzene ring connected thereto is optionally replaced by p52d R 52d Replace, each R 52d The same or different and each independently represents halogen, hydroxyl, mercapto, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy or and p52d represents an integer 0, 1, or 2; (R 52e ) p52e Indicates that the benzene ring connected thereto may be optionally replaced by p52e R 52e Replace, each R 52e The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, -SO2CF3, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p52e represents an integer of 0, 1, 2, 3 or 4; R 52f represents hydrogen, deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy or Where y3 represents an integer 1, 2 or 3; (R 53a ) p53a Represents p53a substituent R 53a , each R 53a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p53a represents an integer of 0, 1, 2, 3, 4 or 5; (R 53b ) p53b Indicates that the benzene ring connected thereto may be optionally replaced by p53b R 53b Replace, each R 53b The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p53b represents an integer of 0, 1, 2, 3 or 4; and R 53c Indicates C 1-6 Alkylene or halogenated C 1-6 alkylene; (R 54a ) p54a Indicates p54a substituent R 54a , each R 54a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p54a represents an integer of 0, 1, 2, 3 or 4; (R 54b ) p54b Indicates that the benzene ring connected thereto may be optionally replaced by p54b R 54b Replace, each R 54b The same or different and each independently represents deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p54b represents an integer of 0, 1, 2, 3 or 4; (R 55a ) p55a Represents p55a substituent R 55a , each R 55a The same or different and each independently represents halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 alkoxy, and p55a represents an integer of 0, 1, 2, 3 or 4; R 55b 、R 55c are the same or different and each independently represent hydrogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 alkyl, or optionally substituted aryl; R in the formula (PBM-55) 55d Representation fragment The symbol ### indicates the connection point with the ring carbon atom, the symbol **** indicates the connection point with the ring nitrogen atom, and R 55e represents an optionally substituted aryl group or an optionally substituted heteroaryl group, and R 55f Represents hydrogen, halogen, C 1-6 Alkyl, halogenated C 1-6 Alkyl or deuterated C 1-6 Alkyl; and R in each general formula c Each independently represents a bond, -O-, -N(R d )-, -NHC(O)-*, -C(O)NH-*, -N(R d )-R f -N(R e )-*、-R f -C(O)NH-*、-R f -NHC(O)-*、-R f -C(O)O-*、-R f -OC(O)-*, -C(O)O-*, -OC(O)-*, -R f -、-R f -N(R d )-*、-OR f -N(R d )-*、 Among them, each ring W 2 are the same or different and each independently represent a nitrogen-containing heterocyclic group, t1 represents an integer of 1 or 2, (R c1 ) m2 Indicates each ring W 2 Each independently optionally represented by m2 R c1 Group substitution, each R c1 Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogen, amino, hydroxy, mercapto, cyano, carboxyl, C 2-6 Alkynyl, C 2-6 Alkenyl, optionally deuterated C 3-6 Cycloalkyl, or R c4 -R c3 -, where R c3 is an optional substituted C 1-6 Alkylene or optionally substituted C 2-6 Alkenylene, R c4 Represents halogen, R c5 R c6 N-, hydroxy, carboxyl, ethynyl, or vinyl, where R c5 and R c6 The same or different and each independently represents hydrogen or C 1-3 alkyl, and m2 represents an integer of 0-20; Each ring W 3 are the same or different and each independently represent a heterocyclylene group, a cycloalkylene group, an arylene group, or a heteroarylene group, t2 represents an integer of 0 or 1, (R c2 ) m3 Indicates each ring W 3 Independently optionally m3 R c2 Group substitution, each R c2 Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogen, amino, hydroxy, mercapto, cyano, carboxyl, C 2-6 Alkynyl, C 2-6 Alkenyl, optionally deuterated C 3-6 Cycloalkyl, or R c8 -R c7 -, where R c7 is an optional substituted C 1-6 Alkylene or optionally substituted C 2-6 Alkenylene, R c8 Represents halogen, R c9 R c10 N-, hydroxy, carboxyl, ethynyl, or vinyl, where R c9 and R c10 The same or different and each independently represents hydrogen or C 1-3 alkyl, and m3 represents an integer of 0-20; and R d and R e Each independently represents hydrogen or C 1-6 Alkyl, R f and R g Each independently represents an optionally substituted C 1-6 Alkylene or optionally substituted C 2-6 alkenylene, and the symbol * indicates the point of attachment to LIN.

4. The compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof according to claim 3, wherein the PBM represents a structure of the following formula: where R c As defined in claim 3.

5. The compound of formula (I) or its salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph as claimed in claim 3, wherein The R c represents a bond, -O-, -NHC(O)-*, -C(O)NH-*, -C(O)O-*, -OC(O)-*, or -NH-, or R c Represents the following structure: -N(R d )-、-N(R d )-R f -N(R e )-*、-R f -C(O)NH-*、-R f -NHC(O)-*、-R f -C(O)O-*、-R f -OC(O)-*、-R f -、-R f -N(R d )-*、-O-R f -N(R d )-*、 Among them, each ring W 2 are the same or different and each independently represent a 4- to 20-membered nitrogen-containing heterocyclic group, t1 represents an integer of 1 or 2, (R c1 ) m2 Indicates each ring W 2 Each independently optionally represented by m2 R c1 Group substitution, each R c1 Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogen, amino, hydroxy, mercapto, cyano, carboxyl, C 2-6 Alkynyl, C 2-6 Alkenyl, optionally deuterated C 3-6 Cycloalkyl, or R c4 -R c3 -, where R c3 is an optional substituted C 1-6 Alkylene or optionally substituted C 2-6 Alkenylene, R c4 Represents halogen, R c5 R c6 N-, hydroxy, carboxyl, ethynyl, or vinyl, where R c5 and R c6 The same or different and each independently represents hydrogen or C 1-3 alkyl, and m2 represents an integer of 0-20; Each ring W 3 are the same or different and each independently represent a 4- to 20-membered nitrogen-containing heterocyclic group, C 3-20 Cycloalkylene, C 6-20 arylene, or 5- to 20-membered heteroarylene, t2 represents an integer of 0 or 1, (R c2 ) m3 Indicates each ring W 3 Independently optionally m3 R c2 Group substitution, each R c2 Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogen, amino, hydroxy, mercapto, cyano, carboxyl, C 2- 6 alkynyl, C 2-6 Alkenyl, optionally deuterated C 3-6 Cycloalkyl, or R c8 -R c7 -, where R c7 is an optional substituted C 1-6 Alkylene or optionally substituted C 2-6 Alkenylene, R c8 Represents halogen, R c9 R c10 N-, hydroxy, carboxyl, ethynyl, or vinyl, where R c9 and R c10 The same or different and each independently represents hydrogen or C 1-3 alkyl, and m3 represents an integer of 0-20; and R d and R e Each independently represents hydrogen or C 1-6 Alkyl, R f and R g Each independently represents an optionally substituted C 1-6 Alkylene or optionally substituted C 2-6 alkenylene; The C 1-6 Alkylene and C 2-6 Each alkenylene group is independently optionally substituted with one or more radicals selected from deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 Substitution of the alkoxy group by a substituent; and The symbol * indicates the connection point to LIN.

6. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof as claimed in any one of claims 3 to 5, wherein Each ring W 2 The same or different and each independently represent a 4- to 15-membered nitrogen-containing heterocyclic group, for example piperidinylene, piperazinylene, morpholinylene, azetidinylene, pyrrolidinylene, imidazolidinylene, pyrazolidinylene, oxazolidinylene, thiazolidinylene, thiomorpholinylene, azepanylene, diazepanylene, azaocinylene, diazaocinylene, azabicyclo[3.1.1]heptanylene, azabicyclo[2.2.1]heptanylene, azabicyclo[3.2.1]octanylene, azabicyclo[2.2.2]octanylene, diazabicyclo[3.1.1]heptanylene, diazabicyclo[2.2.1]heptanylene, diazabicyclo[3.2.1]octanylene, diazabicyclo[2.2.2]octanylene, 3-azaspiro[5.5] Undecylidene, 8-azaspiro[4.5]decanylidene, 2-oxa-8-azaspiro[4.5]decanylidene, or 3-methyl-2-oxa-8-azaspiro[4.5]decanylidene, or Each ring W 2 Each independently optionally represented by m2 R c1 Group substitution, each R c1 Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogen, amino, hydroxy, mercapto, cyano, carboxyl, C 2-6 Alkynyl, C 2-6 Alkenyl, optionally deuterated C 3-6 Cycloalkyl, or R c4 -R c3 -, where R c3 is an optional substituted C 1-6 Alkylene or optionally substituted C 2-6 Alkenylene, R c4 Represents halogen, R c5 R c6 N-, hydroxy, carboxyl, ethynyl, or vinyl, where R c5 and R c6 The same or different and each independently represents hydrogen or C 1-3 Alkyl, and the C 1-6 The alkylene group and the C 2-6 Each alkenylene group is independently optionally substituted with one or more radicals selected from deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 The substituent of the alkoxy group is substituted, and m2 represents an integer of 0-20; Each ring W 3 are the same or different and each independently represent a 4- to 15-membered nitrogen-containing heterocyclic group, C 3-15 Cycloalkylene, 6- to 15-membered arylene, or 5- to 15-membered heteroarylene, for example, piperidinylene, piperazinylene, morpholinylene, azetidinylene, pyrrolidinylene, imidazolidinylene, pyrazolidinylene, oxazolidinylene, thiazolidinylene, thiomorpholinylene, azepanylene, diazepanylene, azacyclooctanylene, diazacyclooctanylene, azabicyclo[3.1.1]heptanylene, azabicyclo[2.2.1]heptanylene, azabicyclo[3.2.1]octanylene, azabicyclo[ 2.2.2] octanylidene, diazabicyclo[3.1.1]heptaneylidene, diazabicyclo[2.2.1]heptaneylidene, diazabicyclo[3.2.1]octanylidene, diazabicyclo[2.2.2]octanylidene, 3-azaspiro[5.5]undecaneylidene, 8-azaspiro[4.5]decaneylidene, 2-oxa-8-azaspiro[4.5]decaneylidene, 3-methyl-2-oxa-8-azaspiro[4.5]decaneylidene Heterospiro[4.5]decanedylene, cyclopropylene, cyclobutylene, cyclopentylene, cyclopentenylene, cyclohexylene, cyclohexenylene, cycloheptylene, cyclooctylene, decahydronaphthylene, octahydropentalenylene, octahydro-1H-indenylene, 2,3-dihydro-1H-indenylene, spirocyclylene, adamantylene, noradamantylene, norbornylene, phenylene, naphthylene, furylene, oxazolylene, isoxazolylene, oxadiazolylene, thienylene, thiazolylene, isothiazolylene, thiadiazolylene, pyrrolylene, imidazolylene, pyrazolylene, triazolylene, pyridinylene, pyrimidinylene, pyridazinylene, pyrazinylene, indolylene, isoindolylene, benzofuranylene, isobenzofuranylene, benzothienylene, Indazolylidene, benzimidazoleylidene, benzoxazolylidene, benzisoxazoleylidene, benzothiazolylidene, benzisothiazolylidene, benzotriazoleylidene, benzo[2,1,3]oxadiazoleylidene, benzo[2,1,3]thiadiazolylidene, benzo[1,2,3]thiadiazolylidene, quinolylene, isoquinolylene, naphthyridinylene, cinnolinylene, quinazolin ... Quinoxaline, phthalazine, pyrazolo[1,5-a]pyridinyl, pyrazolo[1,5-a]pyrimidinyl, imidazo[1,2-a]pyridinyl, 1H-pyrrolo[3,2-b]pyridinyl, 1H-pyrrolo[2,3-b]pyridinyl, pyrrolo[2,1-b]thiazolyl, or imidazo[2,1-b]thiazolyl, or Each ring W 3 Independently optionally m3 R c2 Group substitution, each R c2 Deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogen, amino, hydroxy, mercapto, cyano, carboxyl, C 2-6 Alkynyl, C 2-6 Alkenyl, optionally deuterated C 3-6 Cycloalkyl, or R c8 -R c7 -, where R c7 is an optional substituted C 1-6 Alkylene or optionally substituted C 2-6 Alkenylene, R c8 Represents halogen, R c9 R c10 N-, hydroxy, carboxyl, ethynyl, or vinyl, where R c9 and R c10 The same or different and each independently represents hydrogen or C 1-3 Alkyl, and the C 1-6 The alkylene group and the C 2-6 Each alkenylene group is independently optionally substituted with one or more deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 The substituent of the alkoxy group is substituted, and m3 represents an integer of 0-20.

7. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof as claimed in any one of claims 3 to 6, wherein R c Parts of the general formulas Represents the following groups: in, The groups are each independently optionally further substituted with one or more deuterated C 1-6 Alkyl, optionally halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogen, amino, hydroxy, mercapto, cyano, carboxyl, C 2-6 Alkynyl, C 2-6 Alkenyl, optionally deuterated C 3-6 Cycloalkyl, R c12 -R c11 , or any combination thereof, wherein R c11 is an optional substituted C 1-6 Alkylene or optionally substituted C 2-6 Alkenylene, R c12 Represents halogen, R c13 R c14 N-, hydroxy, carboxyl, ethynyl, or vinyl, where R c13 and R c14 The same or different and each independently represents hydrogen or C 1-3 Alkyl, the C 1-6 Alkylene and C 2-6 Each alkenylene group is independently optionally substituted with one or more radicals selected from deuterium, halogen, hydroxyl, mercapto, cyano, amino, nitro, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy or halogenated C 1-6 The substituents of the alkoxy group are substituted.

8. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof as claimed in any one of claims 3 to 6, wherein R c Represents the following groups: a key, -O-, -NHC(O)-*, -C(O)NH-*, -C(O)O-*, -OC(O)-*, -CH2C(O)O-*, -CH2OC(O)-*, -NH-, -N(CH3)-, -N(CH3)-(CH2)2-N(CH3)-*, -N(CH3)-(CH2)3-N(CH3)-*, -NH-(CH2)2-N(CH3)-*, -N(CH3)-(CH2)3-NH-*, -CH2-NHC(O)-*, -CH2-C(O)NH-*, -CH2-NH-*, -O-(CH2)2-N(CH3)-*, -O-(CH2)2-NH-*, or -CH2-N(CH3)-*, or in, The groups are each independently optionally further substituted with one or more selected from deuterium, C 1-6 Alkyl, deuterated C 1-6 Alkyl, halogenated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 The substituents are alkoxy, halogen, amino, hydroxy, mercapto, cyano, or any combination thereof; and the symbol * indicates the point of attachment to LIN.

9. The compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof as claimed in claim 1, wherein (i) Ring W in the structure of formula (ULM) 1 Indicates: C 6-20 Arylene or 5- to 20-membered monocyclic or bicyclic or polycyclic heteroarylene, the C 6-20 The arylene group and the 5- to 20-membered monocyclic or bicyclic or polycyclic heteroarylene group are each independently optionally substituted by m identical or different R a5 Substituted; preferably wherein the ring W 1 The following is optionally replaced by m identical or different R a5 Substituted groups: phenylene, naphthylene, furylene, oxazolylene, isoxazolylene, oxadiazolylene, thienylene, thiazolylene, isothiazolylene, thiadiazolylene, pyrrolylene, imidazolylene, pyrazolylene, triazolylene, pyridylene, pyrimidylene, pyridazinylene, pyrazinylene, indolylene, isoindolylene, benzofuranylene, isobenzofuranylene, benzothienylene, indazolylene, benzimidazolylene, benzoxazolylene, benzisoxazolylene, benzothiazolylene, benzisothiazolylene, benzotriazolylene, benzo[2,1, 3]oxadiazoleylidene, benzo[2,1,3]thiadiazolylidene, benzo[1,2,3]thiadiazolylidene, quinolinylene, isoquinolinylene, naphthyridinylene, cinnolinylene, quinazolinylene, quinoxalinylene, phthalazinylene, pyrazolo[1,5-a]pyridinylene, pyrazolo[1,5-a]pyrimidinylene, imidazo[1,2-a]pyridinylene, 1H-pyrrolo[3,2-b]pyridinylene, 1H-pyrrolo[2,3-b]pyridinylene, pyrrolo[2,1-b]thiazolylidene, or imidazo[2,1-b]thiazolylidene; Among them, each R a5 Each independently represents halogen, hydroxyl, mercapto, nitro, amino, cyano, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 2-6 Alkenyl, or C 2-6 alkynyl; and m represents an integer of 0, 1, 2, 3 or 4; and / or (ii) X in the structure of formula (ULM) represents a bond or -R b1 -N(R a6 )-R b2 -, where R a6 Represents hydrogen or C 1-6 Alkyl, and R b1 and R b2 Each independently represents an optionally substituted C 0-2 Alkylene, preferably wherein the optionally substituted C 0-2 The substituents of the alkylene group are optionally selected from deuterium, halogen, hydroxyl, mercapto, nitro, amino, cyano, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, deuterated C 1-6 Alkoxy, halogenated C 1-6 alkoxy or any combination thereof.

10. The compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof according to claim 1 or 9, wherein the ULM represents the structure of the following formula (ULM-1) or formula (ULM-2): Wherein A, R a1 、R a2 、R a3 、R a4 、(R a5 ) m 、R a6 、R b1 、R b2 and Ring W 1 As defined in claim 1 or 9, preferably wherein the ULM represents a structure of the formula:

11. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof according to any one of claims 1 to 10, wherein LIN represents: Methylene, which is optionally substituted by 1-2 independently selected from deuterium, hydroxyl, amino, thiol, nitro, halogen, cyano, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 cycloalkyl, 4- to 10-membered heterocyclic group, or any combination thereof; or Optionally substituted linear or branched C 2-15 Alkylene, wherein the linear or branched C 2-15 One or more groups selected from the following may be optionally inserted between any one or more pairs of adjacent carbon atoms of the main carbon chain skeleton of the alkylene group: a 、R b and any combination thereof, each group R a independently selected from O, C(O), OC(O), S, S(O), S(O)2, S(O)2N(R a7 )、N(R a7 )S(O)2、C(O)N(R a7 )、N(R a7 )C(O), N(R a7 ) and N(R a7 )C(O)N(R a7 ), where each R a7 Each independently represents H or C 1-3 Alkyl, and when the linear or branched C 2-15 There are two or more groups R inserted into the main carbon chain skeleton of the alkylene group a When each group R a are not directly connected to each other; and each group R b are independently selected from optionally substituted cycloalkylene (eg, optionally substituted C 3- 20 cycloalkylene), optionally substituted arylene (e.g., optionally substituted C 3-20 arylene), optionally substituted heterocyclylene (e.g., optionally substituted 4- to 20-membered heterocyclylene), optionally substituted heteroarylene (e.g., optionally substituted 5- to 20-membered heteroarylene), alkynylene (e.g., C 2-6 Alkyne), alkenylene (e.g. C 2-6 and any combination thereof, wherein the cycloalkylene, the arylene, the heterocyclylene and the heteroarylene are each independently optionally further selected from deuterium, hydroxyl, amino, thiol, nitro, halogen, cyano, oxo, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 cycloalkyl, 4- to 10-membered heterocyclic group and any combination thereof, and wherein the linear or branched C 2-15 One or more hydrogen atoms of the alkylene group may be further selected from deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, oxo, halo 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 The substituents are substituted by cycloalkyl, 4- to 10-membered heterocyclyl, and any combination thereof.

12. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof according to any one of claims 1 to 10, wherein LIN represents: -C 1-15 Alkylene-; -(C(R a8 )(R a9 )) n1 -(R a (C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(R a (C(R a10 )(R a11 )) n2 ) m1 -(R a (C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(R a (C(R a10 )(R a11 )) n2 ) m1 -(R a (C(R a12 )(R a13 )) n3 ) m2 -(R a (C(R a14 )(R a15 )) n4 ) m3 -; -(C(R a8 )(R a9 )) n1 -(R b (C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(R b (C(R a10 )(R a11 )) n2 ) m1 -(R b (C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(R b (C(R a10 )(R a11 )) n2 ) m1 -(R b (C(R a12 )(R a13 )) n3 ) m2 -(R b (C(R a14 )(R a15 )) n4 ) m3 -; -(C(R a8 )(R a9 )) n1 -(R a -R b -(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(R a (C(R a10 )(R a11 )) n2 ) m1 -(R b (C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(R b -R a -(C(R a10 )(R a11 )) n2 ) m1 -;or -(C(R a8 )(R a9 )) n1 -(R b (C(R a10 )(R a11 )) n2 ) m1 -(R a (C(R a12 )(R a13 )) n3 ) m2 -; in, Each group R a independently selected from O, C(O), OC(O), S, S(O), S(O)2, S(O)2N(R a7 )、N(R a7 )S(O)2、C(O)N(R a7 )、N(R a7 )C(O), N(R a7 ) and N(R a7 )C(O)N(R a7 ), where each R a7 Each independently represents H or C 1-3 Alkyl; each group R b are independently selected from optionally substituted cycloalkylene (eg, optionally substituted C 3-20 cycloalkylene), optionally substituted arylene (e.g., optionally substituted C 3-20 arylene), optionally substituted heterocyclylene (e.g., optionally substituted 4- to 20-membered heterocyclylene), optionally substituted heteroarylene (e.g., 5- to 20-membered heteroarylene), alkynylene (e.g., C 2-6 Alkyne), alkenylene (e.g. C 2-6 and any combination thereof, wherein the cycloalkylene, the arylene, the heterocyclylene and the heteroarylene are each independently optionally further selected from deuterium, hydroxyl, amino, thiol, nitro, halogen, cyano, oxo, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 substituted by cycloalkyl, 4- to 10-membered heterocyclic group, and any combination thereof; R a8 、R a9 、R a10 、R a11 、R a12 、R a13 、R a14 and R a15 Each independently represents H, deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, oxo, halo 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 Cycloalkyl, 4- to 10-membered heterocyclyl, and any combination thereof; and n1, n2, n3, n4, m1, m2, m3 are each independently selected from the integers 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; and The C 1-15 Any one or more hydrogen atoms of the alkylene group may be further replaced by a substituent selected from the group consisting of deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, oxo, halo, C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 cycloalkyl, 4- to 10-membered heterocyclic group, and any combination thereof.

13. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof as claimed in any one of claims 1 to 10, wherein the LIN represents a structure of the following formula: -(C(R a8 )(R a9 )) n1 -(O(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(O(C(R a10 )(R a11 )) n2 ) m1 -(O(C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(O(C(R a10 )(R a11 )) n2 ) m1 -(O(C(R a12 )(R a13 )) n3 ) m2 -(O(C(R a14 )(R a15 )) n4 ) m3 -; -(C(R a8 )(R a9 )) n1 -(N(R a7 )(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(N(R a7 )(C(R a10 )(R a11 )) n2 ) m1 -(N(R a7 )(C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(N(R a7 )(C(R a10 )(R a11 )) n2 ) m1 -(N(R a7 )(C(R a12 )(R a13 )) n3 ) m2 -(N(R a7 )(C(R a14 )(R a15 )) n4 ) m3 -; -(C(R a8 )(R a9 )) n1 -(C(O)N(R a7 )-(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(C(O)N(R a7 )-(C(R a10 )(R a11 )) n2 ) m1 -(C(O)N(R a7 )-(C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(C(O)N(R a7 )-(C(R a10 )(R a11 )) n2 ) m1 -(C(O)N(R a7 )-(C(R a12 )(R a13 )) n3 ) m2 -(C(O)N(R a7 )-(C(R a14 )(R a15 )) n4 ) m3 -; -(C(R a8 )(R a9 )) n1 -(C(O)N(R a7 )-(C(R a10 )(R a11 )) n2 ) m1 -(O-(C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -C(O)N(R a7 )-(C(R a10 )(R a11 )) n2 -(O(C(R a12 )(R a13 )) n3 ) m1 -; -(C(R a8 )(R a9 )) n1 -(N(R a7 )C(O)-(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(N(R a7 )C(O)-(C(R a10 )(R a11 )) n2 ) m1 -(O-(C(R a12 )(R a13 ))) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(N(R a7 )C(O)-(C(R a10 )(R a11 )) n2 ) m1 -(O-(C(R a12 )(R a13 )) n3 ) m2 -(O-(C(R a14 )(R a15 )) n4 ) m3 -; -(C(R a8 )(R a9 )) n1 -N(R a7 )C(O)-(C(R a10 )(R a11 )) n2 -(O(C(R a12 )(R a13 )) n3 ) m1 -; -(C(R a8 )(R a9 )) n1 -N(R a7 )C(O)N(R a7 )-(C(R a10 )(R a11 )) n2 -; -(C(R a8 )(R a9 )) n1 -C(O)-(C(R a10 )(R a11 )) n2 -; -(C(R a8 )(R a9 )) n1 -(arylene-(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(arylene-(C(R a10 )(R a11 )) n2 ) m1 -arylene-(C(R a12 )(R a13 )) n3 -; -(C(R a8 )(R a9 )) n1 -(Heterocyclylene-(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(Heterocyclylene-(C(R a10 )(R a11 )) n2 ) m1 -(Heterocyclylene-(C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(heteroarylene-(C(R a10 )(R a11 )) n2 ) m1 -; -(C(R a8 )(R a9 )) n1 -(heteroarylene-(C(R a10 )(R a11 )) n2 ) m1 -(heteroarylene-(C(R a12 )(R a13 )) n3 ) m2 -; -(C(R a8 )(R a9 )) n1 -(cycloalkylene-(C(R a10 )(R a11 )) n2 ) m1 -;or -(C(R a8 )(R a9 )) n1 -(cycloalkylene-(C(R a10 )(R a11 )) n2 ) m1 -(cycloalkylene-(C(R a12 )(R a13 )) n3 ) m2 -; in, Each R a7 independently represents H or C 1-3 alkyl; The cycloalkylene group (eg C 3-20 Cycloalkylene), the arylene group (such as C 3-20 arylene), the heterocyclylene (e.g., 4- to 20-membered heterocyclylene) and the heteroarylene (e.g., 5- to 20-membered heteroarylene) are each independently further selected from deuterium, hydroxyl, amino, thiol, nitro, halogen, cyano, oxo, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 substituted by cycloalkyl, 4- to 10-membered heterocyclic group, and any combination thereof; R a8 、R a9 、R a10 、R a11 、R a12 、R a13 、R a14 and R a15 Each independently represents H, deuterium, hydroxyl, amino, mercapto, nitro, halogen, cyano, oxo, halo 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 Cycloalkyl, 4- to 10-membered heterocyclyl, and any combination thereof; and n1, n2, n3, n4, m1, m2, m3 are each independently selected from the integers 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10.

14. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof as claimed in any one of claims 11 to 13, wherein LIN represents the following group: -CH2-、-(CH2)2-、-(CH2)3-、-(CH2)4-、-(CH2)5-、-(CH2)6-、-(CH2)7-、-(CH2)8-、-(CH2)9-、-(CH2) 10 -、-(CH2) 11 -、-(CH2) 12 -、-(CH2) 13 -、-(CH2) 14 -、-(CH2) 15 -;-CH2-O-CH2-、-CH2-O-(CH2)2-、-(CH2)1-O-(CH2)3-、-(CH2)1-O-(CH2)4-、-(CH2)1-O-(CH2)5-、-(CH2)1-O-(CH2)6-、-(CH2)1-O-(CH2)7-、-(CH2)1-O-(CH2)8-、-(CH2)1-O-(CH2)9-、-(CH2)1-O-(CH2) 10 -、-(CH2)2-O-(CH2)1-、-(CH2)2-O-(CH2)2-、-(CH2)2-O-(CH2)3-、-(CH2)2-O-(CH2)4-、-(CH2)2-O-(CH2)5-、-(CH2)2-O-(CH2)6-、-(CH2)2-O-(CH2)7-、-(CH2)2-O-(CH2)8-、-(CH2)2-O-(CH2)9-、-(CH2)2-O-(CH2) 10 -、-(CH2)3-O-(CH2)1-、-(CH2)3-O-(CH2)2-、-(CH2)3-O-(CH2)3-、-(CH2)3-O-(CH2)4-、-(CH2)3-O-(CH2)5-、-(CH2)3-O-(CH2)6-、-(CH2)3-O-(CH2)7-、-(CH2)4-O-(CH2)1-、-(CH2)4-O-(CH2)2-、-(CH2)4-O-(CH2)3-、-(CH2)4-O-(CH2)4-、-(CH2)4-O-(CH2)5-、-(CH2)4-O-(CH2)6-、-(CH2)5-O-(CH2)1-、-(CH2)5-O-(CH2)2-、-(CH2)5-O-(CH2)3-、-(CH2)5-O-(CH2)4-、-(CH2)5-O-(CH2)5-、- (CH2)6-O-(CH2)1-、-(CH2)6-O-(CH2)2-、-(CH2)6-O-(CH2)3-、-(CH2)6-O-(CH2)4-、-(CH2)7-O-(CH2)1-、-(CH2)7-O-(CH2)2-、-(CH2)7-O-(CH2)3-、-(CH2)8-O-(CH2)1-、-(CH2)8-O-(CH2)2-、-CH(CH3)-O-(C H2)1-、-CH(CH3)-O-(CH2)2-、-CH(CH3)-O-(CH2)3-、-CH(CH3)-O-(CH2)4-、-CH(CH3)-O-(CH2)5-、-CH(CH3)-O-(CH2)6-、-CH(CH3)-O-(CH2)7-、-CH(CH3)-O-(CH2)8-、-CH(CH3)-O-(CH2)9-、-CH(CH3)-O-(CH2) 10 -、-CH2-(O(CH2)2)2-、-CH2-(O(CH2)2)3-、-CH2-(O(CH2)2)4-、-CH2-(O(CH2)2)5-、-CH2-(O(CH2)2)6-、-CH2-(O(CH2)2)7-、-CH2-(O(CH2)2)1-OCH2-、-CH2-(O(CH2)2)2-OCH2-、-CH2-(O(CH2)2)3-OCH2-、-CH2-(O(CH2)2)4-OCH2-、-CH2-(O(CH2)2)5-OCH2-、-CH2-(O(CH2)2)6-OCH2-、-CH2-(O(CH2)2)7-OCH2-、-(CH2)2-(O(CH2)2)2-、-(CH2)2-(O(CH2)2)3-、-(CH2)2-(O(CH2)2)4-、-(CH2)2-(O(CH2)2)5-、-(CH2)2-(O(CH2)2)6-、-(CH2)2-(O(CH2)2)7-、-(CH2)3-(O(CH2)2)2-、-(CH2)3-(O(CH2)2)3-、-(CH2)3-(O(CH2)2)4-、-(CH2)3-(O(CH2)2)5-、-(CH2)3-(O(CH2)2)6-、-(CH2)3-(O(CH2)2)7-、-(CH2)4-(O(CH2)2)2-、-(CH2)4-(O(CH2)2)3-、-(CH2)4-(O(CH2)2)4-、-(CH2)4-(O(CH2)2)5-、-(CH2)4-(O(CH2)2)6-、-(CH2)4-(O(CH2)2)7-、-CH2-(O(CH2)3)2-、-CH2-(O(CH2)3)3-、-CH2-(O(CH2)3)4-、-(CH2)2-(O(CH2)3)2-、-(CH2)2-(O(CH2)3)3-、-(CH2)2-(O(CH2)3)4-、-(CH2)3-(O(CH2)3)2-、-(CH2)3-(O(CH2)3)3-、-(CH2)3-(O(CH2)3)4-、-CH2-O-(CH2)2-O-(CH2)3-、-CH2-(O(CH2)2)2-(O(CH2)3)2-、-CH2-(O(CH2)2)3-(O(CH2)3)3-、-CH2-(O(CH2)2)4-(O(CH2)3)4-、(CH2)2-O-(CH2)2-O-(CH2)3-、-(CH2)2-(O(CH2)2)2-(O(CH2)3)2-、-(CH2)3-O-(CH2)2-O-(CH2)3-、-(CH2)3-(O(CH2)2)2-(O(CH2)3)2-、-CH2-O-(CH2)3-O-(CH2)2-、-CH2-(O(CH2)3)2-(O(CH2)2)2-、-(CH2)2-O-(CH2)3-O-(CH2)2-、-(CH2)2-(O(CH2)3)2-(O(CH2)2)2-、-(CH2)3-O-(CH2)3-O-(CH2)2-、-(CH2)3-(O(CH2)3)2-(O(CH2)2)2-、-CH2-O-(CH2)2-O-CH2-、-(CH2)2-O-(CH2)2-O-CH2-、-(CH2)2-(O(CH2)2)2-O-(CH2)3-、-(CH2)2-(O(CH2)2)3-O-(CH2)3-、-(CH2)2-(O(CH2)2)4-O-(CH2)3-、-(CH2)5-(O(CH2)2)2-O-(CH2)5-、-(CH2)5-(O(CH2)2)2-O-(CH2)6-、-(CH2)1-N(R、 a7 )-(CH2)1-、-(CH2)1-N(R a7 )-(CH2)2-、-(CH2)1-N(R a7 )-(CH2)3-、-(CH2)1-N(R a7 )-(CH2)4-、-(CH2)1-N(R a7 )-(CH2)5-、-(CH2)1-N(R a7 )-(CH2)6-、-(CH2)1-N(R a7 )-(CH2)7-、-(CH2)1-N(R a7 )-(CH2)8-、-(CH2)1-N(R a7 )-(CH2)9-、-(CH2)1-N(R a7 )-(CH2) 10 -、-(CH2)2-N(R a7 )-(CH2)1-、-(CH2)2-N(R a7 )-(CH2)2-、-(CH2)2-N(R a7 )-(CH2)3-、-(CH2)2-N(R a7 )-(CH2)4-、-(CH2)2-N(R a7 )-(CH2)5-、-(CH2)2-N(R a7 )-(CH2)6-、-(CH2)2-N(R a7 )-(CH2)7-、-(CH2)2-N(R a7 )-(CH2)8-、-(CH2)2-N(R a7 )-(CH2)9-、-(CH2)2-N(R a7 )-(CH2) 10 -、-(CH2)3-N(R a7 )-(CH2)1-、-(CH2)3-N(R a7 )-(CH2)2-、-(CH2)3-N(R a7 )-(CH2)3-、-(CH2)4-N(R a7 )-(CH2)1-、-(CH2)4-N(R a7 )-(CH2)2-、-(CH2)4-N(R a7 )-(CH2)3-、-(CH2)4-N(R a7 )-(CH2)4-、-(CH2)5-N(R a7 )-(CH2)1-、-(CH2)5-N(R a7 )-(CH2)2-、-(CH2)5-N(R a7 )-(CH2)3-、-(CH2)5-N(R a7 )-(CH2)4-、-(CH2)5-N(R a7 )-(CH2)5-、-(CH2)6-N(R a7 )-(CH2)1-、-(CH2)6-N(R a7 )-(CH2)2-、-(CH2)6-N(R a7 )-(CH2)3-、-(CH2)7-N(R a7 )-(CH2)1-、-(CH2)7-N(R a7 )-(CH2)2-、-(CH2)7-N(R a7 )-(CH2)3-、-(CH2)8-N(R a7 )-(CH2)1-、-(CH2)8-N(R a7 )-(CH2)2-、-(CH2)8-N(R a7 )-(CH2)3-、-CH(CH3)-N(R a7 )-(CH2)1-、-CH(CH3)-N(R a7 )-(CH2)2-、-CH(CH3)-N(R a7 )-(CH2)3-、-CH(CH3)-N(R a7 )-(CH2)4-、-CH(CH3)-N(R a7 )-(CH2)5-、-CH(CH3)-N(R a7 )-(CH2)6-、-CH(CH3)-N(R a7 )-(CH2)7-、-CH(CH3)-N(R a7 )-(CH2)8-、-CH(CH3)-N(R a7 )-(CH2)9-、-CH(CH3)-N(R a7 )-(CH2) 10 -、-CH2C(O)NHCH2-、-(CH2)2C(O)NH(CH2)2-、- (CH2)2C(O)NH(CH2)3-, -(CH2)2C(O)NH(CH2)4-, -(CH2)2C(O)NH(CH2)5-, -(CH2)3C(O)NH(CH2)3-, -(CH2)3C(O)NH(CH2)4-, -(CH2)4C(O)NH(CH2)4 -, -(CH2)5C(O)NH(CH2)5-, -(CH2)6C(O)NH(CH2)7-, -(CH2)6C(O)NH(CH2)6-, -(CH2)7C(O)NH(CH2)7-, -(CH2)2C(O)NH(CH2)2-O-(CH2)2-, -CH2NHC (O)CH2-, -(CH2)2NHC(O)(CH2)2-, -(CH2)2NHC(O)(CH2)3-, -(CH2)2NHC(O)(CH2)4-, -(CH2)2NHC(O)(CH2)5-, -(CH2)3NHC(O)(CH2)3-, -(CH2)3NHC (O)(CH2)4-, -(CH2)4NHC(O)(CH2)4-, -(CH2)5NHC(O)(CH2)5-, -(CH2)6NHC(O)(CH2)7-, -(CH2)6NHC(O)(CH2)6-, -(CH2)7NHC(O)(CH2)7-, -(CH2)4 NHC(O)(CH2)8-, -(CH2)2NHC(O)(CH2)2-O-(CH2)2-, -(CH2)4NHC(O)CH2-, -CH2-phenylene-CH2-, -CH2-phenylene-(CH2)2-, -CH2-phenylene-(CH2)3-, -CH2-phenylene-(CH2)4-, -CH2-phenylene-(CH2)5-, -CH2-phenylene-(CH2)6-, -CH2-phenylene-(CH2)7-, -CH2-phenylene-(CH2)8-, -(CH2)2-phenylene-(CH2)1-, -(CH2)2-phenylene-(CH2)2-, -(CH2)2-phenylene -(CH2)3-, -(CH2)2-phenylene-(CH2)4-, -(CH2)2-phenylene-(CH2)5-, -(CH2)2-phenylene-(CH2)6-, -(CH2)2-phenylene-(CH2)7-, -(CH2)2-phenylene-(CH2)8-, -(CH2)3-phenylene-CH2-, -(CH2)3-phenylene-(CH2)2-, -(CH2)3-phenylene-(CH2)3-, -(CH2)3-phenylene-(CH2)4-, -(CH2)3-phenylene-(CH2)5-, -(CH2)3-phenylene-(CH2)6-, -(CH2)3-phenylene-(CH2)7-,-(CH2)3-phenylene-(CH2)8-, -(CH2)4-phenylene-CH2-, -(CH2)4-phenylene-(CH2)2-, -(CH2)4-phenylene-(CH2)3-, -(CH2)4-phenylene-(CH2)4-, -(CH2)4-phenylene-(CH2)5-, -(CH2)4-phenylene-(CH2)6-, -(CH2)4-phenylene-(CH2)7-, -(CH2)4-phenylene-(CH2)8-, -(CH2)5- Phenylene-(CH2)1-, -(CH2)5-phenylene-(CH2)2-, -(CH2)5-phenylene-(CH2)3-, -(CH2)5-phenylene-(CH2)4-, -(CH2)5-phenylene-(CH2)5-, -(CH2)5-phenylene-(CH2)6-, -(CH2)5-phenylene-(CH2)7-, -(CH2)5-phenylene-(CH2)8-, -(CH2)6-phenylene-(CH2)1-, -(CH2)6-phenylene-(CH2) H2)2-, -(CH2)6-phenylene-(CH2)3-, -(CH2)6-phenylene-(CH2)4-, -(CH2)6-phenylene-(CH2)5-, -(CH2)6-phenylene-(CH2)6-, -(CH2)6-phenylene-(CH2)7-, -(CH2)6-phenylene-(CH2)8-, -(CH2)7-phenylene-(CH2)1-, -(CH2)7-phenylene-(CH2)2-, -(CH2)7-phenylene-(CH2)3-, -(CH2)7-phenylene-(CH2)4-, -(CH2)7-phenylene-(CH2)8-, -(CH2)8-phenylene-CH2-, -(CH2)8-phenylene-(CH2)2-, -(CH2)8-phenylene-(CH2)3-, -(CH2)8-phenylene-(CH2)4-, -(CH2)8-phenylene-(CH2)5-, -(CH2)8-phenylene-(CH2)6-, -(CH2)8-phenylene-(CH2)7-, -CH2-N(R, a7 )-CH2-phenylene-CH2-, -CH2-N(R a7 )-CH2-phenylene-(CH2)2-, -CH2-N(R a7 )-CH2-phenylene-(CH2)3-, -CH2-N(R a7 )-CH2-phenylene-(CH2)4-, -CH2-N(R a7 )-CH2-phenylene-(CH2)5-, -CH2-N(R a7 )-CH2-phenylene-(CH2)6-, -CH2-N(R a7 )-CH2-phenylene-(CH2)7-, -CH2-N(R a7 )-CH2-phenylene-(CH2)8-, -CH2-N(R a7 )-(CH2)2-phenylene-CH2-, -CH2-N(R a7 )-(CH2)2-phenylene-(CH2)2-, -CH2-N(R a7 )-(CH2)2-phenylene-(CH2)3-, -CH2-N(R a7 )-(CH2)2-phenylene-(CH2)4-, -CH2-N(R a7 )-(CH2)2-phenylene-(CH2)5-, -CH2-N(R a7 )-(CH2)2-phenylene-(CH2)6-, -CH2-N(R a7 )-(CH2)2-phenylene-(CH2)7-, -CH2-N(R a7 )-(CH2)2-phenylene-(CH2)8-, -(CH2)2-N(R a7 )-CH2-phenylene-CH2-, -(CH2)2-N(R a7 )-CH2-phenylene-(CH2)2-, -(CH2)2-N(R a7 )-CH2-phenylene-(CH2)3-, -(CH2)2-N(R a7 )-CH2-phenylene-(CH2)4-, -(CH2)2-N(R a7 )-CH2-phenylene-(CH2)5-, -(CH2)2-N(R a7 )-CH2-phenylene-(CH2)6-, -(CH2)2-N(R a7 )-CH2-phenylene-(CH2)7-, -(CH2)2-N(R a7 )-CH2-phenylene-(CH2)8-, -(CH2)3-N(R a7 )-CH2-phenylene-CH2-, -(CH2)3-N(R a7 )-CH2-phenylene-(CH2)2-, -(CH2)3-N(R a7 )-CH2-phenylene- (CH2)3-、-(CH2)3-N(R a7 )-CH2-phenylene-(CH2)8-, -(CH2)4-N(R a7 )-CH2-phenylene-CH2-, -(CH2)4-N(R a7 )-CH2-phenylene-(CH2)2-, -(CH2)4-N(R a7 )-CH2-phenylene-(CH2)3-、-(CH2)4-N(R a7 )-CH2-phenylene-(CH2)8-, -(CH2)5-N(R a7 )-CH2-phenylene-(CH2)3-, -(CH2)5-N(R a7 )-CH2-phenylene-(CH2)8-, -(CH2)6-N(R a7 )-CH2-phenylene-(CH2)3-、-(CH2)6-N(R a7 )-CH2-phenylene-(CH2)8-, -(CH2)7-N(R a7 )-CH2-phenylene-(CH2)3-, -(CH2)8-N(R a7 )-CH2-phenylene-CH2-, -(CH2)8-N(R a7 )-CH2-phenylene-(CH2)2-, -(CH2)8-N(R a7 )-CH2-phenylene-(CH2)3-, -(CH2)8-N(R a7 )-CH2-phenylene-(CH2)4-、-(CH2)8-N(R a7 )-CH2-phenylene-(CH2)5-, -(CH2)8-N(R a7 )-CH2-phenylene-(CH2)6-, -CH2-piperidinylene-CH2-, -CH2-piperidinylene-(CH2)2-, -CH2-piperidinylene-(CH2)3-, -CH2-piperidinylene-(CH2)4-, -CH2-piperidinylene-(CH2)5-, -CH2-piperidinylene-(CH2)6-, -CH2-piperidinylene-(CH2)7-, -CH2-piperidinylene-(CH2)8-, -(CH2)2-piperidinylene-(CH2)1-, -(CH2)2-piperidinylene-(CH2)2-, -(CH2)2-piperidinylene-(CH2)3-, -(CH2)2-piperidinylene-(CH2)4-, -(CH2 )2-piperidinylene-(CH2)5-, -(CH2)2-piperidinylene-(CH2)6-, -(CH2)2-piperidinylene-(CH2)7-, -(CH2)2-piperidinylene-(CH2)8-, -(CH2)3-piperidinylene-CH2-, -(CH2)3-piperidinylene-(CH2)2-, -(CH2)3-piperidinylene-(CH2)3-, -(CH2)3-piperidinylene-(CH2)4-, -(CH2)3-piperidinylene-(CH2)5-, -(CH2)3-piperidinylene-(CH2)6-, -(CH2)3-piperidinylene-(CH2)7-, -(CH2)3-piperidinylene-(CH2)8-, -(CH 2)4-piperidinylene-CH2-, -(CH2)4-piperidinylene-(CH2)2-, -(CH2)4-piperidinylene-(CH2)3-, -(CH2)4-piperidinylene-(CH2)4-, -(CH2)4-piperidinylene-(CH2)5-, -(CH2)4-piperidinylene-(CH2)6-, -(CH2)4-piperidinylene-(CH2)7-, -(CH2)4-piperidinylene-(CH2)8-, -(CH2)5-piperidinylene-(CH2)1-, -(CH2)5-piperidinylene-(CH2)2-, -(CH2)5-piperidinylene-(CH2)3-, -(CH2)5-piperidinylene-(CH2)4-, -(C H2)5-piperidinylene-(CH2)5-, -(CH2)5-piperidinylene-(CH2)6-, -(CH2)5-piperidinylene-(CH2)7-, -(CH2)5-piperidinylene-(CH2)8-, -(CH2)6-piperidinylene-(CH2)1-, -(CH2)6-piperidinylene-(CH2)2-, -(CH2)6-piperidinylene-(CH2)3-, -(CH2)6-piperidinylene-(CH2)4-, -(CH2)6-piperidinylene-(CH2)5-, -(CH2)6-piperidinylene-(CH2)6-, -(CH2)6-piperidinylene-(CH2)7-, -(CH2)6-piperidinylene-(CH2)8-,-(CH2)7-piperidinylene-(CH2)1-, -(CH2)7-piperidinylene-(CH2)2-, -(CH2)7-piperidinylene-(CH2)3-, -(CH2)7-piperidinylene-(CH2)4-, -(CH2)7-piperidinylene-(CH2)8-, -(CH2)8-piperidinylene-CH2-, -(CH2)8-piperidinylene-(CH2)2-, -(CH2)8-piperidinylene-(CH2)3-, -(CH2)8-piperidinylene-(CH2)4-, -(CH2)8-piperidinylene-(CH2)5-, -(CH2)8-piperidinylene-(CH2)6-, -(CH2)8-piperidinylene-(CH2)7-, -CH2-N(R, a7 )-CH2-piperidinyl-CH2-, -CH2-N(R a7 )-CH2-piperidinyl-(CH2)2-, -CH2-N(R a7 )-CH2-piperidinyl-(CH2)3-, -CH2-N(R a7 )-CH2-piperidinyl-(CH2)4-, -CH2-N(R a7 )-CH2-piperidinyl-(CH2)5-, -CH2-N(R a7 )-CH2-piperidinyl-(CH2)6-, -CH2-N(R a7 )-CH2-piperidinyl-(CH2)7-, -CH2-N(R a7 )-CH2-piperidinyl-(CH2)8-, -CH2-N(R a7 )-(CH2)2-piperidinyl-CH2-, -CH2-N(R a7 )-(CH2)2-piperidinyl-(CH2)2-, -CH2-N(R a7 )-(CH2)2-piperidinyl-(CH2)3-, -CH2-N(R a7 )-(CH2)2-piperidinyl-(CH2)4-, -CH2-N(R a7 )-(CH2)2-piperidinyl-(CH2)5-, -CH2-N(R a7 )-(CH2)2-piperidinyl-(CH2)6-, -CH2-N(R a7 )-(CH2)2-piperidinyl-(CH2)7-, -CH2-N(R a7 )-(CH2)2-piperidinyl-(CH2)8-, -(CH2)2-N(R a7 )-CH2-piperidinyl-CH2-, -(CH2)2-N(R a7 )-CH2-piperidinyl-(CH2)2-, -(CH2)2-N(R a7 )-CH2-piperidinyl-(CH2)3-, -(CH2)2-N(R a7 )-CH2-piperidinyl-(CH2)4-, -(CH2)2-N(R a7 )-CH2-piperidinyl-(CH2)5-, -(CH2)2-N(R a7 )-CH2-piperidinyl-(CH2)6-, -(CH2)2-N(R a7 )-CH2-piperidinyl-(CH2)7-, -(CH2)2-N(R a7 )-CH2-piperidinyl-(CH2)8-, -(CH2)3-N(R a7 )-CH2-piperidinyl-CH2-, -(CH2)3-N(R a7 )-CH2-piperidinyl-(CH2)2-, -(CH2)3-N(R a7 )-CH2-piperidinyl-(CH2)3-, -(CH2)3-N(R a7 )-CH2-piperidinylene- (CH2)8-、-(CH2)4-N(R a7 )-CH2-piperidinyl-CH2-, -(CH2)4-N(R a7 )-CH2-piperidinyl-(CH2)2-, -(CH2)4-N(R a7 )-CH2-piperidinyl-(CH2)3-, -(CH2)4-N(R a7 )-CH2-piperidinyl-(CH2)8-, -(CH2)5-N(R a7 )-CH2-piperidinyl-(CH2)3-, -(CH2)5-N(R a7 )-CH2-piperidinyl-(CH2)8-, -(CH2)6-N(R a7 )-CH2-piperidinyl-(CH2)3-, -(CH2)6-N(R a7 )-CH2-piperidinyl-(CH2)8-, -(CH2)7-N(R a7 )-CH2-piperidinyl-(CH2)3-, -(CH2)8-N(R a7 )-CH2-piperidinyl-CH2-, -(CH2)8-N(R a7 )-CH2-piperidinyl-(CH2)2-, -(CH2)8-N(R a7 )-CH2-piperidinyl-(CH2)3-, -(CH2)8-N(R a7 )-CH2-piperidinyl-(CH2)4-、-(CH2)8-N(R a7 )-CH2-piperidinyl-(CH2)5-, -(CH2)8-N(R a7 )-CH2-piperidinylene-(CH2)6-, -CH2-piperazinylene-CH2-, -CH2-piperazinylene-(CH2)2-, -CH2-piperazinylene-(CH2)3-, -CH2-piperazinylene-(CH2)4-, -CH2-piperazinylene-(CH2)5-, -CH2-piperazinylene-(CH2)6-, -CH2-piperazinylene-(CH2)7-, -CH2-piperazinylene-(CH2)8-, -(CH2)2-piperazinylene-(CH2)1-, -(CH2)2-piperazinylene-(CH2)2-, -(CH2)2-piperazinylene-(CH2)3-, -(CH2)2-piperazinylene-(CH2)4-, -(CH 2)2-Piperazinylene-(CH2)5-, -(CH2)2-Piperazinylene-(CH2)6-, -(CH2)2-Piperazinylene-(CH2)7-, -(CH2)2-Piperazinylene-(CH2)8-, -(CH2)3-Piperazinylene-CH2-, -(CH2)3-Piperazinylene-(CH2)2-, -(CH2)3-Piperazinylene-(CH2)3-, -(CH2)3-Piperazinylene-(CH2)4-, -(CH2)3-Piperazinylene-(CH2)5-, -(CH2)3-Piperazinylene-(CH2)6-, -(CH2)3-Piperazinylene-(CH2)7-, -(CH2)3-Piperazinylene-(CH2)8-, -(CH 2)4-Piperazinylene-CH2-, -(CH2)4-Piperazinylene-(CH2)2-, -(CH2)4-Piperazinylene-(CH2)3-, -(CH2)4-Piperazinylene-(CH2)4-, -(CH2)4-Piperazinylene-(CH2)5-, -(CH2)4-Piperazinylene-(CH2)6-, -(CH2)4-Piperazinylene-(CH2)7-, -(CH2)4-Piperazinylene-(CH2)8-, -(CH2)5-Piperazinylene-(CH2)1-, -(CH2)5-Piperazinylene-(CH2)2-, -(CH2)5-Piperazinylene-(CH2)3-, -(CH2)5-Piperazinylene-(CH2)4-, -(C H2)5-piperazinylene-(CH2)5-, -(CH2)5-piperazinylene-(CH2)6-, -(CH2)5-piperazinylene-(CH2)7-, -(CH2)5-piperazinylene-(CH2)8-, -(CH2)6-piperazinylene-(CH2)1-, -(CH2)6-piperazinylene-(CH2)2-, -(CH2)6-piperazinylene-(CH2)3-, -(CH2)6-piperazinylene-(CH2)4-, -(CH2)6-piperazinylene-(CH2)5-, -(CH2)6-piperazinylene-(CH2)6-, -(CH2)6-piperazinylene-(CH2)7-, -(CH2)6-piperazinylene-(CH2)8-,-(CH2)7-piperazinylene-(CH2)1-, -(CH2)7-piperazinylene-(CH2)2-, -(CH2)7-piperazinylene-(CH2)3-, -(CH2)7-piperazinylene-(CH2)4-, -(CH2)8-piperazinylene-CH2-, -(CH2)8-piperazinylene-(CH2)2-, -(CH2)8-piperazinylene-(CH2)3-, -(CH2)8-piperazinylene-(CH2)4-, -(CH2)8-piperazinylene-(CH2)5-, or -(CH2)8-piperazinylene-(CH2)6-; Among them, each R a7 independently represents H or C 1-3 alkyl; The phenylene, the piperazinyl and the piperidinyl are each independently further selected from deuterium, hydroxyl, amino, thiol, nitro, halogen, cyano, oxo, C 1-6 Alkyl, halogenated C 1-6 Alkyl, deuterated C 1-6 Alkyl, C 1-6 Alkoxy, halogenated C 1-6 Alkoxy, C 3-6 Cycloalkyl, halogenated C 3-6 Cycloalkyl, deuterated C 3-6 The substituents are substituted by cycloalkyl, 4- to 10-membered heterocyclic group, and any combination thereof.

15. A compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof according to claim 1, which is also represented by the following formula (I-1), formula (I-2), formula (I-3), formula (I-4), formula (I-5), formula (I-6), formula (I-7), formula (I-8-1), formula (I-8-2), formula (I-8-3), formula (I-8-4), formula (I-9), formula (I-10), formula (I-11), formula (I-12), formula (I-13), formula (I-14), formula (I-15), formula (I-16), formula (I-17), formula (I-18), formula (I-19) , formula (I-20-1), formula (I-20-2), formula (I-20-3), formula (I-20-4), formula (I-21-1), formula (I-21- 2), formula (I-22), formula (I-23), formula (I-24), formula (I-25-1), formula (I-25-2), formula (I-26), formula (I- 27), formula (I-28), formula (I-29), formula (I-30), formula (I-31), formula (I-32), formula (I-33), formula (I-34- 1), formula (I-34-2), formula (I-35), formula (I-36), formula (I-37), formula (I-38), formula (I-39-1), formula (I- 39-2), formula (I-40), formula (I-41), formula (I-42), formula (I-43), formula (I-44), formula (I-45), formula (I-46), formula (I-47), formula (I-48), formula (I-49), formula (I-50), formula (I-51), formula (I-52), formula (I-53), formula (I-54), or formula (I-55) represents the structure: where A, R a1 , R a2 , R a3 , R a4 , X, ring W 1 , (R a5 ) m , LIN, R c , (R 1a ) p1a , R 1b , (R 1c ) p1b , R 1d , (R 2a ) p2a , (R 2b ) p2b , R 2c , (R 3a ) p3a , R 3b , R 4a , R 4b , (R 4c ) p4a , R 5a , R 5b , ring A, ring B, ring C, R 7a , (R 7b ) p7a , R 8a , R 8b , (R 8c ) p8a , R 8d , R 8e , X1, X2, X3, R 9a , R 9b , (R 9c ) p9a , (R 9d ) p9b , X4, X5, X6, X7, (R 10a ) p10a , (R 10b ) p10b , R 10c , R 10d , (R 11a ) p11a , R 11b , R 11c , R 12a , R 12b , (R 12c ) p12a , R 12d , X8, X9, X 10 , X 11 , X 12 , (R 13a ) p13a , (R 14a ) p14a 、R 14b 、(R 15a ) p15a 、(R 15b ) p15b 、R 16a 、(R 16b ) p16a 、(R 16c ) p16b 、(R 17a ) p17a 、R 17b 、(R 18a ) p18a 、(R 18b ) p18b 、R 19a 、R 19b 、(R 19c ) p19a 、(R 19d ) p19b 、R 20a 、R 20b 、R 20c 、R 20d 、(R 20e ) p20a 、R 21a 、R 21b 、(R 21c ) p21a 、R 21d 、R 22a 、R 22b 、ring E, R 23a 、R 23b 、(R 24a ) p24a 、(R 24b ) p24b 、y, (R 25a ) p25a 、R 25b 、R 25c 、R 25d 、R 25e 、R 25f 、R 25g 、R 25i 、R 26a 、R 26b 、(R 26c ) p26a 、R 27a 、R 27b 、R 27c 、R 27d 、R 28a 、(R 28b ) p28a 、R 28c 、R 28d 、(R 28e ) p28b 、R 29a 、R 29b 、R 29c 、R 29d 、R 29e 、R 30a 、R 30b 、R 30c 、R 30d 、(R 30e ) p30a 、R 31a 、R 31b 、R 31c 、R 31d 、(R 31e ) p31a 、(R 31f ) p31b 、ring F、(R 32a ) p32a 、(R 32b ) p32b 、R 32c 、R 32d 、R 32e 、(R 33a ) p33a 、(R 33b ) p33b 、R 33c 、R 33d 、(R 33e ) p33c 、X 13 、X 14 、X 15 、ring G、R 34a 、R 34b 、R 34c 、(R 34d ) p34a 、(R 34e ) p34b 、X 16 、X 17 、X 18 、(R 35a ) p35a 、R 35b 、(R 35c ) p35b 、(R 36a ) p36a 、(R 36b ) p36b 、 (R 37a ) p37a 、(R 37b ) p37b 、(R 38a ) p38a 、R 38b 、R 38c 、R 38d 、R 39a 、R 39b 、R 39c 、R 39d 、y1、(R 40a ) p40a 、R 41a 、R x3 、R 41b 、R 41c 、(R 41d ) p41a 、(R 42a ) p42a 、R 42b 、(R 42c ) p42b 、(R 43a ) p43a 、R 43b 、ring H、R 44a 、R 44b 、R 44c 、R 44d 、(R 44e ) p44a 、(R 44f ) p44b 、(R 44g ) p44c 、(R 45a ) p45a 、(R 45b ) p45b 、R c1 、R 46a 、(R 46b ) p46a 、(R 46c ) p46b 、R 47a 、R 47b 、R 47c 、(R 47d ) p47a 、(R 47e ) p47b 、(R 47f ) p47c 、ring I、R 48a 、R 48b 、R 48c 、(R 48d ) p48a 、R 48e 、R 48f 、R 49a 、R 49b 、(R 49c ) p49a 、(R 49d ) p49b 、Ring J、(R 50a ) p50a 、R 50b 、(R 51a ) p51a 、(R 51b ) p51b 、(R 51c ) p51c 、(R 52a ) p52a 、(R 52b ) p52b 、(R 52c ) p52c 、(R 52d ) p52d 、(R 52e ) p52e 、R 52f 、(R 53a ) p53a 、(R 53b ) p53b 、R 53c 、(R 54a ) p54a 、(R 54b ) p54b 、(R 55a ) p55a 、R 55b 、R 55c and R 55d As defined in claim 3.

16. A compound of formula (I) according to claim 1 or a salt, enantiomer, stereoisomer, solvate, isotopically enriched analog, prodrug or polymorph thereof, selected from: N-(2-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)ethyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(4-(2,6-dioxopiperidin-3-yl)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(3-(2,6-dioxopiperidin-3-yl)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(2,6-dioxopiperidin-3-yl)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; N-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)-4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-carboxamide; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(2,6-dioxopiperidin-3-yl)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(3-(2,6-dioxopiperidin-3-yl)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(2-(2,6-dioxopiperidin-3-yl)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(2-chloro-3-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((2S)-5-amino-1-(2-chloro-3-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenoxy)-5-oxopentan-2-yl)carbamoyl)-3-methyl-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; ((2-(((5S,8S,10aR)-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-3-((1-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)methyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazaoctatetraen-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid; 6-(1-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(1-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((4-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((3-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((2-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((4-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((3-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-((2-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 6-(4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)-2-(4-phenoxyphenyl)nicotinamide; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluorophenyl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluorophenyl)piperidine-2,6-dione; 3-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluorophenyl)piperidine-2,6-dione; 3-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluorophenyl)piperidine-2,6-dione; 3-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluorophenyl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluorophenyl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluorophenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluorophenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluorophenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluorophenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluorophenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluorophenyl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluorophenyl)amino)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridazin-3-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridazin-3-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-4-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridazin-4-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridazin-4-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-4-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrazin-2-yl)piperidine-2,6-dione; 3-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrazin-2-yl)piperidine-2,6-dione; 3-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-2-yl)piperidine-2,6-dione; 3-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-4-yl)piperidine-2,6-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-4-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridazin-4-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridazin-4-yl)dihydropyrimidine-2,4(1H,3H)-dione 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-4-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrazin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrazin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-4-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((3-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-3-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-2-fluoropyridin-3-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridin-2-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-6-fluoropyridin-2-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridazin-3-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-4-fluoropyridazin-3-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-4-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-5-fluoropyridazin-4-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)-3-fluoropyridazin-4-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-4-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrazin-2-yl)amino)piperidine-2,6-dione; 3-((6-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrazin-2-yl)amino)piperidine-2,6-dione; 3-((4-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyridazin-3-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-2-yl)amino)piperidine-2,6-dione; 3-((5-((4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)methyl)pyrimidin-4-yl)amino)piperidine-2,6-dione; 3-(4-(((3R,4S)-4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3-fluoropiperidin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((3R,4S)-4-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3-fluoropiperidin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-((4-(1-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluorobenzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluorobenzyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; (R)-3-((4-(1-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperidin-4-yl)phenyl)amino)-5-(3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; 3-((4-(1-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide; 3-(4-((4-(4-(1,2-bis(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-(1,2-bis(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-(1,2-bis(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-(1,2-bis(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-(1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-(1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-(1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-(1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-(1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-(1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-(1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-(1,2-bis(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-(1,2-bis(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-(1,2-bis(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-chloro-1,2-di(4-hydroxyphenyl)but-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-chloro-1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-Fluoro-4-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-Fluoro-4-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((4-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(3-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(1-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(1-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-((4-(1-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-((4-(1-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(1-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-fluoro-4-((4-(1-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-((4-(1-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-fluoro-4-((4-(1-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-fluoro-4-((4-(1-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(1-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(1-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((3-((4-(1-(4-((1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(1-(4-((1S,2R)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(2-fluoro-4-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-fluoro-4-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(1-(4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-Fluoro-4-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-Fluoro-4-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((4-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-((3S,4R)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-((3R,4S)-7-hydroxy-3-phenylchroman-4-yl)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(3-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-fluoro-4-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(3-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-fluoro-4-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(1-(4-(7-hydroxy-3-phenylchroman-4-yl)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((1-(3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(3-(6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((3-((3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)thio)-2-chlorophenyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(3-(3-amino-5-(4-amino-4-methylpiperidin-1-yl)pyrazin-2-yl)-2-chlorophenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((((3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-((3-amino-5-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)pyrazin-2-yl)thio)pyridin-2-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)piperidine-2,6-dione; 3-(4-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)piperidine-2,6-dione; 3-(2-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)piperidine-2,6-dione; 1-(4-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((2,3-difluoro-6-(2-morpholinothiazol-4-yl)phenoxy)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)piperidine-2,6-dione; 3-(3-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)piperidine-2,6-dione; 3-(2-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)piperidine-2,6-dione; 1-(4-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-fluoro-4-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-fluoro-4-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(2-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-4-(methylsulfonyl)phenoxy)methyl)phenyl)amino)piperidine-2,6-dione; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)nicotinamide; N-((1r,3r)-3-(3-chloro-4-cyanophenoxy)-2,2,4,4-tetramethylcyclobutyl)-6-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)nicotinamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluorobenzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazine-3-carboxamide; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluorobenzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(4-((5-(3,5-dimethylisoxazol-4-yl)-2-methylphenyl)((1-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)methyl)amino)phenyl)cyclopropane-1-carbonitrile; 1-(5-((4-chloro-2-(7-chloro-5-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)phenoxy)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-chloro-2-(7-chloro-5-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-chloro-2-(7-chloro-5-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)phenoxy)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 3-(4-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(6-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(6-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)pyridazin-3-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-4,9-dihydro-3H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(1-(4-((9-cyclopentyl-8-(phenylamino)-9H-purin-2-yl)amino)phenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-fluoro-4-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(3-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-Fluoro-4-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-nitrophenyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; N-(2-((2-((4-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((3-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((2-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluorobenzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-(((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-(((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((4-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((3-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; N-(2-((2-((2-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide; 3-(4-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)-2-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluorobenzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)propoxy)quinazolin-6-yl)acrylamide; 3-(4-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-(((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)piperidine-2,6-dione; (S)-1-(4-(((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; (S)-1-(4-(((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; (S)-1-(3-(((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; (S)-1-(2-(((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; (S)-1-(6-(((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; (S)-1-(6-(((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; (S)-1-(4-(((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)methyl)phenyl)amino)piperidine-2,6-dione; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)but-2-enamide; (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)but-2-enamide; 3-(4-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(4-((5-bromo-4-((5-(dimethylphosphono)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((5-bromo-4-((5-(dimethylphosphono)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(4-((5-bromo-4-((5-(dimethylphosphono)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((5-bromo-4-((5-(dimethylphosphono)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(4-((5-bromo-4-((5-(dimethylphosphono)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(4-((5-bromo-4-((5-(dimethylphosphono)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphono)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(1-(4-((5-bromo-4-((5-(dimethylphosphonyl)quinoxalin-6-yl)amino)pyrimidin-2-yl)amino)-5-methoxy-2-methylphenyl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 2-(7-((4-(2,6-dioxopiperidin-3-yl)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((3-(2,6-dioxopiperidin-3-yl)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((2-(2,6-dioxopiperidin-3-yl)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-(((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-(((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((4-((2,6-dioxopiperidin-3-yl)amino)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((3-((2,6-dioxopiperidin-3-yl)amino)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(7-((2-((2,6-dioxopiperidin-3-yl)amino)benzyl)amino)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((4-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((3-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((2-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,6-dioxopiperidin-3-yl)-2-fluoropyridin-3-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((4-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((3-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-((2-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6-(6-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)pyridazin-3-yl)-1-oxoisoindolin-2-yl)-2-(5-fluoro-2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2-(2,6-dioxopiperidin-3-yl)pyridin-4-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,6-dioxopiperidin-3-yl)pyridin-2-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,6-dioxopiperidin-3-yl)pyridin-3-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,6-dioxopiperidin-3-yl)-2-fluoropyridin-3-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-5-fluoropyridin-4-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((6-(2,4-pyrrolo[1,2-c]imidazol-1(2H)-yl)pyridin-3-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 1-(5-((4-(4-(2-(1-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(thiazol-2-ylamino)ethyl)-7-fluoro-3-oxoisoindolin-5-yl)phenyl)piperazin-1-yl)methyl)-6-fluoropyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyrazin-2-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2-((2,6-dioxopiperidin-3-yl)amino)pyridin-3-yl)methyl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(4-(2,6-dioxopiperidin-3-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(3-(2,6-dioxopiperidin-3-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(2-(2,6-dioxopiperidin-3-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1S,4S)-5-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(4-(2,6-dioxopiperidin-3-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(3-(2,6-dioxopiperidin-3-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(2-(2,6-dioxopiperidin-3-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((2-(2,6-dioxopiperidin-3-yl)pyridin-4-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((2-(2,6-dioxopiperidin-3-yl)-5-fluoropyridin-4-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,6-dioxopiperidin-3-yl)pyridin-2-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,6-dioxopiperidin-3-yl)pyridin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,6-dioxopiperidin-3-yl)-2-fluoropyridin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluoropyridin-2-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-5-fluoropyridin-4-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluoropyridin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyrazin-2-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyrazin-2-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-((1R,4R)-5-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(4-(2,6-dioxopiperidin-3-yl)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(3-(2,6-dioxopiperidin-3-yl)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(2-(2,6-dioxopiperidin-3-yl)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(8-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)-3,8-diazabicyclo[3.2.1]octan-3-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((4-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((3-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2-(2,6-dioxopiperidin-3-yl)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)pyridin-4-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-5-fluoropyridin-4-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,6-dioxopiperidin-3-yl)pyridin-2-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,6-dioxopiperidin-3-yl)pyridin-3-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-3-fluoropyridin-2-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-5-fluoropyridin-4-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluoropyridin-3-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyrazin-2-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyrazin-2-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((4-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((3-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((2-((2,6-dioxopiperidin-3-yl)amino)benzyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(((2-((2,6-dioxopiperidin-3-yl)amino)pyridin-3-yl)methyl)(methyl)amino)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)piperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperazin-1-yl)-3,3-difluoropiperidin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(3-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(2-(2,6-dioxopiperidin-3-yl)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-3-yl)methyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)piperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,6-dioxopiperidin-3-yl)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,6-dioxopiperidin-3-yl)-3-fluorobenzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(3-(2,6-dioxopiperidin-3-yl)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(2-(2,6-dioxopiperidin-3-yl)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-fluorobenzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(2-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-((5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-2-yl)methyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-((6-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridazin-3-yl)methyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-((3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)pyridin-4-yl)methyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(4-((2,6-dioxopiperidin-3-yl)amino)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(3-((2,6-dioxopiperidin-3-yl)amino)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(6-(4-(4-(1-(2-((2,6-dioxopiperidin-3-yl)amino)benzyl)-3,3-difluoropiperidin-4-yl)piperazin-1-yl)phenyl)-4-fluoro-1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetamide; 3-(4-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-((4-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperazin-1-yl)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(4-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 3-(2-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)piperidine-2,6-dione; 1-(4-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-ethyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 3-((4-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((3-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-((2-(((1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)(methyl)amino)methyl)phenyl)amino)piperidine-2,6-dione; 3-(4-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(4-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)-2-fluorophenyl)piperidine-2,6-dione; 3-(3-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 3-(2-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)piperidine-2,6-dione; 1-(4-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(4-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)-3-fluorophenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(3-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(2-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-3-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(5-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)pyridin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione; 1-(6-((4-(1-(6-((2-(1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-1-isopropyl-1H-pyrazolo[4,3-c]pyridin-3-yl)piperidin-4-yl)piperazin-1-yl)methyl)pyridazin-3-yl)dihydropyrimidine-2,4(1H,3H...

Citation Information

Cited By

  • Compound and application thereof

    CN117126133A

  • A compound and uses thereof

    CN117126133B

  • Compound for targeted degradation of ALK protein as well as preparation method and application of compound

    CN120025316A